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Background: The majority of stroke patients are discharged home dependent on informal caregivers, usually
family members, to provide assistance with activities of daily living (ADL), including bathing, dressing
and toileting. Many caregivers feel unprepared for this role and this may have a detrimental effect on both
the patient and caregiver.
Objective: To evaluate whether or not a structured, competency-based training programme for caregivers
[the London Stroke Carer Training Course (LSCTC)] improved physical and psychological outcomes for
patients and their caregivers after disabling stroke, and to determine if such a training programme is
cost-effective.
Design: A pragmatic, multicentre, cluster randomised controlled trial.
Setting: Stratiﬁed randomisation of 36 stroke rehabilitation units (SRUs) to the intervention or control group
by geographical region and quality of care.
Participants: A total of 930 stroke patient and caregiver dyads were recruited. Patients were eligible if they
had a conﬁrmed diagnosis of stroke, were medically stable, were likely to return home with residual
disability at the time of discharge and had a caregiver available, willing and able to provide support after
discharge. The caregiver was deﬁned as the main person – other than health, social or voluntary care
provider – helping with ADL and/or advocating on behalf of the patient.
Intervention: The intervention (the LSCTC) comprised a number of caregiver training sessions and
competency assessment delivered by SRU staff while the patient was in the SRU and one recommended
follow-up session after discharge. The control group continued to provide usual care according to national
guidelines. Recruitment was completed by independent researchers and participants were unaware
of the SRUs' allocation.
Main outcome measures: The primary outcomes were self-reported extended ADL for the patient and
caregiver burden measured at 6 months after recruitment. Secondary outcomes included quality of life,
mood and cost-effectiveness, with ﬁnal follow-up at 12 months.v
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ABSTRACT
viResults: No differences in primary outcomes were found between the groups at 6 months. Adjusted mean
differences were –0.2 points [95% conﬁdence interval (CI) –3.0 to 2.5 points; p=0.866; intracluster
correlation coefﬁcient (ICC)=0.027] for the patient Nottingham Extended Activities of Daily Living score and
0.5 points (95% CI –1.7 to 2.7 points; p=0.660; ICC=0.013) for the Caregiver Burden Scale. Furthermore,
no differences were detected in any of the secondary outcomes. Intervention compliance varied across the
units. Half of the participating centres had a compliance rating of >60%. Analysis showed no evidence of
higher levels of patient independence or lower levels of caregiver burden in the SRUs with better levels of
intervention compliance. The economic evaluation suggests that from a patient and caregiver perspective,
health and social care costs, societal costs and outcomes are similar for the intervention and control groups at
6 months, 12 months and over 1 year.
Conclusions: We have conducted a robust multicentre, cluster randomised trial, demonstrating for the ﬁrst
time that this methodology is feasible in stroke rehabilitation research. There was no difference between
the LSCTC and usual care with respect to improving stroke patients' recovery, reducing caregivers' burden, or
improving other physical and psychological outcomes, nor was it cost-effective compared with usual care.
Compliance with the intervention varied, but analysis indicated that a dose effect was unlikely. It is possible
that the immediate post-stroke period may not be the ideal time for the delivery of structured training.
The intervention approach might be more relevant if delivered after discharge by community-based teams.
Trial registration: Current Controlled Trials ISRCTN49208824.
Funding: This project was funded by the MRC and is managed by the NIHR (project number 09/800/10) on
behalf of the MRC–NIHR partnership, and will be published in full in Health Technology Assessment; Vol. 17,
No. 46. See the NIHR Journals Library website for further project information.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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Stroke is the commonest cause of severe disability in the community. After discharge from hospital many
patients will require continuing help with activities of daily living (ADL), such as moving, bathing, dressing
and toileting. This help is often provided by informal caregivers. This burden of care, however, has an
important effect on caregivers' well-being, with nearly half of caregivers reporting health problems and
two-thirds a decline in social life, and there are high self-reported levels of strain.
Reducing the burden of caregiving after stroke may not only improve the caregiver's health but may also
enhance the recovery and adjustment of the stroke patient. A Cochrane review has examined the
effectiveness of interventions for caregivers of stroke survivors in reducing caregiver burden or enhancing
caregiver well-being. This review concluded that, at present, it is not possible to determine the usefulness
of any existing interventions. In the Cochrane review, the intervention identiﬁed as having the most potential
to beneﬁt both caregivers and patients was a caregiver training programme designed and evaluated by
Kalra et al. in a London stroke unit (Kalra L, Evans A, Perez I, Melbourn A, Patel A, Knapp M, et al. Training
care givers of stroke patients: randomised controlled trial. BMJ 2004;328:1099–101). The intervention
was the London Stroke Carer Training Course (the LSCTC), a training programme for caregivers, which
included training on knowledge and skills essential for the day-to-day care of disabled stroke survivors.
The results of the study suggested that providing caregivers with the LSCTC was associated with a signiﬁcant
reduction in health-care costs, caregiver burden, and a signiﬁcant improvement in caregiver and patient
mood and health-related quality of life. However, generalisability was limited because the training
programme was tested in a single hospital, delivered by the team who were responsible for developing the
intervention and who might be expected to have heightened motivation and expertise, and the patient
population was predominantly recruited from a middle-class suburban area that might be more responsive to
a training programme.
The aim of the TRACS (Training Caregivers After Stroke) trial was to assess the effectiveness of the LSCTC
once embedded in usual practice in stroke units across the UK, thereby testing wider generalisability in
settings in which the population, health and social care provision differ.Objectives
The primary patient objective of the trial was to determine whether or not the provision of the LSCTC
improves functional independence in extended ADL for patients after disabling stroke. The primary caregiver
objective was to determine whether or not the provision of the LSCTC reduces burden for caregivers of
patients after disabling stroke. The secondary objectives were to determine whether the provision of the
LSCTC was (1) associated with improved physical and psychological outcomes for patients after disabling
stroke; (2) associated with improved physical and psychological outcomes for caregivers of patients after
disabling stroke; and (3) cost-effective.Methods
The TRACS trial was a pragmatic, multicentre, cluster randomised controlled trial.xiii
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SCIENTIFIC SUMMARY
xivSetting
Thirty-six stroke rehabilitation units (SRUs) participated in TRACS in four geographical regions in the UK. SRUs
were eligible to participate if they met four out of ﬁve key criteria used to deﬁne a stroke unit, as suggested
by the Royal College of Physicians of London for the National Sentinel Stroke Audit (NSSA) 2006.Randomisation
The unit of randomisation was the SRU. SRUs were randomised on a 1 :1 basis to either the intervention or
the control group. The randomisation was stratiﬁed by geographical region and quality of care (deﬁned as
being on and above, or below, the median on the key 12-indicator score of the 2006 NSSA). Block
randomisation was used to ensure that these important covariates were balanced between the arms of
the trial.Intervention
Stroke rehabilitation units randomised to the intervention group were required to incorporate the LSCTC as a
part of their usual care, so that every eligible caregiver received this training. The LSCTC consists of
14 training components (six mandatory) that were identiﬁed as important knowledge/skills that caregivers
would need to be able to care for the stroke patient after discharge home. The LSCTC was delivered to
caregivers while the patient was an inpatient in the SRU, with one recommended ‘follow through’ session
provided in person or by telephone after hospital discharge. A key component of the LSCTC was the
requirement for the multidisciplinary team (MDT) to check the caregiver's competency on each of the training
components delivered and to ‘sign off’ the competency as achieved. Training would continue until the
caregiver was deemed competent (or until it was agreed by the MDT that the caregiver was unable to
become competent). This permitted the level of training to be both individualised to the caregiver and
standardised across the SRUs.Control
Stroke rehabilitation units randomised to the control group were asked to continue usual practice, providing
care based on the National Clinical Guidelines for stroke.Participants
Patients were eligible for TRACS if they had a conﬁrmed primary diagnosis of new stroke, weremedically stable,
were likely to return home with residual disability, and had a caregiver available, willing and able to
provide support after discharge. The caregiver was deﬁned as the main person, other than health, social or
voluntary care provider, helping with ADL and/or advocating on behalf of the patient. Patient and caregiver
dyads were excluded if the patient was in need of palliative care, if discharge was planned within 1 week
of admission to the SRU, or if the patient or caregiver were registered to the trial on a previous admission.
Patients and caregivers in both arms of the study consented to data collection and questionnaire
completion. Participant recruitment and baseline assessments were undertaken by researchers independent
of the clinical MDT. Eligible patients and caregivers in the intervention arm received the LSCTC as a part
of standard care, whether or not they consented to the study procedures. Participants were blinded to
the SRUs allocation, and the MDT staff in each SRU were not informed of the patients/caregivers who
had consented to study procedures.Outcome measures
The primary patient outcome was functional independence, measured at 6 months using the Nottingham
Extended Activities of Daily Living (NEADL) scale. The primary caregiver outcome was caregiver burden,
measured at 6 months using the Caregiver Burden Scale (CBS). Secondary patient outcomes included
self-report measures of mood [Hospital Anxiety and Depression Scale (HADS)], health state [EuroQol
5-dimension health-state measure: European Quality of Life-5 Dimensions (EQ-5D)], ADL (Barthel Index),
functional ability and health-related quality of life [Stroke Impact Scale (SIS)], death, hospital readmission
and institutionalisation, all measured at both 6 and 12 months after recruitment, and with the NEADL
scale at 12 months.NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta17460 HEALTH TECHNOLOGY ASSESSMENT 2013 VOL. 17 NO. 46Secondary caregiver outcomes included self-report measures of social restriction [Frenchay Activities Index
(FAI)]; mood (HADS); health state (EQ-5D); death; hospitalisation and institutionalisation at 6 and 12 months,
and caregiver burden (CBS) at 12 months.
The TRACS trial also assessed the cost-effectiveness and cost–utility of the LSCTC for both patients and
caregivers from health and social care and societal perspectives. Costs were combined with the NEADL score
and quality-adjusted life-years (QALYs) for patients and the CBS and QALYs for caregivers. Resource use
was measured using the self-completed Client Service Receipt Inventory. Hospital records were checked for
patient hospital readmissions and caregiver hospital admissions at 6 and 12 months post registration.Sample size
The original target recruitment was 900 patient and caregiver dyads, 25 dyads from each of the 36 SRUs.
The sample size calculations assumed a clinically relevant six-point difference in the patient primary outcome
measure (NEADL). Thirty-six SRUs, each recruiting 25 patients, would result in 450 patients in each
group and provide close to 90% power at 5% signiﬁcance level to detect the clinically relevant difference of
six points on the NEADL score. A sample size of 900 patients provides more than 85% power at the 5%
signiﬁcance level to detect an effect size of one-third in any of the other outcomes. The power of the trial
was adversely affected, however, by a higher than expected loss to follow-up and unequal cluster sizes.
By estimating maximum and minimum cluster sizes, the predicted imbalance decreased the power by 1–3%.
To preserve ﬁnal power of 90%, the trial sample size was increased to between 950 and 1000 patient
and caregiver dyads, with a maximum of 35 dyads from each of the 36 SRUs to compensate for
low recruitment at some centres.Results
In total, 930 patients were registered between February 2008 and February 2010, of whom 928 patients and
their caregivers provided consent to the trial (450 LSCTC, 478 control).
No evidence of a clinical or statistical difference was found between the groups in the patient primary
outcome at 6 months measured by the NEADL scale [adjusted mean score in intervention 27.4, in control
27.6, difference –0.2 points, 95% conﬁdence interval (CI) –3.0 to 2.5 points; p-value=0.866; adjusted
intracluster correlation coefﬁcient (ICC)=0.027].
Similarly, no evidence of a clinical or statistical difference was found between the groups in the caregivers'
primary outcome at 6 months, measured by the CBS (adjusted mean score in intervention 45.5, in control
45.0, difference 0.5 points, 95% CI –1.7 to 2.7 points; p-value=0.660, adjusted ICC=0.013).
In terms of other physical and psychological outcomes for patients, no differences between the two groups of
patients were found in any of the secondary end points at 6 months: anxiety (HADS) [adjusted mean score in
intervention 6.7, in control 6.6, difference 0.1 points (95% CI –0.5 to 0.7 points, p-value=0.629, adjusted
ICC=0)], depression (HADS) [adjusted mean score in intervention 7.3, in control 7.2, difference 0.1 points
(95% CI –0.5 to 0.7 points; p-value=0.759; adjusted ICC=0)], ADLs (Barthel Index) [adjusted mean score in
intervention 14.2, in control 14.1, difference 0.1 points (95% CI –0.6 to 0.7 points; p-value=0.825; adjusted
ICC=0)], health state (EQ-5D) (adjusted mean score in intervention 0.441, in control 0.443, difference
–0.002 points; p-value=0.946; adjusted ICC=0) or SIS physical domain [adjusted mean score in intervention
52.7, in control 52.0, difference 0.7 points (95% CI –2.3 to 3.7 points; p-value=0.641; adjusted ICC=0.001).
At 12 months, no differences between patient groups were found in extended ADLs (NEADL), anxiety
(HADS), depression (HADS), ADLs (Barthel Index), health state (EQ-5D) or SIS physical domain.
Comparison of caregiver self-reported outcomes at 6 months detected no differences between the two
groups in anxiety (HADS) [adjusted mean score in intervention 7.0, in control 7.5, difference –0.5 pointsxv
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xvi(95% CI –1.2 to 0.1 points; p-value=0.084; adjusted ICC=0.016)], depression (HADS) [adjusted mean score
in intervention 5.2, in control 5.5, difference –0.3 points, 95% (CI –0.9 to 0.3 points; p-value=0.308;
adjusted ICC=0.013)], social restriction (FAI) [adjusted mean score in intervention 31.4, in control 32.2,
difference –0.8 points (95% CI –1.82 to 0.26 points; p-value=0.136; adjusted ICC=0)] or health state
(EQ-5D) (adjusted mean score in intervention 0.777, in control 0.790, difference –0.014 points;
p-value=0.358; adjusted ICC=0).
Similarly, analysis of caregiver self-reported outcomes at 12 months found no differences between the
groups in burden experienced by caregivers (CBS), anxiety (HADS), depression (HADS), social restriction (FAI)
or health state (EQ-5D).
Thus, overall there is no evidence that the LSCTC improves patients' physical or psychological outcomes
following stroke at 6 and 12 months, and there is no evidence that it reduces caregivers' burden or improves
their physical or psychological outcomes.
Intervention compliance, as assessed by completed and returned caregiver training records, varied across the
units; half of the participating centres had a compliance rating of >60%. Compliance analysis shows no
evidence of higher levels of patient independence or lower levels of caregiver burden in the SRUs with better
levels of intervention compliance.
Patients in both groups had similar length of stay for the initial stroke admission, and patients and
caregivers had similar total health and social care and societal costs at all assessment points. Total LSCTC
development and staff training costs were £102,577. When applied to intervention group individuals
proportionately to the amount of caregiver training received, this resulted in a mean cost of £39 per
patient/caregiver dyad. There were no signiﬁcant differences in patient or caregiver QALYs. For patients
and caregivers, probabilities of cost-effectiveness based on QALYs were low.Conclusions
We have conducted a robust multicentre cluster randomised trial: the world's largest completed stroke
rehabilitation trial. The sample size of 930 patients and caregiver dyads is far greater than any study
previously reported. We have demonstrated for the ﬁrst time that this methodology can feasibly be
implemented in stroke rehabilitation research. The intervention evaluated had reported beneﬁts in a previous
single-centre evaluation but these beneﬁts have not been replicated in this large, multicentre trial. There was
no difference between the LSCTC and usual care with respect to improving stroke patients' recovery,
reducing caregivers' burden or improving other physical and psychological outcomes, nor is it cost-effective
when compared with usual care.
Training in the intervention was provided at national training days during which materials were provided to
support cascade training to other members of the multidisciplinary stroke team. This had variable success and
has implications for the implementation of other service changes. Compliance with the intervention varied
across stroke units but analysis demonstrated no link between the degree of compliance and associated
patient or caregiver outcomes, indicating that a dose effect is unlikely. The LSCTC provided a structured
framework for caregiver training. It is possible that the immediate post-stroke period, when potential
caregivers are coming to terms with their new situation, may not be the ideal time for the delivery of
structured training. The intervention approach might be more relevant if delivered after discharge by
community-based teams.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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Stroke remains a major health problem in the 21st century, with incidence rates of 1.65 per 1000population for ﬁrst-ever strokes.1 After the recommended hospital admission, most patients are
discharged home with some residual disability.2 There is considerable reliance on informal caregivers, usually
family members, to provide assistance with activities of daily living (ADL), including bathing,
dressing, and toileting after hospital discharge.3 For some, this informal care avoids or delays admission to
institutional care, and the economic value of the informal care provided is considerable.4 Indeed, it is
suggested that the economic costs of informal care total £2.4B annually, almost equivalent to the
hospital and social care costs that total £2.8B annually.5
This burden of care also has an important effect on caregivers' physical and psychosocial well-being,6 with up
to 48% of caregivers reporting health problems, two-thirds a decline in social life7 and high self-reported
levels of strain. With the current emphasis on shorter hospital stays, caregivers will play an increasingly
important role in the care and continued rehabilitation of patients after stroke. The successful adjustment of
patients and their caregivers to the aftermath of stroke is clearly interlinked. Caregivers have an important
role in enhancing patients' rehabilitation, and coping strategies that lead to negative experiences are
associated with increasing dependence.8 The caregivers of patients with poor physical and emotional states
often have poor emotional outcomes themselves.9 Effective interventions directed at caregivers of stroke
patients are essential, as they may not only improve their own health but may also improve the recovery and
adjustment of the stroke patient.10 However, despite the physical, psychological and social consequences of
caregiving, its economic cost to society and its importance in patient recovery, caregivers' central role is often
given low priority in the management of stroke.11Previous researchA range of systematic reviews of qualitative7,12 and quantitative13 stroke literature have conﬁrmed
the diversity, complexity and frequency of problems faced by patients and caregivers during recovery
from, and adjustment to, a disabling stroke. A Cochrane review has summarised the effectiveness of
non-pharmacological interventions for caregivers of stroke survivors in reducing caregiver burden or
enhancing caregiver well-being.14 In eight randomised controlled trials (RCTs) involving 1007 participants,
interventions evaluated were categorised as support and information provision;15–18 caregiver training
programme;19 and psychoeducational.20–24 Three of these studies were inpatient interventions;15,17,19 one was
started as inpatient and crossed over into the community,21 two were conducted post discharge in the
non-acute phase,18,22 and the location of delivery of two was unclear,16,20 although participants were
recruited as inpatients. The comparator in six of the studies was usual care,15–19,21 one study used a crossover
wait list design20 and one study used written information on stress management.22
Only one study – the caregiver training programme19 – was seen to have a signiﬁcant effect on reducing
caregiver burden. The combined results of the support and information provision,15–18 and the
psychoeducational20–22 interventions revealed no impact on caregiver burden.
A number of secondary outcomes were examined by the studies. Two studies (one support and information
provision16 and one psychoeducational20) assessed global measures of stress or distress, and revealed no
signiﬁcant beneﬁt of the intervention over usual care. One study (caregiver training programme19) assessed
anxiety, and the analysis conducted by the reviewers revealed no signiﬁcant effect of the intervention on
caregiver anxiety. Of the ﬁve studies measuring depression,16,18–21 only the caregiver training programme19
was seen to have a signiﬁcant beneﬁcial effect. Three studies15,16,19 (the caregiver training programme19
and two support and information provision interventions15,16) assessed health-related quality of life. The
caregiver training programme19 demonstrated a signiﬁcant improvement in the intervention group, one
support and information provision study showed no signiﬁcant beneﬁt,15 and the second support and1
© Queen's Printer and Controller of HMSO 2013. This work was produced by Forster et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided
that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to:
NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
INTRODUCTION
2information provision study16 showed signiﬁcant improvements in 5 out of 8 SF-36 health domains. The
review authors conclude that, with limited available studies the caregiver training programme19 was the most
promising intervention. However, the evidence for this was from one single-centre RCT.19
The conclusions of the Cochrane review support the ﬁndings of earlier reviews of stroke caregiver
interventions:10,23,24 that previous studies have methodological limitations; further robust evaluation is
required; and the effects of caregiver interventions on the patient also need to be assessed.
In the Cochrane review, the caregiver training programme,19 which included education and some practical
‘hands-on’ skills training, was identiﬁed as having the most potential to beneﬁt both caregivers and patients.
This is supported by evidence from our Cochrane review of information provision (n=17 trials), which
concluded that stroke education programmes improve patient and carer knowledge of stroke, aspects of
patient satisfaction, and reduce patient depression scores.25,26 There was also some evidence that education
interventions that actively involve patients and carers and include planned follow-up for clariﬁcation and
reinforcement are likely to be more successful than simply providing information.25,26 Furthermore, caregivers
have identiﬁed the information and skills training required to implement physical care as their most
important pre-discharge needs.27 Although caregiver support is a key component of stroke unit care,
caregivers report that there are missed opportunities for structured skills training prior to the stroke patients
discharge,28 and that support, as currently provided, is not compatible with their expressed needs, and their
ability to care is not assessed.10,27Caregiver training programmeLiterature searches conducted by the authors prior to publication of the Cochrane review on the
effectiveness of caregiver interventions identiﬁed no effective early training programmes for caregivers of
patients after stroke, other than the caregiver training programme evaluated by Kalra et al.19 in an
individually randomised single-centre study. This intervention – the London Stroke Carers Training Course
(LSCTC) – was a systematic and structured training programme for caregivers, which included assessment in
competencies in skills essential for the day-to-day management of disabled stroke survivors. The LSCTC was
based on a survey among stroke caregivers, asking them to identify major problems experienced after
hospital discharge. Although many reported satisfaction with involvement in discharge planning, most found
themselves unprepared for the task of providing ‘hands-on’ care at home. The components of the LSCTC
were therefore devised to address the knowledge and skills required to effectively care for stroke patients on
discharge from hospital.
The single-centre study participants were 300 patients and caregivers admitted to a stroke rehabilitation
unit in south London, UK.19 Patients and caregivers were block randomised to receive either usual care or
the LSCTC prior to discharge home. The primary outcome was the cost to health and social services
during the ﬁrst year of stroke. Total health and social care costs over 1 year were signiﬁcantly lower in the
intervention group, with a mean difference of £4043.29 This cost difference was largely due to a shorter
length of stay for patients in the intervention group than in the control group. There was no difference in
quality-adjusted life-years (QALYs) in caregivers.29 Signiﬁcant secondary outcomes for caregivers
receiving the intervention included a reduction in caregiver burden (as measured by the Caregiver Burden
Scale; CBS30), improved quality of life [EuroQol 5-dimension health-state measure: European Quality of
Life-5 Dimensions (EQ-5D) visual analogue scale31] and mood [Hospital Anxiety and Depression Scale
(HADS)32]. There was no signiﬁcant difference in social activity levels [Frenchay Activities Index (FAI)33]. For
the patients whose caregivers had received the training, there was a signiﬁcant improvement in quality of
life (EQ-5D visual analogue scale) and mood (HADS). No signiﬁcant differences were seen in patients'
physical recovery (Barthel Index34 and modiﬁed Rankin Scale35), mortality or institutionalisation.19NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta17460 HEALTH TECHNOLOGY ASSESSMENT 2013 VOL. 17 NO. 46Justiﬁcation for the current studyThere were important limitations to the generalisability of the ﬁndings of the study of Kalra et al.19 The
LSCTC was tested in a single centre, delivered by the LSCTC development team, who might be expected to
have heightened motivation and expertise, and the patient population was predominantly recruited from a
middle-class suburban area, and might be more responsive to a training and education programme. In
addition, having demonstrated beneﬁt for caregivers on a range of domains, it was important to evaluate the
effectiveness of the LSCTC programme on improving patient outcomes. The aim of the TRACS (Training
Caregivers after Stroke) trial was to assess the effectiveness of the LSCTC on patient outcomes (once
embedded in usual practice) in stroke units across the UK, thereby testing wider generalisability in settings in
which the population, health and social care provision differ.3
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Carers Training CourseDevelopment of the modiﬁed London Stroke Carers
Training CourseThe LSCTC consists of 14 core caregiver competencies that required training and testing. These
competencies were important knowledge/skills that informal caregivers would need to be able to care
effectively for the stroke patient on discharge home, for example demonstrating understanding of what a
stroke is; knowledge of the patient-speciﬁc problems associated with stroke (which may be related to
speech, mobility, memory, diet and swallowing, vision and reading, washing and dressing, transfer and
walking); knowledge of how to manage and provide support for personal ADLs, including continence
management if required. Modiﬁcation of the LSCTC was required for the multicentre TRACS trial to allow the
intervention to be implemented in different NHS settings, and by members of the stroke rehabilitation
units' (SRUs') multidisciplinary teams (MDTs) with a range of skills and expertise. The LSCTC was modiﬁed
and a training programme for staff was developed by the original LSCTC MDT (AM, MW and JS), based
on what had worked in the single-centre study and what could be transferred to other settings. The modiﬁed
LSCTC maintained the original structure of 14 core competencies; six of the training components were
listed as mandatory, requiring the MDT to train all caregivers on these items, and the remaining eight
components were to be completed as appropriate dependent on each individual patient's ability and their
caregiver's needs. A full description of the 14 training components is provided in Table 1. To facilitate
replicable delivery, a training manual was created, which described in detail the objective of each training
component and recommendations on how to deliver the information/training, resources available (i.e.
relevant stroke association information leaﬂets), and suggested ways to assess the caregivers competency
(verbal/observations, etc.). A summary of the underpinning principles was also provided; for example,
training should be individualised to the caregivers at the required level and should be based on the needs of
the patient. Further modiﬁcations were made following pilot use of the modiﬁed LSCTC by the SRUs
randomised to the intervention.London Stroke Carers Training Course Caregiver training recordTo support the training and standardisation of delivery of the LSCTC, a structured training record was
created, which listed the 14 training components and provided a section to indicate whether or not that
particular component was mandatory/appropriate for the individual carer. If mandatory/appropriate, the
component could be ticked off once the training had been given, and the caregiver's competency could be
signed off once assessed. A further section allowed documentation of the total time taken to deliver
the training. On the ﬁnal page, space was provided to document progress of training and so the record acted
as a work in progress throughout the patient's stay and a way of communicating training progress and
ongoing needs throughout the team. For each caregiver the MDT staff were asked to complete a
training record. A copy of the training record can be seen in Appendix 1.
Training of the intervention
Two training sessions were provided for the SRUs randomised to deliver the LSCTC. The training days
were delivered by the original LSCTC development team and were held over 2 days, 1 month apart.
The same sessions were repeated twice; once in Leeds for the Yorkshire and North West centres and once in
London for the London and the South East and South West Peninsula centres. The aim of the ﬁrst5
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ABLE 1 The London Stroke Carers Training Course training components
The caregiver has demonstrated a knowledge and understanding of:
1 His/her relative having had a stroke (mandatory)
2 What a stroke is (mandatory)
3 His/her relative's speciﬁc stroke-related problems. Possible incomplete recovery and residual unresolved problems:
(a) Communication and reading
(b) Cognition
(c) Personality and mood changes
(d) Diet and swallowing
(e) Vision
(f) Personal ADL
(g) Transfers and mobility
(as appropriate)
4 The importance of a healthy lifestyle and secondary preventions:
(a) Control of blood pressure
(b) Use of aspirin/warfarin or similar
(c) Smoking
(d) Appropriate diet, including prevention of excess weight gain
(e) Exercise
(f) Pain management
(mandatory)
5 Dietary needs and feeding techniques:
(a) Special diet
(b) Techniques to assist eating, including use of specialist equipment if necessary
(as appropriate)
6 How to communicate with dysphasic relative (as appropriate)
7 How to manage relative's personal washing, dressing, toiletry needs (as appropriate)
8 The importance of limb positioning and the management of pressure areas and skin integrity (as appropriate)
9 Continence management (as appropriate)
10 Bowel management, ﬂuid and dietary intake for the prevention of constipation (as appropriate)
11 Appropriate techniques and ability in:
(a) Safe transfers
(b) Safely assisting mobility
(c) Floor routine following a fall
(d) Safely assisting in climbing stairs
(e) Good use of a wheelchair
(f) Use of aids
(as appropriate)
12 The importance of compliance with medication (including supervision of self-medication or routine medication)
(mandatory)
13 Post-discharge arrangements and where and whom to seek help from after discharge (mandatory)
14 Adapting the knowledge and skills taught to the home environment following discharge (follow-up visit or telephone
call) (mandatory)
THE INTERVENTION: THE LONDON STROKE CARERS TRAINING COURSE
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DOI: 10.3310/hta17460 HEALTH TECHNOLOGY ASSESSMENT 2013 VOL. 17 NO. 46training day was to ensure that the MDTs delivering the LSCTC were clear about what they needed to deliver
to the caregivers, and to consider how best to implement the training within their local unit. The day
covered, through presentations and group workshops, the background to the LSCTC, the training
components and suggested delivery and use of the training records (see Appendix 2). This training day was
ﬁlmed and provided the basis for a training CD to be used to cascade the training to all staff on the
SRUs. Staff were provided with the training manual (see Appendix 3).
After the ﬁrst session, the attendees were required to cascade the LSCTC training to the rest of the MDT on
their SRUs. The LSCTC was then piloted on a small number of caregivers on each SRU, including
completion of the training record. A second training day was held approximately 1 month later. This session
allowed open discussion on possible reﬁnement of delivery of the LSCTC by the MDT and modiﬁcation
of the training manual and records (see Appendix 2). After this meeting the LSCTC was gradually
implemented as a part of standard practice on the SRUs. All centres then received a visit from the TRACS trial
manager who used the completed training records as a basis for discussions on structure and process.
Further local training sessions were arranged if necessary to provide feedback and support, and discuss any
problems with LSCTC provision. The programme was then delivered for a duration of 24 months
while the TRACS trial recruitment took place.Training attendeesThe TRACS team suggested that at least two key MDT members from each of the 18 intervention
centres attended the initial training days. In practice, 1–13 members from each centre attended, with an
average of three attendees per centre. The attendees came from a range of disciplines, primarily senior
physiotherapists, senior occupational therapists and senior nurses, but also included Band 5 nurses,
consultant physicians and senior speech and language therapists. The attendees were identiﬁed as ‘TRACS
champions,’ who had responsibility to cascade the intervention within their site.
All centres were offered a local refresher course by the TRACS trial manager midway through the trial in
September–October 2008. In total, 13 out of 18 centres received this refresher training; four centres said
that they were completing the LSCTC successfully and did not require further training [three such centres did
have good return rates of the training records, one centre (294) had not yet returned the records so
compliance could not be assessed]. One centre remained non-compliant and refused further training.
As the TRACS trial recruitment period was extended for an additional 10 months, a further central
training day was provided in London in August 2009; staff from 11 centres attended this day.London Stroke Carers Training Course deliveryThe LSCTC was designed to be delivered to caregivers while the patient was an inpatient with one
‘follow through’ session provided in person or by telephone after hospital discharge. The training was
individualised to the caregivers' required level of understanding. The timing of the sessions was not dictated,
and could begin at anytime from admission, and throughout the patients stay, depending on
when the team felt it appropriate for that particular caregiver, along with other factors, such as varying
lengths of stay and local procedures. It was recognised that different components could be covered in
a number of different ways, by different professionals depending on individual circumstances.
A key component of the LSCTC was the requirement to check each caregiver's competency on each of the
training components delivered and for an appropriate member of the MDT to ‘sign off’ the competency as
achieved. Competency was deﬁned as ‘The caregiver has taken on board the knowledge/skills required to
be able to deliver the support that that patient needs’. Training would continue until the caregiver was deemed
competent (or until it was agreed by the MDT that the caregiver was unable to become competent).
This allowed the level of training to be both individualised to the caregiver and standardised across SRUs.7
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8Monitoring of deliveryThe completed LSCTC training record for all trial participants was returned to the trial manager and was
included as a standard monitoring report to the Trial Management Group (TMG) and Trial Steering
Committee (TSC). This enabled monitoring of compliance with the intervention delivery in the SRUs, and the
time taken and competencies achieved by each caregiver. In instances where there were concerns about SRU
compliance, the trial manager directly engaged with the sites to explore difﬁculties. The chief investigator
wrote to the local principal investigators (PIs) of two units to express concerns.NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta17460 HEALTH TECHNOLOGY ASSESSMENT 2013 VOL. 17 NO. 46Chapter 3 MethodsTrial designTraining Caregivers After Stroke was a pragmatic, multicentre, cluster RCT designed to evaluate whether
or not a structured, competency-based training programme for caregivers (LSCTC) improved physical
and psychological outcomes for patients and their caregivers after disabling stroke and to determine if
such a training programme was cost-effective.
Training Caregivers After Stroke was designed as a pragmatic trial. Thus the eligibility criteria were broad
and inclusive, the intervention was highly ﬂexible in application and was delivered in a full range of SRUs by the
local MDT staff. Monitoring of participant and practitioner compliance/adherence was unobtrusive with no
special strategies to improve compliance. Outcomes were objective and meaningful to patients. The primary
analysis was intention to treat (ITT) as a test of whether or not the treatment worked in the context of all
inherent real-life noise.36
Figure 1 summarises the study methods, and the study protocol can be viewed in Appendix 4.Justiﬁcation of a cluster randomised designThe cluster randomised trial design was purposely selected to reduce between-group treatment
contamination. Within the pragmatic trial, the LSCTC intervention was incorporated into usual practice and
delivered by the whole MDT. If randomisation had been at the level of individual patients, the MDT would
have had to operate two approaches (usual care and the LSCTC) with an associated high risk of
between-group contamination as it would not have been possible to blind members of the MDT, thus it
seemed likely that the new care process would have been extended to patients in the usual care group.
Randomisation was therefore at the level of the (service) stroke unit. In order to minimise selection bias, there
was a clear separation between the provision of the intervention by clinical staff and the recruitment and
consent of patients and caregivers by research practitioners.Primary objectivesThe primary patient objective of the trial was to determine whether or not the provision of the LSCTC
improved functional independence. The primary caregiver objective was to determine whether or not the
provision of the LSCTC reduced burden for caregivers.Secondary objectivesThe secondary objectives were to determine whether or not the provision of the LSCTC (1) improved physical
and psychological patient outcomes in the long term, (2) improved physical and psychological caregivers
outcomes and (3) was cost-effective based on (a) patient outcomes, from both health/social care and societal
perspectives and (b) caregiver outcomes, from a health-care perspective.
Stroke unit (cluster) eligibility
Stroke rehabilitation units were eligible to participate in the TRACS trial if they met four out of ﬁve key criteria
used to deﬁne a stroke unit, as suggested by the Royal College of Physicians of London (RCP) for the9
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End of trial: stroke rehabilitation unit process questionnaire and observation of practice
12-month follow-up
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•
•
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•
•
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Provide patient/caregiver information leaflet
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LSCTC staff training for MDT
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FIGURE 1 Study flow chart.
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DOI: 10.3310/hta17460 HEALTH TECHNOLOGY ASSESSMENT 2013 VOL. 17 NO. 46National Sentinel Stroke Audit (NSSA) 2006.37 The ﬁve key criteria are (1) consultant physician with
responsibility for stroke, (2) formal links with patient and caregiver organisations, (3) MDT meetings at least
weekly to plan patient care, (4) provision of information to patients about stroke and (5) continuing education
programmes for staff. Additional eligibility criteria were that a substantial number of patients on the unit
had a diagnosis of stroke, the unit was able to deliver the LSCTC and the majority of patients were discharged
to a permanent place of residence.Randomisation and stratiﬁcationCluster randomisation of the 36 eligible SRUs was performed centrally at the Clinical Trials Research Unit (CTRU).
SRUs were randomised on a 1:1 basis to either the intervention or the control group. The randomisation was
stratiﬁed by geographical region (Yorkshire, the North West, the South West Peninsula, and London and the
South East) and quality of care (deﬁned as being on and above, or below, the median on the key 12-indicator
score of the 2006 NSSA37). Block randomisation was used to ensure these important covariates were balanced
between the arms of the trial.Intervention units
In SRUs randomised to the intervention group, usual care was augmented by provision of a modiﬁed LSCTC
programme (as described in Chapter 2), incorporated into ward practice and delivered to all patients on the
SRU if a caregiver was available. Recruitment was opened 4–6 months after the initial training meeting,
providing sufﬁcient time for the implementation of the LSCTC into standard ward practice.Control units
Stroke Rehabilitation Units randomised to the control arm were asked to continue with their usual care,
based on National Clinical Guidelines.38,39 As a minimum, this care involved:
l weekly MDT meetings
l information provision to patients and carers
l ad hoc training of skills to caregivers (e.g. percutaneous endoscopic gastrostomy feeds, transfers, etc.).
Stroke rehabilitation units in the control arm opened to recruitment at the same time as the intervention centres.
Details of usual involvement of patients and caregivers on the SRUs was collected via interviews with senior
staff prior to randomisation, and during and at the end of participant recruitment (details below).Process informationProcess data were collected before, during and after recruitment at each participating SRU to monitor any
changes in eligibility in SRUs, and in the process of care that prepared patients and caregivers for discharge in
SRUs. Data were collected on the NSSA scores completed during the trial (2006 and 2008); ward type
(combined acute and rehabilitation or rehabilitation); number of stroke beds; MDT staff ratios; use of
community and early supported discharge stroke teams; and usual MDT working. Senior MDT staff
(where possible, therapy and nursing staff) were asked open-ended questions to describe usual ward practice
and discharge preparation, and how patients and caregivers were involved with this. Responses were
recorded on the ﬁrst visit, and on following visits the initial responses were cross-checked with the new
responses and any changes/additions/losses to service updated. Any such changes were monitored by the
trial manager through visits to the centres and discussions with the researchers, PIs and MDTs, and were
reported back to the TMG for discussion and decision-making.11
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12Participant eligibilityPatients were eligible for TRACS if they had a conﬁrmed primary diagnosis of new stroke, were medically
stable, were likely to return home with residual disability, and had a caregiver available, willing and able to
provide support after discharge. The caregiver was deﬁned as the main person, other than health, social, or
voluntary care provider, helping with ADL and/or advocating on behalf of the patient. Written informed
patient consent/caregiver declaration and caregiver consent were obtained prior to any trial-speciﬁc
procedures. Patient and caregiver dyads were excluded if the patient was in need of palliative care, if
discharge was planned within 1 week of admission to the SRU, or if the patient or caregiver was previously
registered to the trial.BlindingParticipant recruitment and baseline assessments were undertaken by researchers independent of the clinical
MDT. The clinical MDTs in both the intervention and control arms conducted the LSCTC/usual care with all
eligible patients' caregivers whether or not they consented to study procedures. The MDTs were not
informed of which patients/caregivers consented to study procedures. Participants were blinded to the
SRUs allocation.Participant recruitment
Screening
All patients admitted to the SRUs were screened for eligibility for the TRACS trial. The researchers
completed a screening log that included reasons why patients were not eligible, reasons for which
patients/caregivers did not consent and length of stay and anonymous patient demographic information
(age, ethnicity, usual living circumstances, and relationship to caregiver). The screening data permitted
monitoring of rates of identiﬁcation, recruitment and refusals at all sites, as well as a comparison of the
patient populations being admitted and recruited into the two arms of the study.Recruitment
To avoid selection bias, participants were recruited by researchers from the Stroke Research Network
(SRN) who were independent of the clinical MDT. Where researchers worked part-time as clinical staff,
they were not permitted to recruit into TRACS, and other SRN researchers came into that SRU at least
weekly to screen and recruit participants into the study.
Written informed consent was obtained from both patients and caregivers. When patients were unable to
provide written consent owing to stroke-related disability and/or a lack of mental capacity, a caregiver
declaration was obtained. For patients who were unable to consent for themselves, this study complies with
the Mental Capacity Act 2005.40 In such cases, the caregiver acted as consultee.
Patients and caregivers in both arms of the study consented to data collection and questionnaire completion.Registration
To be registered into the study, the patient and caregiver dyad must have provided written informed
consent and completed the baseline questionnaires. The researcher was also required to collect all
necessary baseline information after consent but prior to registration. Registration was performed centrally
using an automated 24-hour telephone registration system at the CTRU, University of Leeds, Leeds, UK.Withdrawal
Patients and caregivers were free to withdraw at any time from the study without giving reasons and without
prejudicing the patient's treatment. Where patients or caregivers requested to withdraw from the studyNIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta17460 HEALTH TECHNOLOGY ASSESSMENT 2013 VOL. 17 NO. 46procedures, there was clariﬁcation of whether this was withdrawal from postal follow-up or from medical
records searches or both.Primary outcomesThe primary patient outcome was functional independence measured at 6 months using the Nottingham
Extended Activities of Daily Living (NEADL) scale.41,42
The primary caregiver outcome was caregiver burden measured at 6 months using the CBS.30Secondary outcomesSecondary patient outcomes included self-reported measures of mood (HADS32); health state (EQ-5D);31,43,44
ADLs (Barthel Index);34,45 functional ability and health-related quality of life [Stroke Impact Scale (SIS)];46–51
death; hospital readmission and institutionalisation, all measured at both 6 and 12 months after recruitment,
and functional independence (NEADL) at 12 months.
Secondary caregiver outcomes included self-reported measures of social restriction (FAI);33,52 mood (HADS);
health state (EQ-5D); death; hospitalisation and institutionalisation at 6 and 12 months, and caregiver burden
(CBS) at 12 months.
The cost-effectiveness of the LSCTC for both patients and caregivers was also assessed. Resource use was
measured using the self-completed Client Service Receipt Inventory (CSRI).29,53 Hospital records were checked
for patient hospital readmissions and caregiver hospital admissions at 6 and 12 months post registration.Assessment instruments
Nottingham Extended Activities of Daily Living Scale
Functional independence was measured using the NEADL scale.41,42 It was designed as a postal
questionnaire and assesses aspects of physical and social independence performance across 22 items [score
range is from 0 (low independence) to 66 (high independence)] grouped in four categories (mobility,
kitchen, domestic and leisure activities). It has been widely used as an outcome measure in rehabilitation
trials.54,55 It has proven validity, reliability56 and has demonstrated responsiveness to change and able to
discriminate between services.57Hospital Anxiety and Depression Scale
Both patients and caregivers mood was assessed using the 14-component HADS.32 It was initially developed
as an instrument to identify anxiety disorders and depression in medical outpatients,32 but has since proven
to exhibit wider generalisability.58 HADS score is reported from 0 (normal level of anxiety/depression) to
21 (abnormal level of anxiety/depression).EuroQol 5-dimension health-state measure
The non-disease-speciﬁc EQ-5D instrument31,43,44 was used to evaluate health-related quality of life of
both patients and caregivers via a six-component questionnaire. It was developed to yield a fundamental
index of health, which can be used to calculate QALY gains and, thus, facilitates the health economic
evaluation. EQ-5D is scored from –0.59 (worst possible health state) to 1 (full health).Barthel Index
Patient ADL and mobility were assessed using the Barthel Index.34,45 This instrument was used to evaluate
patients' disability and level of dependence on their caregiver via assessment of their ability in bathing,13
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14transferring from bed to chair, dressing, feeding, mobility, climbing stairs, toilet use, grooming, and bladder
and bowl continence. Barthel Index is scored 0 (dependent) to 20 (independent).Stroke Impact Scale
Functional ability and health-related quality of life of the patients was measured using the SIS.46,47,50,51 This
scale consists of eight components measuring strength, memory and thinking, emotion, communication,
activities and independent ADL, mobility, hand function, and social participation. It was developed for use as a
self-reporting questionnaire, which has proven to be reliable, valid and sensitive to change.49,51 SIS has also
been validated for use as a postal questionnaire.48 Each domain is scored from 0 (worst) to 100 (best).Client Service Receipt Inventory
Data on patient sociodemographics and use of health and other formal care services and informal care were
collected using a CSRI validated for use with stroke patients.29,53 A reduced form of this instrument was used
with caregivers.Caregiver Burden Scale
Caregiver burden was measured using a proven and reliable CBS.30 This 22-item scale assesses various
aspects of caregiver burden including general strain, isolation, disappointment, emotional involvement and
environment. CBS is scored from 22 to 88, with a higher score representing a more subjective burden.Frenchay Activities Index
The social restriction on caregivers was assessed using the FAI.33,52 Although initially validated to assess the
activities of acute stoke patients, this assessment instrument is applicable to caregivers of patients with
disabling stroke.19 FAI scores are from 0 (inactive) to 45 (highly active).Caregiver time logs and training records
Multidisciplinary team staff in the control centres were requested to complete caregiver time logs (see
Appendix 1) for two periods of 3 months during recruitment. These logs recorded the time that all MDT staff
spent with patients' caregivers. MDT staff in the intervention centres were requested to complete training
records (see Appendix 1) throughout the trial as a part of the LSCTC intervention. The training records
logged the time that all MDT staff spent delivering the LSCTC with patient's caregivers. The control and
intervention logs of MDT time were used to assess the costs associated with delivering the LSCTC. The
training records were also used to monitor compliance with the LSCTC in each intervention centre. Caregiver
time logs and training records were completed on all eligible patients' caregivers; the logs for caregivers who
did not consent to trial procedures were returned to the trial team without any identiﬁcation on them.
Further data on the costs of implementing the LSCTC were collected by logging the time taken for all MDT
staff to attend the training days and for all MDT staff to cascade/receive cascaded training on the SRUs.Baseline and follow-up data
Baseline patient information collected included demographic details (age, sex, ethnicity, living circumstances,
relationship of patient to the caregiver, education and employment), pre-stroke Barthel Index, modiﬁed
Rankin Scale, classiﬁcation of stroke, language ability, Six-item Cognitive Impairment Test (6CIT)59 and the
Edinburgh stroke case-mix factors.60 Caregiver information collected included demographic details (age, sex,
ethnicity, education and employment) and modiﬁed Rankin Scale. The baseline patient questionnaire
included pre-stroke NEADL scale, HADS, EQ-5D, Barthel Index, SIS46–48,50,51 and CSRI. The caregiver
questionnaire included FAI, HADS, EQ-5D and the CSRI (details below).
The 6- and 12-month questionnaires for the patients collected the same measurements as the baseline
questionnaire. At 12 months an additional question was included to ask if the patient had been aware of
receiving different treatment because of this research. The 6- and 12-month questionnaires for the caregivers
collected the same measurements as the baseline questionnaire, and also included the CBS and questions
relating to caregiver preparation to care for their relative/friend at the time of their discharge from hospitalNIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta17460 HEALTH TECHNOLOGY ASSESSMENT 2013 VOL. 17 NO. 46(6 months only); if the caregiver was still caring for the patient; caregiver's stroke knowledge;61,62 and if the
caregiver had been aware of receiving/being denied an enhanced training package (at 12 months only).
Researchers at each site collected patient and caregiver hospital readmissions and deaths using the local
health records.Procedures for data collection
Baseline questionnaires were completed by the patient and caregiver after consent, but prior to registration.
Where patients were unable to complete the baseline questionnaire owing to stroke-related disabilities, a
friend/relative could complete the questionnaire using the patient's verbal responses. Where the patient
could not understand the questions and/or communicate responses, a friend/relative could complete the
questionnaire on their behalf. Details of proxy completion were collected and comparisons between the two
arms of the study were undertaken. MDT staff and the researchers were not permitted to help with
questionnaire completion. Data were collected by the researcher after consent but prior to registration from
both the patient and the caregiver. Discharge details and the occurrence of any expected adverse events
(AEs) or serious AEs (SAEs) were collected at the point of discharge.
Patients and caregivers were followed-up by postal questionnaires at 6 and 12 months post registration
administered by CTRU. CTRU staff were blinded to the allocation of the SRUs.
Postal reminders were used if the questionnaires were not returned within 2 weeks, followed by a telephone
reminder 2 weeks later if the questionnaire had still not been received. If the questionnaire was still
outstanding, then, where possible, a telephone interview was conducted to obtain the primary outcomes.
General practitioner (GP) checks conﬁrmed that the patient and caregiver were alive prior to contact.
If the patient had died, then no further follow-up was undertaken. If the caregiver had died, then patient
follow-up was still undertaken.
The cut-off point for questionnaires to be considered for primary end point at 6 months was set at 10 months
since registration: follow-up for patients and caregivers started at 6 months post registration.Intervention compliance
The training records were used to evaluate each intervention centres compliance with the intervention. A
deﬁnition of compliance was agreed by the LSCTC development team independent of the research team.
Following consideration of what was felt to be a minimal acceptable level of training input for each caregiver
and recognising that heterogeneity of the patient and caregiver dyads. Compliance was deﬁned as follows:
It was indicated on the training record that training on all six mandatory components was delivered and
competency achieved by the caregiver, and/or the training record was signed off by a member of the MDT,
indicating that all necessary training had been delivered and competency achieved.Sample size
The original target recruitment was 900 patient and caregiver dyads, 25 dyads from 36 SRUs. The sample
size calculations assumed that a clinically relevant difference was six points [as deﬁned in the Trial of
Occupational Therapy And Leisure (TOTAL) study54,63] in the patient primary outcome measure (NEADL).
A range of three to nine points was taken to be a clinically relevant difference in previous studies. We
have deﬁned six points as a difference of clinical relevance to the patient and caregiver (patient requiring less
help in at least two activities) and also substantive enough to inﬂuence commissioners to change service
delivery. Thirty-six stroke rehabilitation units, each recruiting 25 patients, would result in 450 patients in each
group and provide close to 90% power at 5% signiﬁcance level to detect a clinically relevant difference of six
points on the NEADL scale [scored 0–66, standard deviation (SD) 18]. The sample size incorporates an
inﬂation factor of 1.9 owing to clustering [cluster size of 19 after loss to follow-up; intracluster correlation
coefﬁcient (ICC) no greater than 0.0564] and 25% loss to follow-up. The assumption that the ICC would
be no larger than 0.05 was based on methodological research65 showing that ICCs for patient outcomes in15
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16the community are generally <0.05. A sample size of 900 patients provided more than 85% power at
the 5% signiﬁcance level to detect an effect size of one-third in any of the other outcomes. Such an effect
size is usually considered moderate. So, for instance, this ensured more than 85% power to detect a
difference of 4.3 points on the CBS at 6 months, assuming the same variability as in the single-centre study19
(i.e. SD of 12.9 at 6 months).Revised sample size
The power of the trial was, however, adversely affected by a slightly higher than expected loss to follow-up
and unequal cluster sizes. By estimating maximum and minimum cluster sizes66 the predicted imbalance
decreased the power by 1–3%. To preserve ﬁnal power of close to 90%, the trial target was increased
to between 950 and 1000 patient and caregiver dyads, with a maximum of 35 dyads from each of
the 36 SRUs to compensate for low recruitment at some centres.Analysis methodsAll data analyses were conducted to a prespeciﬁed analysis plan. All data analyses were performed using SAS
version 9.2 (SAS Institute Inc., Cary, NC, USA). All hypothesis testing was performed at the 5% two-sided
signiﬁcance level. Analysis of health economic data was performed using SPSS (SPSS Inc., Chicago, IL, USA).Populations
The ITT population was deﬁned as all patients registered for active follow-up regardless of non-compliance
with the intervention. All patients (and the corresponding caregivers) within a stroke unit were analysed
according to the intervention that stroke unit was randomised to. All analyses and data summaries were
carried out using the ITT population. Patients whose written informed consent had not been received
were not included in this population. The analysis population included all patients returning
6-month questionnaires.Baseline characteristics
The baseline characteristics of the ITT population were tabulated using frequencies and summary statistics for
each treatment group. Two-sample t-tests to compare percentages and means, weighted by the number of
patients in treatment and control centres, were used to detect potential bias in recruitment.Primary analysisFor all analyses, means and 95% conﬁdence intervals (CIs) together with values of unadjusted and adjusted
ICCs are reported. Summaries from raw and predicted data from the ﬁnal model are provided.Patients
The primary analysis was based on a complete case analysis, with no substitution for missing outcome data.
The ITT analysis included all patients with a valid 6-month NEADL score. The 6-month NEADL score was
compared between the intervention and control groups using two-level multilevel modelling, with
patients and SRUs being the level one and level two units, respectively. The model was adjusted for:
l The following patient-level covariates (level 1) Patient baseline NEADL score, sex, caregiver's education
(age caregiver left education: ≤16 years, >16 years) and caregiver baseline HADS score, the Edinburgh
stroke case-mix adjuster (which includes age; whether or not patient lived alone before the stroke;
whether or not the patient was independent in everyday activities before stroke; whether or not the
patient can talk or he/she orientated in time, place and person; whether or not the patient can lift both
arms; whether or not the patient can walk without help from another person), and
l The following stroke unit-level covariates (level 2) The key 12-indicator score, geographical region and
number of beds in each centre.NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta17460 HEALTH TECHNOLOGY ASSESSMENT 2013 VOL. 17 NO. 46A number of sensitivity analyses were used to examine the robustness of the conclusions of the primary
analysis. First, the analysis was undertaken including patients who died and assumed a NEADL score of 0
(worst possible outcome). Second, an analysis without proxy responses was performed to assess the impact
of proxy responses. Third, the time of completion of 6-month questionnaires was compared between both
arms using a t-test and, if signiﬁcant, a sensitivity analysis would be undertaken to determine if the results
were inﬂuenced by patients responding late in the follow-up period.Caregivers
The primary analysis of caregiver outcomes was based on a complete case analysis with no substitution
for missing data. The ITT analysis included all caregivers with a valid 6-month CBS score. The 6-month
CBS was compared between the intervention and control groups using two-level multilevel modelling,
with patients and SRUs being the level 1 and level 2 units, respectively. The model was adjusted for:
l The following caregiver-level covariates (level 1): caregiver baseline HADS anxiety and depression scores,
age, sex, caregiver's education (age caregiver left education: ≤16 years, >16 years).
l The following stroke unit-level covariates (level 2): the key 12 indicator score, geographical region, and
number of beds in each centre. [In the analysis, the age that the caregiver left education is used as a
binary covariate ‘≤16 years’ and ‘>16 years’. Unknown and missing categories were investigated and
based on caregiver baseline data compared with the general characteristics; these were imputed
accordingly (in all instances they fell into the category ‘Age caregiver left education “≤16 years”’).]
The sensitivity analysis relating to time of questionnaire completion was repeated for caregivers.Secondary analysesAll analyses of secondary end points were conducted on the ITT population. Means, 95% CIs and values of
unadjusted and adjusted ICCs are reported. Summaries from raw and predicted data from the ﬁnal model
are provided.
Two-level random intercept models were used, with patients being level one and stroke units being level
two. Fixed parts were patient-level covariates (level one), stroke unit-level covariates (level two) and
treatment. Data were assumed missing at random.Patient end points at 6 months
The 6-month HADS scores, EQ-5D score, Barthel Index and SIS were summarised by treatment group. For SIS,
the score was summarised for each domain separately and included the four physical domains as one
(strength, hand function, mobility and ADL/instrumental ADL).
The 6-month HADS scores, EQ-5D score, Barthel Index and SIS were compared between the intervention
and control groups using two-level multilevel modelling, with patients and stroke rehabilitation units
being the level 1 and level 2 units, respectively. The model was adjusted for the same variables as in the
primary patient end point apart from the baseline NEADL score. The baseline HADS scores, EQ-5D score,
Barthel Index and SIS were used when comparing the 6-month HADS scores, EQ-5D score, Barthel index
and SIS, respectively, between the two groups.Patient end points at 12 months
The 12-month NEADL score, HADS scores, EQ-5D score, Barthel Index and SIS were summarised by
treatment group.
The 12-month NEADL score, HADS scores, EQ-5D score, Barthel Index and SIS were compared between the
intervention and control groups using the same process as for end points at 6 months.17
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18Caregiver end points at 6 months
The 6-month FAI, HADS and EQ-5D scores were summarised by treatment group.
The 6-month FAI, HADS and EQ-5D scores were compared between the intervention and control groups
using two-level multilevel modelling, with patients and stroke rehabilitation units being the level 1 and
level 2 units, respectively. The model for HADS scores was adjusted for the same variables as in the primary
caregiver end point. The rest was adjusted for the same variables as in the primary caregiver end point apart
from the baseline HADS scores. The baseline FAI and EQ-5D score was when comparing the 6-month FAI
and EQ-5D score, respectively, between the two groups.Caregiver end points at 12 months
The 12-month CBS, FAI, HADS and EQ-5D scores were summarised by treatment group.
The 12-month CBS, FAI, HADS and EQ-5D scores were compared between the intervention and control
groups using the same process as for caregivers at 6 months.Process data
Data in intervention and control sites collected before trial commenced and during trial were summarised
by the trial manager to ascertain whether or not care has changed over the course of the trial. During
the trial, the number of training records received from the SRUs was summarised. The data from the training
records were summarised for all intervention patients in terms of the number of mandatory and
non-mandatory components delivered and the number of these where the caregiver achieved competence.
The proportion of training records compliant with the intervention by the SRU was summarised. The number
of caregivers achieving competence for each component was also summarised.
The relationship between patient and caregiver outcome and compliance with intervention was explored.
Number of mandatory components achieved as per training records completion was summarised.Safety
Falls – the number of patient falls between registration and discharge were summarised by arm and centre.
The number of falls that resulted in a SAE was presented by arm as well as the mean number of falls (of those
patients who fell).
The percentage of patients and caregivers who died from any cause between registration and 12-month
follow-up were summarised by arm and centre and the cause of death was presented. No statistical
comparison between the intervention and control groups was undertaken. The number of patients' and
caregivers' admissions or readmissions (self-reported and researcher completed) to a hospital, nursing home
or residential care home, was summarised at the 6- and 12-month follow-ups by arm. No statistical
comparison between the intervention and control groups was undertaken. Related and unexpected serious
adverse events (RUSAEs) were listed and detailed, up to, and including, the 12-month follow-up.Economic evaluationThe purpose of the economic evaluation was to examine the cost-effectiveness and cost–utility of the LSCTC.
There were two parallel economic evaluations: one for patients and another for caregivers. The primary
economic evaluation was cost-effectiveness analyses based on the patient and caregiver primary outcome
measures (NEADL and CBS, respectively). The secondary economic evaluation was cost–utility analyses based
on QALYs.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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The patient and caregiver evaluations were each undertaken from (a) a health and social care cost
perspective and (b) a societal cost perspective. Health and social care costs included nursing/residential care;
hospital inpatient, outpatient, day hospital and accident and emergency services; and primary care/
community-based health/social care services. Societal costs included all of these categories plus informal
care costs.Time horizon
In keeping with the outcomes analyses, the cost-effectiveness and cost–utility analyses were primarily
focused on ﬁndings at 6 months. We further examined costs and outcomes at 12 months and over one
year to enable a more direct comparison of ﬁndings with the single-centre study on which this one was
based.19,29 One-year costs were estimated as the sum of costs from the 6- and 12-month assessments
and 1-year QALYs were the sum of QALYs at 6 and 12 months. The time horizon was limited to 1 year
because we focused on within-trial costs only.Resource-use data
Data on the use of health and social care and informal care were collected at the individual-level
using a CSRI29 that was speciﬁcally adapted for use with stroke patients. A reduced version of this
instrument was used with caregivers, containing questions about their use of core health and social
care services and informal care that they provided. For both patients and caregivers, the CSRI was
administered as a face-to-face interview at the baseline assessment (with reference to the previous
3 months) and then as a self-complete postal questionnaire alongside other measures at 6 and
12 months (with reference to the time since previous assessment).Costs
Individual-level resource-use quantities were combined with unit costs to calculate a cost per participant. Unit
cost estimates, their sources and any assumptions made for their estimation are in Appendix 5 and are
summarised in Table 2. National unit costs were used where possible to represent the geographical spread of
the sites and to facilitate the generalisability of results.ABLE 2 Summary of unit costs
Category Unit Unit cost (£, 2009–10)
Residential care home stay Night 74
Nursing home stay Night 73
Inpatient services: stroke, acute Bed-day 294
Inpatient services: stroke, acute Stay 2808
Inpatient services: stroke, rehabilitation Bed-day 361
Inpatient services: other Bed-day Range 110–1229
Inpatient services: other Stay Range 110–3877
Day hospital/day-case services Activity Range 368–1149
Outpatient services and procedures Visit Range 5–785
Primary care/community-based services Contact Range 6–129
Primary care/community-based services Hour Range 23–158
Primary care/community-based services Item Range 3–6
Value of caregiver time: average wage Hour 15
Value of caregiver time: home care worker Hour 28T19
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20Costs of the initial stroke admission were estimated by multiplying length of stay by the unit cost for a
non-elective long-stay unit cost from the 2009–10 NHS reference costs67 (£294). If either the admission or
discharge date was missing, then an average admission cost for the same service was applied (£2808).
Costs of other hospital admissions were estimated similarly by mapping participant-reported specialty or
reason for the admission to Healthcare Resource Groups (HRGs) and then applying weighted average
non-elective, long-stay bed-day or admission costs for each of those HRGs. Where participants did
not state a specialty, the reason for the admission was used to infer specialty. Alternative assumptions
were necessary for a few specialties that did not readily ﬁt into a HRG (see Appendix 5).
Where multiple specialties were reported for one admission, an average weighted unit cost across all relevant
specialties was used. For admissions with no information on specialty or reason, an average cost of all
HRGs was applied. Outpatient costs were estimated using the same approach.
The patient CSRI included a question asking respondents to report use of any other services not covered by
the previous questions. Many responses to this question were for services already itemised in the
instrument. We report these total ‘other’ costs separately rather than amalgamate them into the speciﬁc
resource categories.
Informal care represents an important input to the health of people with stroke. We estimated the
monetary value of such inputs using the opportunity cost approach,68 which involves valuing caregivers'
time according to the opportunities they have forgone owing to time spent care giving. Often the
opportunity forgone is paid employment and so the monetary value attached to this could be wages
forgone. For care provided by the main caregiver enrolled in the trial, we distinguished opportunity costs as
either lost employment or lost leisure on the basis of their employment status at each assessment.
Where it was assumed that the caregiver could otherwise have been working (those working part-time
and those unemployed and seeking work), we applied the national average wage. Where it was assumed
that the caregiver was unlikely to instead be working (those working full-time, at home not seeking work,
retired, redundant/early retired, unable to work and students), we applied an estimate of the cost of
leisure time. For anyone whose employment status was ‘other’ or missing (and for other caregivers), we
applied the average of the two unit costs. We assumed that if the main caregiver lived with the patient, all
reported live-in informal care inputs were by that caregiver and that all live-out inputs were provided by
others. Conversely, if the main caregiver did not live with the patient, we assumed that all live-out informal
care inputs were provided by that person and that all live-in inputs were provided by others.
The cost of the LSCTC was incorporated into the evaluation. We included only the costs of its development
and staff training, not the cost of delivery to caregivers, as the latter is inherently included in the unit cost
applied to the stroke admission given that it was part of routine practice in the intervention arm stroke units.
Developing and delivering the staff training to ensure that ward staff were competent in delivering the
LSCTC to caregivers was a multistage process consisting of the following key resource components:
The project team:
l developing the staff training package
l preparing and delivering four core training days
l preparing and delivering one refresher training day
l delivering local refresher training sessions at all intervention sites.
Ward staff:
l attending the core training days
l attending the refresher training day
l receiving local refresher trainingNIHR Journals Library www.journalslibrary.nihr.ac.uk
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l attending cascaded training session.
There were three elements of data collection to measure the resources associated with each of these
components. First, resources associated with all main training events were recorded by the staff associated
with delivering those events. Second, ward staff attending these events and then cascading that training to
other staff on their ward recorded the time, profession and salary band for all of the staff involved with
delivering and receiving that cascaded training. Third, ward staff providing training inputs to caregivers
recorded those time inputs on a training record. Resulting cost estimates are summarised in Table 3,
with further details of each component described in Appendix 6.
We transformed the total cost of the development and staff training into an average cost per minute of input
to caregivers to enable the cost of LSCTC to vary at the individual level according to inputs provided, rather
than be a ﬁxed cost across all participants. We calculated this as follows. First, we multiplied the average amount
of time spent with each caregiver in the trial intervention arm (136 minutes) by the total number of eligible
patients identiﬁed during the screening/recruitment process (n=1256) to estimate the total caregiver input
time that the LSCTC development and staff training potentially ‘purchased’ (170,816 minutes/2846 hours).
We then divided the total training cost (£102,577 including development costs) by this total input time to
estimate the training cost per minute of caregiver input provided (£0.60). This cost per minute was applied to
each intervention arm participant according to the amount of time input provided by ward staff to the caregiver.
Total costs were computed for each patient and caregiver at each assessment point (baseline, 6 months,
12 months and 1 year), from both perspectives. It was not necessary to discount costs or outcomes because
the evaluation covered only 1 year. All unit costs were standardised at 2009–10 levels, where relevant.Outcome measures for the economic evaluation
Patients:
l NEADL score at 6 months (primary patient outcome measure) and 12 months
l QALYs between baseline and 6 months, between 6 months and 12 months and over 1 year.ABLE 3 The London Stroke Carers Training Course unit cost: summary of all staff training components
Staff training component Costs (£, 2009–10 prices)
1. Core training and refresher training: development 7680
2. Core training: preparation 3554
3. Refresher training: preparation 753
4. Core training: delivery 23,317
5. Refresher training: delivery 5603
6. Local refresher visits: delivery 16,593
7. Ward staff time 45,077
Total including development costs 102,577
Total excluding development costs 94,897
Cost per minute of input to caregivers, including development costs 0.60
Cost per minute of input to caregivers, excluding development costs 0.56T21
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22Caregivers:
l CBS at 6 months (primary caregiver outcome measure) and 12 months
l QALYs between baseline and 6 months, between 6 months and 12 months and after 1 year.
The concept of utility refers to the value of a particular level of health status (or improvement on level of health
status) and can bemeasured by the preferences of individuals or society for any set of health outcomes. Themost
common value-based measure of health outcomes used in cost–utility analysis is the QALY.69 The quality
adjustment is based on a set of utilities, one for each possible predeﬁned health state. QALYs are calculated by
multiplying the preference value for a particular health state by the time spent in it. For example, if a health state
associated with receiving a particular intervention is valued at 0.6, 2 years in that health state equates to
1.2 QALYs. Results of cost–utility analyses are usually expressed in terms of additional cost per additional QALY
gained by undertaking one intervention instead of another. In this study, health states were measured using the
EQ-5D31 at baseline, 6 months and 12 months. Utility weights from a UK general population survey70 were
attached to health states at each time point, with appropriate adjustments for the period of time involved. Utility
weights and QALY gains were not estimated for those who died (or were lost to follow-up), as such cases were
not included in the primary analysis and would anyway have missing resource-use/cost data. QALYs were
then estimated using linear interpolation to calculate the area under the QALY curve as follows:
6month QALYs ¼ ½ðbaseline utilityþ 6-month utilityÞ / 2  0.5 years ð1Þ
12month QALYs¼ ½ð6-month utilityþ 12-month utilityÞ / 2  0.5 years ð2Þ
1year QALYs ¼ ½ðbaseline utilityþ 6-month utilityÞ / 2  0.5 years
þ ½ð6-month utilityþ 12-month utilityÞ / 2  0.5 years
ð3Þ
Cost-effectiveness and cost–utility analyses
Cost-effectiveness/cost–utility analysis is concerned with linking costs with outcomes and comparisons
between two or more alternatives.The primary economic evaluation at 6 months, the cost-effectiveness analyses, involved examining the
following four cost–outcome combinations between the two randomisation groups.
Patients:
l the additional cost per additional point improvement on the NEADL scale from the health and social
care perspective
l the additional cost per additional point improvement on the NEADL scale from the societal perspective.
Caregivers:
l the additional cost per additional point improvement on the CBS from the health and social
care perspective
l the additional cost per additional point improvement on the CBS from the societal perspective.
The secondary economic evaluation at 6 months, the cost–utility analyses, involved the following four further
cost–outcome combinations:
Patients:
l the additional cost per additional QALY from the health and social care perspective
l the additional cost per additional QALY from the societal perspective.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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l the additional cost per additional QALY from the health and social care perspective
l the additional cost per additional QALY from the societal perspective.
Further considering cost-effectiveness and cost–utility over 1 year involved examining these cost–outcome
combinations once more. There were thus a total of 16 cost–outcome combinations to consider.
Cost-outcome comparisons between the intervention and control groups can produce one of four outcomes:
l If costs are lower and outcomes are higher for one group, then it is considered to ‘dominate’ the other
and is clearly more cost-effective.
l If outcomes are similar between groups, then the one with lower costs can be regarded as more
cost-effective (or if costs are similar between groups then the one with better outcomes is regarded as
more cost-effective).
l If both costs and outcomes are lower for one group, then there are value judgements involved in trading
off outcomes for cost savings.
l If both costs and outcomes are higher for one group, then it falls on relevant decision-makers to decide
whether or not the additional beneﬁts are worth paying for. In this scenario, results of a cost-
effectiveness/cost–utility analysis are generally expressed as incremental cost-effectiveness ratios (ICERs),
which represent the additional cost associated with one additional unit of the outcome for one person;
these are calculated by dividing the mean difference in cost by the mean difference in outcome.
Each of these scenarios can be represented on a cost-effectiveness plane (Figure 2), in which the vertical axis
represents the additional costs of one intervention against another, and the horizontal axis represents
the additional outcomes. The location of a co-ordinate representing incremental cost and incremental
outcome indicates which of the four scenarios the cost-effectiveness ﬁnding falls into.
We constructed cost-effectiveness planes using non-parametric bootstrapped regressions (5000 replications,
with replacement) of study group upon 6-month health and social care costs, patient and caregiver
QALYs, total NEADL score and total CBS score, in turn, with cluster adjustment for centre and baseline values
of the dependent variable (except in the case of CBS), age and sex included as covariates. The resulting
coefﬁcients of group differences were saved and plotted using scatter graphs (Stata version 10.1,
StataCorp LP, College Station, TX, USA) in relevant cost–outcome combinations.LSCTC more costly
than control
LSCTC less costly
than control
LSCTC less
effective than
control
LSCTC more
effective than
control
LSCTC costs more
and has better outcomes.
Trade-off needed
LSCTC has worse
outcomes. Even though
costs less, unlikely to be
chosen
Control dominates
so LSCTC is rejected
LSCTC dominates and is
intuitively preferred
FIGURE 2 Cost-effectiveness plane.
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24We calculated ICERs for any cost–outcome combinations where the intervention group had higher costs
and better outcomes (the top-right quadrant of the cost-effectiveness plane). Although ICERs have been
one of the most common ways of presenting the results of cost-effectiveness analyses, they carry two
important limitations. First, they are point estimates that do not provide information about the uncertainty
surrounding the estimates, a problem that is compounded with the complexity of examining CIs around
ICERs. Second, their use to decision-makers is limited as they provide no information about what an
‘acceptable’ level of cost-effectiveness would be, or whether or not the likelihood of cost-effectiveness
would differ according to how much decision-makers would be willing to invest. Both of these limitations
can be addressed by cost-effectiveness acceptability curves (CEACs) based on the net beneﬁt approach.71
We use CEACs alongside cost-effectiveness planes to examine any uncertainty surrounding the
cost-effectiveness and cost–utility results.
Net beneﬁts provide a single summary monetary measure of costs and outcomes for each individual
(removing the need to examine ratios) and account for the value (λ) that a decision-maker would be willing
to pay for a greater net beneﬁt. They are calculated as follows:
Net benefit ¼ ðλ outcomeÞ − cost ð4Þ
For each cost–outcome combination, a series of net beneﬁts were calculated for a range of relevant λ values.
For the QALY-based analyses, these values ranged from £0 to £50,000 (£10,000 increments), to incorporate
the £20,000–30,000 per QALY gain threshold range currently speciﬁed for National Institute for Health
and Care Excellence (NICE) decision-making in England and Wales.72 For the NEADL- and CBS-based
analyses, the ‘acceptable threshold’ is unclear so we examined a range that incorporated NEADL- and
CBS-related ICER values at 6 months, £0–2000 (£500 increments). Net beneﬁts were then compared at the
level of randomisation group using non-parametric bootstrapped regressions (5000 replications, with
replacement) of study group upon net beneﬁt, with a cluster adjustment for centre and baseline values
of costs from the relevant perspective, age and sex, baseline utility for QALY-based CEACs and baseline
NEADL score for NEADL-based CEACs included as covariates. For each value of λ, the proportion of
iterations indicating a higher net benefit for the LSCTC group were calculated and plotted. These plots
formed the CEACs, which represent the probability of the LSCTC group being cost-effective compared
with the control for a range of values that a decision-maker would be willing to pay for an additional unit
of the NEADL score, CBS score and QALYs.
Statistical analyses
All cost and QALY data are reported as mean values with SDs. To accommodate a cluster randomisationprocedure indesign, differences in costs between groups were tested by multilevel modelling using the xtreg
Stata 10.1, from which we report 95% CIs and p-values for the differences in means. Baseline values of the
dependent variable, age and sex (plus baseline NEADL score for patients) were included as covariates.
Individuals were analysed according to the group to which they were randomised. As described above, net
beneﬁt comparisons for the purpose of CEAC constructions were undertaken using non-parametric
bootstrapped regressions (5000 replications, with replacement), controlling for site clusters.
Missing data
The base-case economic evaluation was based on available cases (i.e. it did not impute missing data duewever, weto loss of follow-up) under the assumption that loss of follow-up was missing at random. Ho
report CSRI and EQ-5D completion rates and describe baseline characteristics of those with and without
these data at the primary end point – 6 months.
Resource-use data from the CSRI formed the basis of the total cost calculations for each participant.
Self-complete applications of such complex instruments inevitably include missing items on returned
questionnaires and to allow the computation of total costs that reﬂect variations in resource use rather than
variations in data completeness, we imputed missing cost items on returned CSRIs as follows. If there
was no report of use of a particular resource, we assumed that it was not used and thus imputed a zero cost.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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use based on the mean cost for participants with data for that item at the same assessment point and
in the same randomisation group (this was done separately for patients and caregivers). All such imputations
were made to the cost data, rather than the resource-use data. Therefore, resource-use data are based
on data availability for each item with no imputation for missing values.
Missing data transformations (or lack of) for the NEADL scale and CBS were as for the main outcomes
analyses. Missing EQ-5D data were not imputed.
Sensitivity analyses
We altered some key assumptions made in the economic evaluation to explore their consequences for the
results at the primary end point – 6 months.Our ﬁrst sensitivity analysis concerned the LSCTC development and staff training costs. Training record return
rates were low so there were a signiﬁcant number of intervention arm participants with missing data on
ward staff time inputs to caregivers. As we estimated individual-level LSCTC development and staff training
costs on the basis of time spent with caregivers, we were unable to allocate any LSCTC costs to many
participants. For analysis purposes, such individuals were allocated a zero LSCTC cost. This may obviously
have led us to underestimate the contribution of LSCTC costs to total care costs. We therefore examined the
effect on patient and caregiver total health and social care costs at the primary end point, 6 months, of
imputing LSCTC costs for intervention group participants with missing training records. Imputation values
were based on the mean LSCTC cost for those with training record data (£81.90).
In the base-case analyses, we estimated informal care costs using the opportunity cost approach. However,
there are controversies in valuing informal care,73 and it is important to explore alternative approaches
given the notable size of informal care costs in this group. Therefore, our second sensitivity analysis examined
the effect of adopting a replacement cost approach to informal care, i.e. the cost of replacing informal
care inputs with paid professionals. We applied the cost of a local authority home care worker and examined
the effect on patient and caregiver total societal costs at the primary end point – 6 months.
Our ﬁnal two sensitivity analyses examined the effect of loss of follow-up by imputing missing patient
and caregiver health and social care costs and QALYs at the primary end point, 6 months. We used the
multiple imputation procedure in Stata 10.1. Cost imputations were based on key variables expected to
predict follow-up costs: randomisation group, sex, baseline age and baseline total health and social care
costs. Predictor variables for QALY imputations were the same except that they included baseline utility
score rather than cost.
For each of these four sensitivity analyses, we report the same statistics around means and mean
differences (and the same covariates for comparisons of means) as for the base-case analyses, and we
also examine the impact of the alternative scenarios on CEACs.
Deﬁnition of end of trialcompleted.The end of the trial was deﬁned as the date that the last 12-month postal questionnaire wasAdverse events and safety monitoringEvents such as patient falls and caregiver musculoskeletal injury represent an inherent consequence of
an active rehabilitation process and, therefore, cannot be entirely avoided. Similarly, in this patient
population, acute illness resulting in hospitalisation, new medical problems and deterioration of existing
medical problems were expected. In recognition of this, events fulﬁlling the deﬁnition of an AE or an
25
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26expected SAE were not reported in this study, with the following exceptions: patient falls wit
fracture that occurred at any time between the date of consent and date of discharge; patient and/or
caregiver death (SAE); patient and/or caregiver hospital admissions and readmissions for any reason (SAE);
patient and/or caregiver institutionalisation (AE); and patient and/or caregiver treatment on an emergency
outpatient basis (AE). Summaries of the above expected AEs and SAEs by treatment arm were reported
quarterly to the Data Monitoring and Ethics Committee (DMEC).
Data monitoring
Data were monitored for quality and completeness by the CTRU, using established veriﬁcation, validation
and checking processes. Missing data (except patient and caregiver completed data items collected via the
baseline and postal questionnaires) were chased until received, conﬁrmed as not available, or the trial was
at analysis.Data Monitoring and Ethics Committee
An independent DMEC was established to review the safety and ethics of the trial. Detailed unblinded
reports were prepared for the DMEC during set-up and annually during the recruitment and intervention
periods. SAEs were summarised by treatment group in a quarterly report sent to the DMEC, to enable
monitoring of safety rates between control and intervention sites.Trial Steering Committee
A TSC was established to provide overall supervision of the trial, in particular trial progress, adherence to
protocol, patient safety and consideration of new information. The committee met once during the set-up
period and 6-monthly thereafter for the duration of the trial.Trial Management Group
The TMG consisted of the report authors, who met monthly during study set-up and recruitment. The TMG
monitored rates of recruitment and refusals at sites and between study arms, LSCTC compliance in the
intervention centres, data quality and compliance, protocol adherence, and potential changes to the process
of care at centres.Ethical approval
The study protocol was approved by Leeds Research Ethics Committee (REC), reference 07/Q1205/12.
Local REC approval and research and development (R&D) approval was obtained at each NHS trust prior to
cluster randomisation.Amendments to the study protocol following commencement
of recruitment
Sample size
Originally the recruitment target was 900 patients, 25 dyads from each of the 36 participating SRUs.
affected by
5%) and
lance
increased toHowever, as described in the sample size section above, the power of the trial was adversely
a higher than expected loss to follow-up (expected to be closer to 30% than the predicted 2
unequal cluster sizes. By estimating maximum and minimum cluster sizes74 the predicted imba
decreased the power by 1–3%. To preserve ﬁnal power of close to 90%, the trial target was
between 950 and 1000 patient and caregiver dyads. The maximum number of dyads that could be
recruited from each SRU was raised to 35 to compensate for some low-recruiting centres. In one SRU,
the upper limit was increased to 38 to compensate for a very low questionnaire response rate at
this centre.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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Deletion of the words ‘competent to undergo training’ from the deﬁnition of a caregiver, as caregivers in the
control arm will not undergo structured training.
Informed consent
The statement ‘patients and caregivers will be given at least 24 hours to consider participation’ has been
replaced with ‘patients and caregivers will be given sufﬁcient time to consider participation’.In accordance with The Mental Capacity Act 2005,40 the term ‘caregiver assent’ has been replaced
throughout the protocol with the preferred recommended term ‘caregiver declaration’.Data collection
Addition of residential/nursing home option to the living circumstances of patients collected on the
screening log.
An additional question has been inserted into the 12-month follow-up questionnaire asking if the patient
was aware of receiving/being denied better treatment because of this research.The question asking if the caregiver was aware of receiving/being denied an enhanced training package will
be collected only at 12-month (not 6-month) follow-up.
Typo: Deletion of the modiﬁed Rankin Score from the data being collected on the screening log.
Typo: The ITT statement has been amended to clarify that all patients and caregivers who are registered
into the study will be considered as part of the ITT population and efforts will be made to follow them up
when appropriate.
References for the stroke knowledge question have been added.36,37
Literature review search strategy
Literature searches were completed using the Cumulative Index to Nursing and Allied Health Literature
(CINAHL), EBSCO, The Cochrane Library (Wiley Online Library), EMBASE (OVID), MEDLINE (OVID), and
PsycINFO (OVID), from January 1999 to November 2011. The International Standard Randomised Controlled
Trial Number (ISRCTN) registry was also searched manually. Appendix 7 provides the full search
strategy used.27
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Cluster-level recruitment
Forty-nine SRUs expressed an interest in TRACS, and 41 SRUs completed feasibility questionnaires and
were assessed for eligibility. Of these 41 SRUs, two did not meet the centre eligibility criteria and three
satisﬁed the centre eligibility criteria, but did not complete ethics/R&D approval processes in time to be
entered for randomisation.
The 36 SRUs were randomised equally between control and intervention, stratiﬁed by geographical
region and NSSA score. After randomisation, the characteristics of the SRUs were found to be balanced
between random allocations (Table 4). Once randomised, all 36 SRUs participated throughout the course
of the trial period (see Figures 5 and 6).Participant ﬂow and recruitment
Screening for trial participation
Patient and caregiver dyads were identiﬁed and recruited between February 2008 and February 2010.
Overall, 14,370 patients went through the screening process, 7067 in intervention and 7303 in control
sites, and 12,510 patients were assessed for eligibility, 6205 in intervention and 6305 in control sites.
Of these, 2675 (21.4%) were deemed eligible and 1024 consented (8.2% of assessed, 38.3% of eligible),
490 in intervention and 479 in control sites (see Figure 3 and Table 5). Reasons for non-registration of
patients are summarised in Figure 3. The number of assessed patients varied between SRUs from 149
to 831 patients (Table 6).
In total, 930 (7.4% of assessed, 34.8% of eligible) patients were registered into the trial (see Table 5).
The number of patient and caregiver dyads recruited per SRU ranged from 13 to 38 per centre. The
proportion of recruited dyads out of assessed ranged from 3.6% to 18.6% per SRU.Characteristics of screened participants
Table 7 summarises the characteristics of screened patients. The groups were well balanced with respect to
baseline characteristics.
The mean age of screened patients was 74.4 (SD 13.39) years and the average length of hospital stay
was 27.9 (SD 33.07) days. In total, there were 5967 (47.7%) males; the majority of patients were white
(11,628, 92.9%); 4922 (39.3%) patients lived alone; 6227 (49.8%) patients co-habited and 691 (5.5%)
were nursing or residential care home residents.
The caregiver resided with 5015 (40.1%) patients. In most cases, the caregiver was the patient's family
member: partner in 5047 (40.3%) and offspring in 3587 (28.7%) cases.
Sample size
In total, 930 patients and their caregivers were registered between February 2008 and February 2010
(Figure 4). The number of patient and caregiver dyads recruited per SRU ranged from 13 to 38 per centre.
Although, this is above the original target sample size and below the revised sample size of 950 patients
and caregivers, it still provides us with over 80% power to detect a clinically relevant difference of
six points on the NEADL scale.29
© Queen's Printer and Controller of HMSO 2013. This work was produced by Forster et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided
that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to:
NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
TABLE 4 Characteristics of randomised centres
Centre Intervention (n=18) Control (n=18)
Geographical region, n (%)
North West 6 (33.3) 6 (33.3)
London and the South East 4 (22.2) 4 (22.2)
South West Peninsula 3 (16.7) 3 (16.7)
Yorkshire 5 (27.8) 5 (27.8)
NSSA 2006 score
Mean (SD) 67.8 (13.09) 68.5 (13.55)
Median 68.0 68.5
No. of beds
Mean (SD) 18.6 (7.40) 18.5 (7.68)
TABLE 5 Screened patients
Admitted, n Assessed/screened, n (%)a Eligible, n (%) Consented, n (%) %b Registered, n (%)
Intervention
7067 6205 (87.8) 1256 (20.2) 490 (7.9) 39.0 451 (7.3)
Control
7303 6305 (86.3) 1419 (22.5) 534 (8.5) 37.6 479 (7.6)
Total
14,370 12,510 (87.1) 2675 (21.4) 1024 (8.2) 38.3 930 (7.4)
a For assessed patients, percentages are calculated from ‘admitted’ patients.
b Percentages are calculated from ‘eligible’ patients.
Percentages are calculated from ‘assessed’ patients.
RESULTS
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TABLE 6 Screened patients by centre: non-registration
Centre
Admitted,
n
Assessed/screened,
n (%)a
Eligible,
n (%)
Consented,
n (%)
Consented,
%b
Registered,
n (%)
Intervention
1 183 149 (81.4) 45 (30.2) 23 (15.4) 51.1 20 (13.4)
2 178 173 (97.2) 52 (30.1) 21 (12.1) 40.4 21 (12.1)
3 766 637 (83.2) 71 (11.1) 24 (3.8) 33.8 24 (3.8)
4 865 831 (96.1) 75 (9.0) 33 (4.0) 44.0 30 (3.6)
5 611 579 (94.8) 60 (10.4) 35 (6.0) 58.3 33 (5.7)
6 219 211 (96.3) 85 (40.3) 38 (18.0) 44.7 32 (15.2)
7 563 445 (79.0) 84 (18.9) 33 (7.4) 39.3 27 (6.1)
8 230 222 (96.5) 53 (23.9) 25 (11.3) 47.2 23 (10.4)
9 376 360 (95.7) 115 (31.9) 30 (8.3) 26.1 29 (8.1)
10 542 362 (66.8) 67 (18.5) 25 (6.9) 37.3 25 (6.9)
11 318 194 (61.0) 30 (15.5) 16 (8.2) 53.3 16 (8.2)
12 256 227 (88.7) 106 (46.7) 38 (16.7) 35.8 35 (15.4)
13 167 162 (97.0) 70 (43.2) 16 (9.9) 22.9 14 (8.6)
14 373 362 (97.1) 107 (29.6) 38 (10.5) 35.5 35 (9.7)
15 673 645 (95.8) 69 (10.7) 24 (3.7) 34.8 19 (2.9)
16 277 227 (81.9) 55 (24.2) 17 (7.5) 30.9 17 (7.5)
17 202 171 (84.7) 44 (25.7) 27 (15.8) 61.4 25 (14.6)
18 268 248 (92.5) 68 (27.4) 27 (10.9) 39.7 26 (10.5)
Total 7067 6205 (87.8) 1256 (20.2) 490 (7.9) 39.0 451 (7.3)
Control
19 314 310 (98.7) 74 (23.9) 39 (12.6) 52.7 34 (11.0)
20 929 720 (77.5) 135 (18.8) 32 (4.4) 23.7 27 (3.8)
21 244 235 (96.3) 84 (35.7) 36 (15.3) 42.9 31 (13.2)
22 260 225 (86.5) 44 (19.6) 20 (8.9) 45.5 18 (8.0)
23 514 403 (78.4) 78 (19.4) 26 (6.5) 33.3 25 (6.2)
24 373 284 (76.1) 54 (19.0) 13 (4.6) 24.1 12 (4.2)
25 688 566 (82.3) 88 (15.5) 44 (7.8) 50.0 38 (6.7)
26 189 182 (96.3) 65 (35.7) 25 (13.7) 38.5 23 (12.6)
27 285 270 (94.7) 92 (34.1) 35 (13.0) 38.0 35 (13.0)
28 354 265 (74.9) 85 (32.1) 27 (10.2) 31.8 23 (8.7)
29 775 747 (96.4) 103 (13.8) 37 (5.0) 35.9 30 (4.0)
30 311 285 (91.6) 56 (19.6) 17 (6.0) 30.4 13 (4.6)
31 188 158 (84.0) 46 (29.1) 28 (17.7) 60.9 26 (16.5)
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TABLE 7 Characteristics of screened participants
Baseline characteristics
Intervention
(N=6205) Control (N=6305) Total (N=12,510)
Age (years): mean (SD) 74.1 (13.72), n=6154 74.7 (13.04), n=6224 74.4 (13.39), n=12,378
Length of hospital stay (days): mean (SD) 27.3 (34.47), n=5860 28.5 (31.65), n=6076 27.9 (33.07), n=11,936
Sex (n, %), male 2931 (47.2) 3036 (48.2) 5967 (47.7)
Ethnicity (n, %), white 5742 (92.5) 5886 (93.4) 11,628 (92.9)
Living circumstances (n, %):
Lives alone 2518 (40.6) 2404 (38.1) 4922 (39.3)
Co-habits 3013 (48.6) 3214 (51.0) 6227 (49.8)
Nursing/residential care home 368 (5.9) 323 (5.1) 691 (5.5)
Missing 306 (4.9) 364 (5.8) 670 (5.4)
Co-resident caregiver (n, %) 2356 (38.0) 2659 (42.2) 5015 (40.1)
The caregiver is the patients . . . (n, %):
Partner 2528 (40.7) 2519 (40.0) 5047 (40.3)
Daughter/son 1914 (30.8) 1673 (26.5) 3587 (28.7)
Other relative 421 (6.8) 375 (5.9) 796 (6.3)
Other non-relative 144 (2.3) 157 (2.5) 301 (2.4)
No carer 887 (14.3) 1078 (17.1) 1965 (15.7)
Missing 311 (5.0) 503 (8.0) 814 (6.5)
TABLE 6 Screened patients by centre: non-registration (continued )
Centre
Admitted,
n
Assessed/screened,
n (%)a
Eligible,
n (%)
Consented,
n (%)
Consented,
%b
Registered,
n (%)
32 679 529 (77.9) 107 (20.2) 29 (5.5) 27.1 25 (4.7)
33 513 473 (92.2) 58 (12.3) 21 (4.4) 36.2 17 (3.6)
34 188 188 (100) 67 (35.6) 37 (19.7) 55.2 35 (18.6)
35 261 249 (95.4) 84 (33.7) 32 (12.9) 38.1 32 (12.9)
36 238 216 (90.8) 99 (45.8) 36 (16.7) 36.4 35 (16.2)
Total 7303 6305 (86.3) 1419 (22.5) 534 (8.5) 37.6 479 (7.6)
Overall total 14,370 12,510 (87.1) 2675 (21.4) 1024 (8.2) 38.3 930 (7.4)
a Percentages are out of ‘admitted’.
b Percentages are out of ‘eligible’.
Percentages are calculated out of ‘assessed’.
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DOI: 10.3310/hta17460 HEALTH TECHNOLOGY ASSESSMENT 2013 VOL. 17 NO. 46Analysis populationsConﬁrmation of written informed consent could not be obtained centrally for two patients (one in each of
the two randomised groups); therefore, these patients were not included in the ITT population.
The ITT population contains a total of 928 patients (intervention n=450, control n=478).Trial conductA CONSORT (Consolidated Standards of Reporting Trials) ﬂow diagram of trial progress and loss to follow-up
for SRUs (clusters) and individual participants (patients and caregivers) is presented in Figures 5 (patients) and
6 (caregivers).
Baseline dataPatient summaries
Baseline characteristics and clinical details of the ITT population are presented in Tables 8–11. The two
groups were well balanced with respect to these characteristics.
The mean age at registration was 71.0 (SD 12.76) years and 71.3 (SD 12.18) years in the intervention
and control groups, respectively. There were more males than females: 257 (57.1%) in the intervention
group and 262 (54.8%) in the control group, respectively. The majority of the participants were of
white ethnic background: 429 (95.3%) in the intervention group and 444 (92.9%) in the control group.
Most patients had a formal education: 427 (94.9%) in the intervention group and 457 (95.6%) in the
control group.
At the time of registration, most patients were retired: 311 (69.1%) and 337 (70.5%) in the intervention and
control groups, respectively, followed by patients in full employment, 80 (17.8%) in the intervention group
and 77 (16.1%) in the control group.
The majority of patients' preferred language was English, 439 (97.6%) in the intervention group and 467
(97.7%) in the control group.
In most cases, the caregiver was the patient's close relative: partner [314 (69.8%) in intervention and 315
(65.9%) in control] or offspring [118 (26.2%) in intervention and 135 (28.2%) in control]. A small proportion
of patients lived alone before the stroke: 66 (14.7%) in intervention and 85 (17.8%) in control groups.
The majority of the patients had received no more education since leaving school [270 (60%) intervention;
291 (61.1%) control] and the majority of the patients left education by the age of 16 years [328 (72.9%)
intervention; 381 (79.7%) control].
The clinical details of the patient population include the clinical and pathological classiﬁcation of current
stroke and patient abilities following stroke. The majority of patients had ischaemic stroke [380 (84.4%)
intervention; 401 (83.9%) control]. Some patients had experienced a previous stroke: 71 (15.8%) in
intervention and 96 (20.1%) in control. The number of patients with dysphasia was similar across both
groups: 118 (26.2%) intervention and 112 (23.4%) in control.
Researcher-completed patient baseline scores for the Barthel Index, modiﬁed Rankin Scale and 6CIT are
displayed in Table 12. Scores were similar across both groups. Over one-third of patients able to
complete the cognitive assessment (6CIT) demonstrated a cognitive impairment [135 (36.5%)
intervention; 145 (37.1%) control].35
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FIGURE 5 Clusters and patients.
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FIGURE 6 Clusters and caregivers.
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TABLE 8 Patient demographics (age, sex, ethnicity, education and employment)
Demographics Intervention (N=450) Control (N=478)
Age (years), mean (SD) 71.0 (12.76), n=450 71.3 (12.18), n=478
Sex, n (%): male 257 (57.1) 262 (54.8)
Ethnicity, n (%): white 429 (95.3) 444 (92.9)
Formal education, n (%): yes 427 (94.9) 457 (95.6)
Employment, n (%)
Retired 311 (69.1) 337 (70.5)
Working full time (≥30 hours per week) 80 (17.8) 77 (16.1)
Working part time (<30 hours per week) 18 (4.0) 21 (4.4)
Unable to work (for medical and other
reasons)
17 (3.8) 16 (3.3)
Othera 24 (5.3) 27 (5.6)
a Includes categories ‘at home and not looking for work’, ‘unemployed and looking for work’, ‘made redundant/early
retirement’ and ‘other’.
TABLE 9 Patient demographics (language, relationship with carer, living circumstances before stroke)
Demographics Intervention (N=450) Control (N=478)
Patient's preferred language, n (%)
English 439 (97.6) 467 (97.7)
If other, speaks and understands English?
Yes 6 (1.3) 3 (0.6)
No 5 (1.1) 8 (1.7)
Patient–caregiver relationship, n (%)
Partner 314 (69.8) 315 (65.9)
Daughter/son 118 (26.2) 135 (28.2)
Other relative 17 (3.8) 23 (4.8)
Other non-relative 1 (0.2) 5 (1.0)
Did the patient live alone before the stroke? n (%)
Yes 66 (14.7) 85 (17.8)
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TABLE 10 Patient demographics (further education)
Demographics Intervention (N=450) Control (N=478)
More education since leaving school, n (%)
Yes 156 (34.7) 163 (34.1)
No 270 (60.0) 292 (61.1)
No formal education 23 (5.1) 21 (4.4)
Missing 1 (0.2) 2 (0.4)
Age patient left education, n (%)
≤16 years 328 (72.9) 381 (79.7)
>16 years 97 (21.6) 76 (15.9)
No formal education 23 (5.1) 21 (4.4)
Unknown 1 (0.2) 0 (0.0)
Missing 1 (0.2) 0 (0.0)
TABLE 11 Patient's current stroke details and ability (after this stroke)
Stroke details/ability Intervention (N=450) Control (N=478)
Pathological classification of current stroke, n (%)
Cerebral infarction 380 (84.4) 401 (83.9)
Primary intracerebral haemorrhage 56 (12.4) 72 (15.1)
Subarachnoid haemorrhagea 6 (1.3) 5 (1.0)
Other 7 (1.6) 0 (0.0)
Missing 1 (0.2) 0 (0.0)
Clinical classification of stroke symptoms, n (%)
Left hemiparesis 217 (48.2) 253 (52.9)
Right hemiparesis 203 (45.1) 187 (39.1)
Brain stem 16 (3.6) 20 (4.2)
Other 14 (3.1) 18 (3.8)
Has the patient had a previous stroke? n (%)
Yes 71 (15.8) 96 (20.1)
No 376 (83.6) 381 (79.7)
Missing 3 (0.7) 1 (0.2)
Orientated in time, place and person, n (%)
Yes 380 (84.4) 397 (83.1)
No 70 (15.6) 81 (16.9)
Able to lift both arms off the bed, n (%)
Yes 303 (67.3) 327 (68.4)
No 146 (32.4) 151 (31.6)
Missing 1 (0.2) 0 (0.0)
continued
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TABLE 12 Patient baseline scores (researcher completed): Barthel Index, modiﬁed Rankin Scale and 6CIT
Index/scale Intervention (N=450) Control (N=478)
Barthel Index pre stroke (0–20)a, n (%)
Mean (SD) 19.2 (2.22), n=450 18.8 (2.77), n=478
6CIT (0–28)b, n (%)
Number (%) of 6CIT scores recorded
(only patients who were able to
complete those)
370 (82.2) 391 (81.8)
Normal 235 (63.5) 246 (62.9)
Impaired 135 (36.5) 145 (37.1)
Modified Rankin Scale (0–5)c, n (%)
Missing 3 (0.7) 0 (0.0)
0 1 (0.2) 3 (0.6)
1 3 (0.7) 4 (0.8)
2 44 (9.8) 43 (9.0)
3 137 (30.4) 148 (31.0)
4 244 (54.2) 258 (54.0)
5 18 (4.0) 22 (4.6)
a Barthel Index: 0=dependent, 20= independent.
b 6CIT: ≥8=normal, 9–19=moderate impairment, ≥20=severe impairment.
c Modiﬁed Rankin Scale: 0=no symptoms, 5= severe disability.
TABLE 11 Patient's current stroke details and ability (after this stroke) (continued )
Stroke details/ability Intervention (N=450) Control (N=478)
Able to walk without help from others, n (%)
Yes 148 (32.9) 159 (33.3)
No 301 (66.9) 319 (66.7)
Missing 1 (0.2) 0 (0.0)
Patient's language ability, n (%)
Normal 290 (64.4) 307 (64.2)
Dysphasia 118 (26.2) 112 (23.4)
Dysarthria 42 (9.3) 58 (12.1)
Missing 0 (0.0%) 1 (0.2)
Does the patient intend to live alone after discharge? n (%)
No 399 (88.7) 401 (83.9)
Are the patient and caregiver intending to live together after discharge? n (%)
Yes 376 (83.6) 386 (80.8)
a Subarachnoid haemorrhages were not intentionally included in this trial; however, a small number were recruited early
on in the trial before this eligibility criteria were clariﬁed to the researchers.
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Patient-completed scores for Barthel Index, NEADL scale, HADS, EQ-5D and SIS are displayed in
Tables 13–14. Scores were also similar across both groups. The HADS questionnaire was also summarised
categorically: 171 intervention patients (38.0%) and 210 control patients (43.9%) had raised anxiety levels,
whereas 188 (41.8%) intervention patients and 209 (43.7%) control patients had raised levels of depression.
Caregiver summaries
The caregiver baseline demographics of the ITT population are displayed in Tables 15–17. The mean
caregiver age was 61.1 (SD 14.64) years and 60.8 (SD 13.91) years in the intervention and control groups,
respectively. In contrast with patients, more females than males were acting as caregivers in both groups:
310 (68.9%) in the intervention group and 325 (68.0%) in the control group. The majority of caregivers were
of white ethnic background: 430 (95.6%) in the intervention group and 446 (93.3%) in the control group.
A large proportion of caregivers were retired [195 (43.3%) in the intervention group and 221 (46.2%) in the
control group], followed by caregivers in full- and part-time employment [187 (41.5%) in the intervention
group and 188 (39.3%) in the control group].TABLE 13 Patient baseline scores (patient completed): Barthel Index, NEADL scale, HADS and EQ-5D
Index/scale Intervention (N=450) Control (N=478)
NEADL score (0–66)a
Mean (SD) 52.0 (15.77), n=443 52.3 (15.80), n=474
Barthel Index post stroke (0–20)b
Mean (SD) 12.2 (5.38), n=442 12.6 (5.45), n=473
HADS (0–21)c, n (%)
HADS Anxiety score
Normal 256 (56.9) 254 (53.1)
Borderline abnormal 83 (18.4) 98 (20.5)
Abnormal 88 (19.6) 112 (23.4)
Missing 23 (5.1) 14 (2.9)
Mean (SD) 6.7 (4.47), n=427 7.3 (4.65), n=464
HADS Depression score
Normal 241 (53.6) 254 (53.1)
Borderline abnormal 77 (17.1) 86 (18.0)
Abnormal 111 (24.7) 123 (25.7)
Missing 21 (4.7) 15 (3.1)
Mean (SD) 7.3 (4.68), n=429 7.6 (4.81), n=463
EQ-5D indexd (–0.59, 1)
Mean (SD) 0.360 (0.375), n=426 0.380 (0.357), n=459
a Pre-stroke NEADL score: 0= low independence, 66=high independence.
b Barthel Index: 0=dependent, 20= independent.
c HADS score: normal (0–7), borderline (8–10), abnormal (11–21).
d EQ-5D: –0.59=worst possible health, 1= full health.
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ABLE 14 Patient baseline scores (patient completed): SIS
SIS Intervention (N=450) Control (N=478)
SIS (0–100)a
Strength score
Mean (SD) 42.4 (27.00), n=414 45.7 (29.14), n=440
ADL score
Mean (SD) 43.6 (27.23), n=431 46.3 (26.72), n=466
Mobility score
Mean (SD) 41.1 (29.29), n=424 43.2 (29.06), n=459
Hand function score
Mean (SD) 26.9 (33.00), n=426 28.6 (34.02), n=440
Physical domains score
Mean (SD) 39.7 (25.19), n=434 42.3 (25.47), n=466
Memory score
Mean (SD) 66.7 (29.85), n=431 67.9 (29.74), n=467
Mood score
Mean (SD) 69.0 (18.48), n=425 69.7 (17.80), n=462
Communication score
Mean (SD) 76.4 (28.02), n=433 76.9 (28.85), n=471
a SIS: 0=worst, 100=best.
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Demographics Intervention (N=450) Control (N=478)
Age (years), mean (SD) 61.1 (14.64), n=450 60.8 (13.91), n=478
Sex, n (%): male 140 (31.1) 153 (32.0)
Ethnicity, n (%): white 430 (95.6) 446 (93.3)
Formal education, n (%): yes 435 (96.7) 464 (97.1)
Employment, n (%)
Retired 195 (43.3) 221 (46.2)
Working full-time (≥30 hours per week) 127 (28.2) 123 (25.7)
Working part time (<30 hours per week) 60 (13.3) 65 (13.6)
Othera 68 (15.1) 69 (14.4)
a Includes categories ‘student’, ‘at home and not looking for work’, ‘unemployed and looking for work’, ‘made redundant/
took early retirement’, ‘unable to work’ and ‘other’.
NIHR Journals Library www.journalslibrary.nihr.ac.uk
ABLE 16 Caregiver demographics (language, place of residence)
Demographics Intervention (N=450) Control (N=478)
Caregiver's preferred language,a n (%)
English 447 (99.3) 475 (99.4)
In the last 12 months, has the caregiver resided with the patient? n (%)
Yes 356 (79.1) 364 (76.2)
DOI: 10.3310/hta17460 HEALTH TECHNOLOGY ASSESSMENT 2013 VOL. 17 NO. 46Ta All caregivers with preferred language ‘other’ spoke and understood English.
TABLE 17 Caregiver demographics: further education
Demographics Intervention (N=450) Control (N=478)
More education since leaving school, n (%)
Yes 199 (44.2) 211 (44.1)
No 233 (51.8) 245 (51.3)
No formal education 15 (3.3) 13 (2.7)
Missing 3 (0.7) 9 (1.9)
Age caregiver left education,a n (%)
≤16 years 317 (70.4) 339 (70.9)
>16 years 133 (29.6) 139 (29.1)The majority of caregivers had formal education [435 (96.7%) in intervention and 464 (97.1%) in control],
with most caregivers leaving education by the age of 16 years [317 (70.4%) in the intervention group and
339 (70.9%) in the control group].
Nearly all caregivers' preferred language was English [447 (99.3%) in intervention and 475 (99.4%) in
control]. The majority of caregivers lived with the patient during the last 12 months [356 (79.1%) in the
intervention group and 364 (76.2%) in the control group].
Researcher completed caregiver modiﬁed Rankin Scale scores are summarised in Table 18. The majority
of caregivers had a score of 0 or 1 [427 (94.9%) in the intervention group and 453 (94.7%) in the
control group].
The baseline scores in FAI, HADS and EQ-5D completed by caregivers show similarities between the
treatment groups (Table 19). The HADS questionnaire was summarised categorically. A sizeable proportion
of caregivers showed raised levels of anxiety at baseline [236 (52.5%) in the intervention group and 238
(49.8%) in the control group], whereas 122 (27.1%) intervention caregivers and 122 (25.5%) control
caregivers had raised levels of depression.
Cluster-level balance
Two-sample t-tests weighted by inverse number of patients in each centre were used to compare baseline
characteristics of patients and caregivers between intervention and control groups. These tests showed
that there are no statistically signiﬁcant differences between patients (Tables 20 and 21) or caregivers
(Tables 22 and 23).43
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TABLE 19 Caregiver baseline scores (caregiver completed): FAI, HADS and EQ-5D
Index/scale Intervention (N=450) Control (N=478)
FAI (range 0–45)a
Mean (SD) 32.9 (7.99), n=441 33.5 (7.40), n=470
HADS (0–21b), n (%)
HADS Anxiety score, n (%)
Normal 206 (45.8) 232 (48.5)
Borderline abnormal 94 (20.9) 90 (18.8)
Abnormal 142 (31.6) 148 (31.0)
Missing 8 (1.8) 8 (1.7)
Mean (SD) 8.3 (4.87), n=442 8.0 (4.74), n=470
HADS Depression score, n (%)
Normal 320 (71.1) 349 (73.0)
Borderline abnormal 69 (15.3) 81 (16.9)
Abnormal 53 (11.8) 41 (8.6)
Missing 8 (1.8) 7 (1.5)
Mean (SD) 5.2 (4.25), n=442 5.0 (3.89), n=471
EQ-5D index (–0.59, 1)c
Mean (SD) 0.797 (0.232), n=438 0.791 (0.245), n=471
a FAI: 0= inactive, 45=active.
b HADS: normal (0–7), borderline (8–10), abnormal (11–21).
c EQ-5D: –0.59=worst possible health, 1= full health.
TABLE 18 Caregiver baseline scores (researcher completed): modiﬁed Rankin Scale
Modiﬁed Rankin Scale (0–5a) Intervention (N=450), n (%) Control (N=478), n (%)
0 387 (86.0) 385 (80.5)
1 40 (8.9) 68 (14.2)
2 16 (3.6) 19 (4.0)
3 6 (1.3) 4 (0.8)
4 1 (0.2) 2 (0.4)
a Modiﬁed Rankin Scale: 0=no symptoms, 5= severe disability. There are no caregivers with modiﬁed Rankin Scale of 5.
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TABLE 21 t-Tests to compare percentages: baseline data – patients
Patient baseline details Total Intervention, % (SD) Control, % (SD) p-value (two-sided)
Sex: male 36 55.4 (2.03) 54.7 (1.80) 0.8162
Ethnicity: white 36 95.4 (1.79) 94.8 (2.17) 0.8674
Left education aged
≤16 years
36 70.5 (3.43) 76.1 (3.30) 0.305
Independent before this
stroke: yes
36 92.0 (1.28) 89.1 (1.74) 0.24
Lived alone before this
stroke: yes
36 14.5 (1.99) 16.3 (2.29) 0.622
Intends to live alone after
discharge: no
36 89.9 (1.63) 84.7 (2.23) 0.1033
Pathological classiﬁcation of
stroke: cerebral infarction
36 84.8 (1.57) 85.2 (1.52) 0.8897
Clinical classiﬁcation of
stroke: left hemiparesis
36 48.4 (2.50) 54.0 (2.28) 0.1579
Previous stroke: no 36 84.2 (2.17) 78.7 (1.95) 0.1093
Patient can talk and
orientated
36 85.4 (2.38) 85.5 (2.42) 0.9663
Can lift both arms off
the bed
36 67.7 (3.77) 67.1 (3.17) 0.9096
Patient can walk without
help of others
36 32.0 (3.31) 34.5 (2.84) 0.6283
Normal language ability 36 63.7 (3.63) 66.0 (2.95) 0.6728
Two-sample t-test to compare percentages, weighted by inverse number of patients.
TABLE 20 t-Tests to compare means: baseline data – patients
Patient baseline details Total Intervention, mean (SD) Control, mean (SD) p-value (two-sided)
Barthel Index pre stroke score 36 19.3 (0.12) 18.7 (0.21) 0.0536
6CIT score 36 7.9 (0.49) 8.3 (0.61) 0.6082
Age (years) 36 70.2 (0.86) 71.1 (0.87) 0.5326
Barthel Index post-stroke score 36 12.1 (0.26) 12.8 (0.30) 0.1467
NEADL pre-stroke score 36 52.8 (0.75) 51.2 (1.03) 0.2848
SIS Physical score 36 38.3 (1.47) 42.1 (1.29) 0.0994
SIS Memory score 36 66.4 (1.88) 68.1 (2.01) 0.5731
SIS Mood score 36 68.3 (1.07) 70.6 (0.88) 0.1437
SIS Communication score 36 77.0 (1.39) 77.4 (1.45) 0.8697
SIS Recovery score 36 44.3 (1.41) 48.3 (1.23) 0.0739
EQ-5D score 36 0.4 (0.02) 0.4 (0.02) 0.4499
HADS Anxiety score 36 7.0 (0.30) 7.1 (0.20) 0.9262
HADS Depression score 36 7.5 (0.28) 7.4 (0.24) 0.8535
Two-sample t-test to compare means, weighted by inverse number of patients.
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ABLE 22 t-Tests to compare means: baseline data – caregivers
Caregiver baseline
details Total
Intervention,
mean (SD)
Control,
mean (SD)
p-value
(two-sided)
Age (years) 36 60.9 (0.95) 61.3 (1.48) 0.8541
EQ-5D score 36 0.8 (0.02) 0.8 (0.01) 0.838
HADS Anxiety score 36 8.3 (0.27) 8.0 (0.22) 0.4811
HADS Depression score 36 5.4 (0.27) 5.0 (0.14) 0.2081
FAI score 36 33.1 (0.39) 33.3 (0.37) 0.7845
RESULTSTTwo-sample t-test to compare means, weighted by inverse number of patients.
TABLE 23 t-Tests to compare percentages: baseline data – caregivers
Caregiver baseline
details Total
Intervention,
% (SD)
Control,
% (SD)
p-value
(two-sided)
Sex: male 36 32.8 (2.22) 32.2 (2.01) 0.8656
Ethnicity: white 36 95.5 (1.82) 95.0 (2.11) 0.8713
In full-time employment 36 30.4 (1.96) 26.4 (2.94) 0.3358
Modiﬁed Rankin scale=0 36 87.9 (2.24) 82.3 (2.21) 0.1303
Two-sample t-test to compare percentages, weighted by inverse number of patients.
46Trial outcomes
Questionnaire follow-up
Efforts were made to follow all patients and caregivers when appropriate. For primary end point, the cut-off
period was set at 10 months. With this cut-off time-point, only three patients' questionnaires and
10 caregivers' questionnaires were excluded.Patients
At 6 months for patient primary end point, the overall response rate for received questionnaires was 74.4% in
the intervention group and 74.3% in the control group, 74.4% overall. A detailed summary of the reasons as
to why questionnaires were not received is shown in Table 24. The main reasons for not returning the
questionnaires were patients' deaths [73 (7.9%)], patients conﬁrming that they would return questionnaire
but questionnaire was never received [58 (6.3%)] and inability to get hold of participant [51 (5.5%)].
The response rate at 12 months was 67.8% in the intervention group and 69.6% in the control group,
68.8% in total (Table 25). The main reasons for not returning the questionnaires at this time-point were
patients' deaths [104 (11.2%)], inability to get hold of participant [65 (7.0%)] and patients conﬁrming that
they would return questionnaire but questionnaire was never received [54 (6.1%)].
Caregivers
Table 26 displays the response rate for caregivers' questionnaires at 6 months. Overall, 72.5% were received,
73.1% in the intervention and 72.0% in the control group. The main reasons for questionnaires not received
were patients' deaths [70 (7.5%)], caregiver said that they would return questionnaire but questionnaire
was never received [66 (7.1%)] and inability to get hold of caregiver [61 (6.6%)].
The response rates for caregivers' questionnaires at 12 months are summarised in Table 27. The number of
received questionnaires at 12 months was lower than at 6 months. Overall, 65.6% were received: 65.6% inNIHR Journals Library www.journalslibrary.nihr.ac.uk
TABLE 24 Patients' questionnaires follow-up at 6 months
Patient follow-up
Intervention (N=450),
n (%)
Control (N=478),
n (%)
Total (N=928),
n (%)
Questionnaire
Received 329 (73.1) 348 (72.8) 677 (73.0)
Received over the telephone 6 (1.3) 7 (1.5) 13 (1.4)
Patient died 39 (8.7) 34 (7.1) 73 (7.9)
Patient withdrew 5 (1.1) 5 (1.0) 10 (1.1)
Received too late 0 (0.0) 3 (0.6) 3 (0.3)
Questionnaire not returned 71 (15.8) 81 (16.9) 152 (16.4)
Reasons questionnaires not received
Too poorly 10 (2.2) 17 (3.6) 27 (2.9)
Could not get hold of participant 27 (6.0) 24 (5.0) 51 (5.5)
Conﬁrmed received questionnaire and
said that would return
26 (5.8) 32 (6.7) 58 (6.3)
Too busy 2 (0.4) 3 (0.6) 5 (0.5)
Other 6 (1.3) 5 (1.0) 11 (1.2)
TABLE 25 Patients' questionnaires follow-up at 12 months
Patient follow-up
Intervention (N=450),
n (%)
Control (N=478),
n (%)
Total (N=928),
n (%)
Questionnaire
Received 300 (66.7) 329 (68.8) 629 (67.8)
Received over the telephone 5 (1.1) 4 (0.8) 9 (1.0)
Patient died 53 (11.8) 51 (10.7) 104 (11.2)
Patient withdrew 16 (3.6) 13 (2.7) 29 (3.1)
GP not provided conﬁrmation (patient) 1 (0.2) 0 (0.0) 1 (0.1)
Questionnaire not returned 75 (16.7) 81 (16.9) 156 (16.8)
Reasons questionnaires not received
Too poorly 13 (2.9) 7 (1.5) 20 (2.2)
Could not get hold of participant 31 (6.9) 34 (7.1) 65 (7.0)
Conﬁrmed received questionnaire and
said that would return
27 (6.0) 30 (6.3) 57 (6.1)
Too busy 1 (0.2) 4 (0.8) 5 (0.5)
Other 3 (0.7) 6 (1.3) 9 (1.0)
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received were patients' deaths [104 (11.2%)], not being able to get hold of participant [72 (7.8%)] and
caregiver said that they would return questionnaire but questionnaire was never received [63 (6.8%)].
Proxy responses
Proxy responses, where the entire questionnaire was completed on patients' behalf without consulting them,
were anticipated. At baseline, 63 (6.8%) of questionnaires were via a proxy response; at 6 months and
12 months, 37 (5.5%) and 41 (6.5%), respectively, were via a proxy response (Table 28).47
.
TABLE 26 Caregivers' questionnaires: follow-up at 6 months
Caregiver follow-up
Intervention (N=450),
n (%)
Control (N=478 ),
n (%)
Total (N=928),
n (%)
Questionnaire
Received 327 (72.7) 336 (70.3) 663 (71.4)
Received over the telephone 2 (0.4) 8 (1.7) 10 (1.1)
Patient died 37 (8.2) 33 (6.9) 70 (7.5)
Caregiver died 2 (0.4) 0 (0.0) 2 (0.2)
Both withdrew 5 (1.1) 4 (0.8) 9 (1.0)
Received too late 4 (0.9) 5 (1.0) 9 (1.0)
Questionnaire not returned 73 (16.2) 92 (19.2) 165 (17.8)
Reasons questionnaires not received
Too poorly 5 (1.1) 5 (1.0) 10 (1.1)
Could not get hold of participant 25 (5.6) 36 (7.5) 61 (6.6)
Conﬁrmed received questionnaire and
said that would return
29 (6.4) 37 (7.7) 66 (7.1)
Too busy 5 (1.1) 11 (2.3) 16 (1.7)
Other 9 (2.0) 3 (0.6) 12 (1.3)
TABLE 27 Caregivers' questionnaires: follow-up at 12 months
Caregiver follow-up
Intervention (N=450),
n (%)
Control (N=478),
n (%)
Total (N=928),
n (%)
Questionnaire
Received 292 (64.9) 313 (65.5) 605 (65.2)
Received over the telephone 3 (0.7) 1 (0.2) 4 (0.4)
Patient died 53 (11.8) 51 (10.7) 104 (11.2)
Caregiver died 6 (1.3) 4 (0.8) 10 (1.1)
Patient withdrew 1 (0.2) 1 (0.2) 2 (0.2)
Caregiver withdrew 8 (1.8) 5 (1.0) 13 (1.4)
Both withdrew 13 (2.9) 11 (2.3) 24 (2.6)
GP not provided conﬁrmation (patient) 1 (0.2) 0 (0.0) 1 (0.1)
Questionnaire not returned 73 (16.2) 92 (19.2) 165 (17.8)
Reasons questionnaires not received
Too poorly 3 (0.7) 3 (0.6) 6 (0.6)
Could not get hold of participant 35 (7.8) 37 (7.7) 72 (7.8)
Conﬁrmed received questionnaire and
said that would return
27 (6.0) 36 (7.5) 63 (6.8)
Too busy 6 (1.3) 8 (1.7) 14 (1.5)
Other 2 (0.4) 8 (1.7) 10 (1.1)
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ABLE 28 Patients whose outcomes were collected via a proxy responsea
Questionnaire Intervention, n (%) Control, n (%) Total, n (%)
Baseline 33 (7.3), n=450 30 (6.3), n=478 63 (6.8), n=928
6 months 15 (4.5), n=330 22 (6.3), n=348 37 (5.5), n=678
12 months 22 (7.3), n=301 19 (5.8), n=330 41 (6.5), n=631
a Whole questionnaire completed on patients' behalf without consulting them.
DOI: 10.3310/hta17460 HEALTH TECHNOLOGY ASSESSMENT 2013 VOL. 17 NO. 46TPrimary outcomesPatients
Table 29 summarises the unadjusted NEADL scores for patients. Overall, NEADL scores were similar between
the two treatment groups; the mean score decreased at 6 months post stroke when compared with
pre-stroke level and minimally increased at 12 months.
Mean adjusted NEADL scores for 6 months were calculated and shown in Table 30, adjusted for patient- and
SRU-level covariates (see Chapter 3). Results were similar to the unadjusted results, the adjusted NEADL
mean score for the intervention was 27.4 [standard error (SE) 1.00] and for the control 27.6 (SE 0.99), with a
mean difference of –0.2 points [95% conﬁdence interval (CI) –3.0 to 2.5 points; p=0.866] and an adjusted
ICC of 0.027, indicating that there is no evidence of a statistically signiﬁcant difference between the
treatment groups in NEADL scores at 6 months.
In the trial protocol, a clinically relevant difference was deﬁned as 6 (SD 18) points on the NEADL scale. Given
these results, differences between the groups at 6 months were minimal and did not reach either clinical
or statistical signiﬁcance.Caregivers
Table 31 summarises the unadjusted CBS scores and subscales for caregivers. Overall, the total and subscales
CBS scores were similar between the groups at 6 and 12 months.
The mean adjusted CBS scores at 6 months were calculated, Table 32, adjusted for patient-level and
SRU-level covariates (see Chapter 3). Results were similar to the unadjusted results, the adjusted CBS mean
score for intervention was 45.5 (SE 0.83) and for control 45.0 (SE 0.83), with a mean difference of 0.5 points
(95% CI –1.7 to 2.7 points; p=0.660) and adjusted ICC of 0.013, indicating that there is no evidence of
statistically signiﬁcant difference between the groups in caregiver burden at 6 months.
Sensitivity analysesSensitivity analyses for patient primary end point
A sensitivity analysis including patients who had died was undertaken and assumed that these patients had a
NEADL score of 0. This sensitivity analysis showed results similar to the primary analysis: the adjusted
scores were similar between the groups; the adjusted NEADL mean score for the intervention group was
24.2 and for the control group was 25.1, with –0.9 (95% CI –3.5 to 1.8; p=0.507) point difference and
adjusted ICC of 0.019, again indicating no evidence of a difference between the groups (see Table 80).
A sensitivity analysis without proxy responses was performed to assess the impact of proxy responses
on the analysis of the primary end point. This sensitivity analysis also showed results similar to the primary
analysis: the adjusted mean NEADL score for the intervention group was 28.2 points and for the control
group was 28.6 points, with –0.4 (95% CI –3.4 to 2.5; p=0.766) point difference and adjusted ICC of 0.038
(see Appendix 8, Table 80).49
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TABLE 31 Caregivers' primary outcome at different time points by arm
CBS: caregivers' questionnaire scores: unadjusted means
Questionnaire
6 months 12 months
Intervention,
mean (SD), n
Control,
mean (SD), n
Intervention,
mean (SD), n
Control,
mean (SD), n
Total CBSa score (0–88) 46.3 (14.97), 325 45.8 (14.30), 340 45.9 (15.01), 291 45.2 (14.22), 314
Subscales
General strain 2.3 (0.81), 325 2.3 (0.787), 340 2.3 (0.82), 291 2.3 (0.79), 314
Isolation 2.2 (0.82), 324 2.2 (0.86), 340 2.2 (0.79), 291 2.2 (0.83), 314
Disappointment 2.2 (0.83), 325 2.2 (0.78), 343 2.2 (0.81), 291 2.1 (0.76), 314
Emotional involvement 1.6 (0.67), 325 1.6 (0.67), 340 1.6 (0.71), 291 1.7 (0.70), 314
Environment 1.8 (0.71), 324 1.7 (0.67), 340 1.7 (0.72), 291 1.6 (0.65), 314
a CBS: 0=no burden, 88= severe burden. CBS was not measured at baseline.
DOI: 10.3310/hta17460 HEALTH TECHNOLOGY ASSESSMENT 2013 VOL. 17 NO. 46Sensitivity analyses for both patient and caregiver primary end point
The time of completion of questionnaires for primary end points was compared between arms. No
statistically signiﬁcant differences were found for patients (difference –1.2 days, 95% CI –3.4 to 1.0 days;
p=0.2862) or caregivers (difference 0 days, 95% CI –2.1 to 2.2 days; p=0.9836) (see Table 81).Secondary outcomes
Patients
Unadjusted Barthel Index, EQ-5D, HADS and SIS mean scores are shown in Table 33. Mean scores,
differences in means, 95% CIs, p-values, unadjusted and adjusted ICCs for the questionnaires adjusted
for patient- and SRU-level covariates are displayed in Tables 34 and 35. Overall, at both 6 and
12 months there was no evidence of statistically signiﬁcant differences in patients' physical and
psychological outcomes between intervention and control groups.Caregivers
Unadjusted HADS, EQ-5D and FAI mean scores are shown in Table 36. Mean scores for the questionnaires,
differences in means, 95% CIs, p-values, unadjusted and adjusted ICCs adjusted for caregiver- and
SRU-level covariates at 6 months are displayed in Tables 37 and 38. Overall, at both 6 and 12 months,
there was no evidence of statistically signiﬁcant differences in caregivers' physical and psychological
outcomes between intervention and control groups.
ComplianceIntervention compliance
This section summarises the training records documented by the MDT in intervention centres and provides
data related to the delivery of intervention. The number of training records completed and available for
analysis is displayed in Table 39. There were 124 (27.6%) training records not completed by the sites.
In total, 196 (43.6%) records were deﬁned as intervention compliant. Table 40 provides a summary of
intervention compliance by SRUs; the percentage of compliant records varied from 0.0% to 92.9%. The
number of mandatory components achieved by caregivers is summarised in Table 41. Appendix 8
(see Tables 75 and 76) summarises the number of non-mandatory components achieved by caregivers.51
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TABLE 39 Number of training records completed
Training records completed Registered (N=450), n (%)
Yes 326 (72.4)
Conﬁrmed not completed by site 96 (21.3)
Conﬁrmed lost by site 27 (6.0)
Missing 1 (0.2)
TABLE 40 Intervention compliant records
SRU Registered patients Intervention compliant, n (%)
Intervention 450 196 (43.6)
1 20 0 (0.0)
2 21 13 (61.9)
3 24 16 (66.7)
4 30 11 (36.7)
5 32 0 (0.0)
6 32 2 (6.3)
7 27 8 (29.6)
8 23 20 (87.0)
9 29 22 (75.9)
10 25 3 (12.0)
11 16 14 (87.5)
12 35 3 (8.6)
13 14 13 (92.9)
14 35 25 (71.4)
15 19 7 (36.8)
16 17 13 (76.5)
17 25 6 (24.0)
18 26 20 (76.9)
TABLE 41 Number of mandatory components achieved
No. of components achieved Registered (N=450), n (%) Cumulative, n (%)
6 96 (21.3) 96 (21.3)
5 56 (12.4) 152 (33.8)
4 31 (6.9) 183 (40.7)
3 34 (7.6) 217 (48.2)
2 29 (6.4) 246 (54.7)
1 28 (6.2) 274 (60.9)
0a 52 (11.6) 326 (72.4)
Missing 124 (27.6) 450 (100.0)
a Training record was returned, but the information on mandatory components achieved was not completed.
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DOI: 10.3310/hta17460 HEALTH TECHNOLOGY ASSESSMENT 2013 VOL. 17 NO. 46Intervention compliance and participant outcomes
The relationship between centre-level compliance with the intervention and mean patient NEADL score at
6 months is displayed in Figure 7 and mean caregiver CBS score at 6 months is in Figure 8. The tables
show no evidence of higher levels of patient independence or lower level of caregiver burden in the SRUs
with better levels of intervention compliance.
Control group compliance
A summary of the numbers of time logs completed by MDTs in control SRUs is shown in Table 42 and by site
in Appendix 8 (see Table 77).
Time spent with caregivers
The overall time spent with caregivers was similar in the two groups [median of 118 minutes (range 10 to
900 minutes) in the intervention group (training records) and 133 minutes (range 1 to 1130 minutes) in
control group (time logs)] (Table 43; Figures 9 and 10).60
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FIGURE 7 Nottingham Extended Activities of Daily Living scores at 6 months and site compliance with intervention.
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FIGURE 8 Caregiver Burden Scale scores at 6 months and site compliance with intervention. Plot of means
with SD bars.
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FIGURE 10 Overall time spent with carergiver: control.
TABLE 42 Number of time logs completed
Time logs completed Registered (N=478), n (%)
Yes 211 (44.1)
No 5 (1.0)
Not required 174 (36.4)
Conﬁrmed not completed by site 79 (16.5)
TABLE 43 Time spent with caregiver
Time spent with caregiver (minutes) Intervention Control
n 214 180
Mean (SD) 136.5 (118.12) 200.3 (189.12)
Median (range) 117.5 (10–900) 132.5 (1–1130)
Missing 236 298
RESULTS
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DOI: 10.3310/hta17460 HEALTH TECHNOLOGY ASSESSMENT 2013 VOL. 17 NO. 46Patient safety: expected adverse events/serious adverse eventsFalls
Summaries of the number of patients with falls, number of reported patients' falls and number of
SAEs by arm are shown in Table 44 (and by SRUs in Appendix 8, Table 78). In each group there were
35 patients who fell one or more times. The mean number of falls per patient who fell was 1.4 (SE 0.88)
in the intervention group and 1.2 (SE 0.76) in the control group. Two falls in the intervention group and
three in the control group resulted in SAEs.
No RUSAEs were reported.
Deaths
The numbers of patients' and caregivers' deaths by treatment arm are shown in Table 45. There were
12 patients that died before discharge; six in each group. There were 41 (9.1%) patient deaths in theTABLE 44 Summaries of patients' falls between registration and discharge
Summaries of patients' falls between registration and discharge Intervention (N=45) Control (N=478)
Missing form, n (%) 1 (0.2) 0 (0.0)
No. of discharge forms received, n (%) 449 (99.8) 478 (100.0)
No. of patients who fell one or more times, n (%) 35 (7.8) 35 (7.3)
No. of reported falls 50 42
Mean no. (SE) of falls 1.4 (0.88) 1.2 (0.76)
Median 1.0 1.0
Range (1–5) (1–5)
No. of reported SAEs 2 3
Mean no. (SE) of falls that resulted in SAEs (of those who fell) 0.1 (0.24) 0.1 (0.28)
Median 0.0 0.0
Range (0–1) (0–1)
TABLE 45 Patient and caregiver deaths between registration and the end of 6- and 12-month follow-up
Deaths Intervention (N=450), n (%) Control (N=478), n (%)
No. of patient deaths
6 months 41 (9.1) 35 (7.3)
12 months 12 (2.7) 20 (4.2)
No. of caregiver deaths
6 months 2 (0.4) 1 (0.2)
12 months 4 (0.9) 3 (0.6)
Overall
No. of patient deaths 53 (11.8) 55 (11.5)
No. of caregiver deaths 6 (1.3) 4 (0.8)
After the patient's death, the caregiver was not followed up.
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RESULTS
60intervention group and 35 (7.3%) in the control group by 6 months and a further 12 (2.7%) in intervention
and 20 (4.2%) in control by 12 months.
Overall, six (1.3%) caregivers deaths in intervention and four (0.8%) in control were reported. If the patient
died, the caregiver was no longer followed up.
Process data
A summary of the process data collected by the trial manager on the visits before (2007) and after
(2009/2010) recruitment at both control and intervention centres is provided in Appendix 8, Table 85. Data
collected during recruitment (2008) did not vary from that collected after recruitment had completed. The
organisational structure and the process of care on the majority of stroke units did not change signiﬁcantly
throughout the trial. Signiﬁcant changes to the standard process of care of involving patients and their carers
during the inpatient stay was seen in just one centre. Four other centres experienced signiﬁcant changes to
their organisational structure, which did not impact upon the process of care of involving patients and their
caregivers. A brief description of these centres is provided in Appendix 8, Table 86.NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta17460 HEALTH TECHNOLOGY ASSESSMENT 2013 VOL. 17 NO. 46Chapter 5 Economic evaluationClient Service Receipt Inventory and European Quality of Life-5
Dimensions completion ratesTables 46 and 47 summarise CSRI and EQ-5D completion rates, respectively, at each assessment point. Both
measures had similar completion rates at each assessment point and rates were balanced between the
intervention and control arms. Table 48 characterises subsamples with both cost and outcome data at
6 months, a necessary requirement for inclusion in the CEAC-based analyses. Although differences were not
explored statistically, the baseline characteristics of patients and caregivers with the necessary data at
6 months appeared similar to those of the full sample. Therefore, results based on those followed up are
likely to generally be representative of the full sample.
Resource use
Resource-use differences were not compared statistically, ﬁrstly because the economic evaluation was
focused on costs and cost-effectiveness and, secondly, to avoid problems associated with multiple testing.
Therefore, resource-use patterns are described without statistical comparisons.
Tables 49–54 show resource use at each assessment point. These tables are limited to inpatient services plus
other items used by at least 10% of responders in either trial arm at that time point. Full resource-use data
are provided in Appendix 9. The length of the initial stroke admission was similar in both groups (see
Table 50). Other resource use also appeared broadly comparable between the two groups at baseline,
6 months and 12 months. As could be expected, patients' use of inpatient services (other than the stroke
admission), outpatient services, hospital physiotherapy and hospital occupational therapy increased during
the post-stroke period compared with baseline. It is also interesting to note that caregiver's use of inpatient
and outpatient services increased notably during the post-stroke period. With regards to community-based
services, patients most commonly used dentist, chiropodist and optician services at all three time points.
Services most used by caregivers were outpatient services, GP, practice nurse and repeat prescriptions.
In comparison with formal care inputs, patient informal care rates were very high. Care to patients from
non-resident informal caregivers increased at each time point.
Costs and quality-adjusted life-years
The mean cost of the LSCTC training and development was £39 (Table 55). This is the mean across the whole
intervention group, including those allocated zero costs for either receiving no LSCTC inputs or with missing
data regarding such inputs. The mean cost among only those receiving inputs was £82.
The mean cost of the initial stroke admission was similar between groups (mean difference £1243,
95% CI –£1533 to £4019; see Table 55). Total health and social care and societal costs were broadly similar
between both randomisation groups at all assessment points (Tables 56–58), except that caregivers in the
intervention arm had higher health and social care costs at 6 months (+£207, 95% CI £5 to £408;
see Table 58). This difference was no longer present at 12 months and was not apparent when costs from
the two assessment points were combined as 1-year costs. There were also no differences in QALYs for
patients or caregivers at any of the assessment points (Table 59). Although the direction of the
between-group difference is opposite in the patient (positive) and caregiver (negative) evaluations the mean
differences are so small that they are essentially zero. It should also be noted that comparisons of costs
and outcomes do not account for the correlation between these parameters.61
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TABLE 46 Client Service Receipt Inventory completion rates
Patients Caregivers
Baseline n (%) 6 months n (%) 12 months n (%) Baseline n (%) 6 months n (%) 12 months n (%)
Intervention (n=450)
442 (98) 327 (73) 298 (66) 442 (98) 327 (73) 286 (64)
Control (n=478)
474 (99) 348 (73) 327 (68) 474 (99) 340 (71) 313 (66)
Total (n=928)
916 (99) 675 (73) 625 (67) 916 (99) 667 (72) 599 (65)
TABLE 47 European Quality of Life-5 Dimensions completion rates
Patients Caregivers
Baseline n (%) 6 months n (%) 12 months n (%) Baseline n (%) 6 months n (%) 12 months n (%)
Intervention (n=450)
426 (95) 319 (71) 287 (64) 438 (97) 323 (72) 284 (63)
Control (n=478)
459 (96) 337 (71) 311 (65) 471 (99) 338 (71) 313 (65)
Total (n=928)
885 (95) 656 (71) 598 (64) 909 (98) 661 (71) 597 (64)
TABLE 48 Baseline characteristics of the full sample and subsamples included in the 6-month analyses
Baseline characteristics
Full sample (n=928)
Subsample with both
costs and NEADL data
at 6 months (n=663)
Subsample with both
costs and QALY data
at 6 months: (n=630)
Valid n Valid n Valid n
Patients
Age (years), mean 928 71 663 71 630 71
Male, n (%) 928 519 (56) 663 384 (58) 630 365 (58)
Baseline NEADL total score 917 52.15 659 53.53 – –
Baseline utility score 885 0.37 – – 630 0.40
Full sample (n=928)
Subsample with both
costs and CBS data
at 6 months (n=652)
Subsample with both
costs and QALY data
at 6 months (n=649)
Valid n Valid n Valid n
Caregivers
Age (years), mean 928 61 652 62 649 62
Female, n (%) 928 635 (68) 652 448 (69) 649 444 (68)
Baseline utility score 909 0.79 – – 649 0.80
ECONOMIC EVALUATION
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TABLE 49 Patient resource use at baseline (for previous 3 months)a
Resource Unit
Intervention (N=450) Control (N=478)
N users/valid n Meanb SD N users/valid n Meanb SD
Inpatient services Bed-days 42/441 14 21 67/472 11 14
Outpatient services Activities/visits 111/437 2 2 126/466 2 3
Community-based services
GP
Surgery visit Visits 225/408 2 2 251/428 2 2
Practice nurse
Surgery visit Visits 111/383 2 1 124/392 2 2
Repeat prescription Occurrences 235/393 3 1 294/417 2 2
Chiropodist Contacts 58/411 2 1 63/436 2 2
Dentist Contacts 61/410 1 1 65/433 2 1
Optician Contacts 62/408 1 <1 79/431 1 1
Informal care from co-residents
Personal care Hours 55/427 170 361 67/458 203 419
Providing transport Hours 83/430 101 322 94/453 83 151
Preparing meals Hours 110/429 156 258 127/454 125 111
Housework/laundry Hours 110/426 111 260 113/458 98 112
DIY Hours 53/420 127 446 68/446 40 47
Gardening Hours 87/423 73 289 90/447 45 57
Shopping Hours 117/429 77 247 130/453 55 51
Outings Hours 82/428 106 327 92/447 60 48
Socialising Hours 104/427 270 387 128/451 407 576
Help managing ﬁnances Hours 99/430 64 275 104/455 37 34
Informal care from non-residents
Providing transport Hours 43/421 32 44 63/443 38 52
Housework/laundry Hours 38/423 48 65 52/443 43 56
Gardening Hours 26/421 21 21 50/437 19 21
Shopping Hours 46/423 32 32 57/441 28 27
Outings Hours 45/423 36 50 57/441 41 39
Socialising Hours 53/419 113 196 69/442 140 343
a Inpatient services plus other items used by at least 10% of either group.
b Mean for valid users only.
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TABLE 50 Patient resource use at 6 months (in previous 6 months)a
Resource Unit
Intervention (N=450) Control (N=478)
N users/valid n Meanb SD N users/valid n Meanb SD
Initial stroke admission Bed-days 448/448 45 33 478/478 42 29
Other inpatient services Bed-days 56/319 12 22 65/338 8 10
A&E Occurrences 52/311 2 1 63/338 1 1
Outpatient services Activities/visits 178/308 3 4 158/328 3 5
Physiotherapist, hospitalc Visits 97/258 9 16 114/289 9 78
Occupational therapist,
hospitalc
Visits 30/235 4 3 50/267 8 12
Community-based services
GP
Surgery visit Visits 177/270 3 2. 202/301 3 2
Home visit Visits 124/252 2 2 135/267 2 2
Telephone call Calls 85/230 2 1 95/247 2 2
Practice nurse
Surgery visit Visits 116/241 3 3 116/250 3 3
Physiotherapist
Home visit Visits 159/264 9 8 158/285 11 11
Occupational therapist
Home visit Visits 164/270 8 9 144/284 6 8
Speech and language therapist
Home visit Visits 65/262 7 8 65/271 7 6
Social worker
Home visit Visits 65/274 2 2 70/297 2 2
Telephone call Calls 31/274 4 2 49/297 3 1
Repeat prescription Occurrences 208/264 5 3 253/288 5 3
Community/district nurse Contacts 112/261 5 4 108/277 6 7
Chiropodist Contacts 60/242 2 1 84/274 2 1
Dentist Contacts 58/243 2 1 79/261 2 1
Optician Contacts 66/247 1 1 92/264 2 1
Home help personal care Visits 71/275 87 134 70/297 81 117
Informal care from co-residents
Personal care Hours 206/302 226 332 211/317 324 449
Providing transport Hours 190/286 130 223 193/304 138 159
Preparing meals Hours 224/295 286 292 237/316 305 213
Housework/laundry Hours 228/299 220 293 239/313 238 198
DIY Hours 119/272 108 321 139/300 67 90
Gardening Hours 159/284 91 228 166/304 73 69
Shopping Hours 225/300 108 202 231/315 133 116
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TABLE 50 Patient resource use at 6 months (in previous 6 months)a (continued )
Resource Unit
Intervention (N=450) Control (N=478)
N users/valid n Meanb SD N users/valid n Meanb SD
Outings Hours 182/288 127 223 187/310 132 122
Socialising Hours 213/289 980 1293 213/307 775 936
Help managing ﬁnances Hours 205/296 90 212 203/312 125 267
Informal care from non-residents
Personal care Hours 52/281 83 168 59/308 133 143
Providing transport Hours 102/282 50 113 118/311 45 55
Preparing meals Hours 53/278 28 28 57/305 95 131
Housework/laundry Hours 54/279 55 62 67/305 101 103
DIY Hours 56/274 27 30 48/303 36 59
Gardening Hours 61/276 26 22 56/304 25 31
Shopping Hours 75/280 45 64 81/306 52 44
Outings Hours 96/285 47 69 86/305 67 82
Socialising Hours 113/281 105 138 110/300 122 141
Help managing ﬁnances Hours 43/278 29 20 53/304 62 93
a Inpatient services plus other items used by at least 10% of either group.
b Mean for valid users only.
c Separate to other outpatient visits.
TABLE 51 Patient resource use at 12 months (in previous 6 months)a
Resource Unit
Intervention (N=450) Control (N=478)
N users/valid n Meanb SD N users/valid n Meanb SD
Inpatient services Bed-days 43/288 9 12 58/312 9 12
A&E Occurrences 48/284 2 1 52/311 2 1
Outpatient services Activities/
visits
126/281 3 2 130/310 3 3
Physiotherapist, hospitalc Visits 61/244 9 8 58/284 9 7
Community-based services
GP
Surgery visit Visits 167/246 3 2 197/276 3 2
Home visit Visits 86/227 2 2 86/237 2 2
Telephone call Calls 56/202 2 2 69/232 3 4
Practice nurse
Surgery visit Visits 110/223 2 3 135/248 3 3
Physiotherapist
Home visit Visits 54/232 8 11 44/265 6 8
Repeat prescription Occurrences 191/234 5 4 226/265 5 3
Community/district nurse Contacts 67/233 6 8 82/275 6 9
continued
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TABLE 51 Patient resource use at 12 months (in previous 6 months)a (continued )
Resource Unit
Intervention (N=450) Control (N=478)
N users/valid n Meanb SD N users/valid n Meanb SD
Chiropodist Contacts 78/241 2 1 80/273 2 2
Dentist Contacts 84/231 2 1 73/259 2 1
Optician Contacts 69/223 2 1 75/261 1 1
Informal care from co-residents
Personal care Hours 153/263 256 376 170/285 319 352
Providing transport Hours 139/253 110 104 158/281 150 146
Preparing meals Hours 175/263 281 157 206/287 318 216
Housework/laundry Hours 170/258 207 159 200/280 185 154
DIY Hours 97/247 46 45 116/268 56 61
Gardening Hours 123/250 74 87 134/273 73 87
Shopping Hours 174/257 101 85 183/279 115 93
Outings Hours 143/251 113 102 152/277 138 135
Socialising Hours 163/251 646 694 165/282 866 1000
Help managing ﬁnances Hours 161/259 145 491 163/283 76 80
Informal care from non-residents
Providing transport Hours 73/254 50 47 86/284 40 52
Preparing meals Hours 39/255 70 59 50/286 91 137
Housework/laundry Hours 40/255 82 65 60/287 88 107
Gardening Hours 50/251 27 24 52/281 46 74
Shopping Hours 44/256 59 62 70/287 43 43
Outings Hours 63/256 39 48 79/287 42 60
Socialising Hours 77/252 124 149 90/286 114 168
a Inpatient services plus other items used by at least 10% of either group.
b Mean for valid users only.
c Separate to other outpatient visits.
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TABLE 52 Caregiver resource use at baseline (in previous 3 months)a
Resource Unit
Intervention (N=450) Control (N=478)
N users/valid n Meanb SD N users/valid n Meanb SD
Inpatient services Bed-days 7/440 <1 1 16/470 <1 4
Outpatient services Activities/visits 88/440 2 2 92/470 2 2
Community-based services
GP
Surgery visit Visits 199/425 2 1 228/460 2 1
Practice nurse
Surgery visit Visits 120/404 2 1 101/430 2 3
Repeat prescription Occurrences 214/415 2 1 229/443 2 1
Informal care provided to patient
Personal care Hours 72/420 117 173 105/451 83 107
Providing transport Hours 141/419 58 98 158/448 58 72
Preparing meals Hours 228/426 104 96 240/455 124 209
Housework/laundry Hours 229/421 77 114 254/452 87 113
DIY Hours 88/412 35 79 101/442 30 44
Gardening Hours 159/423 32 64 158/451 34 35
Shopping Hours 233/422 44 59 264/452 45 50
Outings Hours 140/414 60 87 163/443 65 83
Socialising Hours 239/425 281 409 269/448 274 400
Help managing ﬁnances Hours 175/425 27 57 193/450 35 46
a Inpatient services plus other items used by at least 10% of either group.
b Mean for valid users only.
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TABLE 53 Caregiver resource use at 6 months (in previous 6 months)a
Resource Unit
Intervention (N=450) Control (N=478)
N users/valid n Meanb SD N users/valid n Meanb SD
Inpatient services Bed-days 20/320 <1 2 15/335 <1 1
Outpatient services Activities/visits 83/315 3 3 93/326 3 2
Community-based services
GP
Surgery visit Visits 176/290 3 2 197/318 3 2
Practice nurse
Surgery visit Visits 116/267 2 2 111/287 2 2
Repeat prescription Occurrences 152/273 4 2 178/299 5 3
Informal care provided to patient
Personal care Hours 238/306 222 332 243/323 370 601
Providing transport Hours 201/295 140 220 201/309 144 172
Preparing meals Hours 282/310 253 239 295/330 286 227
Housework/laundry Hours 278/310 182 202 295/325 218 223
DIY Hours 130/285 99 311 151/290 56 62
Gardening Hours 181/294 82 210 196/307 64 71
Shopping Hours 281/307 109 182 297/321 111 107
Outings Hours 205/293 114 204 214/310 123 132
Socialising Hours 271/303 741 984 262/317 679 1023
Help managing ﬁnances Hours 258/309 70 172 268/317 72 96
a Inpatient services plus other items used by at least 10% of either group.
b Mean for valid users only.
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TABLE 54 Caregiver resource use at 12 months (in previous 6 months)a
Resource Unit
Intervention (N=450) Control (N=478)
N users/valid n Meanb SD N users/valid n Meanb SD
Inpatient services Bed-day 18/282 <1 2 15/306 <1 3
Outpatient services Activities/visits 71/275 3 3 82/303 2 2
Community-based services
GP
Surgery visit Visits 151/263 2 2 191/290 2 2
Practice nurse
Surgery visit Visits 105/239 2 1 124/263 2 2
Repeat prescription Occurrences 139/238 4 2 164/264 4 2
Informal care provided to patient
Personal care Hours 187/256 244 346 207/288 279 398
Providing transport Hours 173/251 108 107 188/279 150 149
Preparing meals Hours 243/265 265 197 265/296 298 206
Housework/laundry Hours 229/260 195 181 257/289 192 179
DIY Hours 129/241 47 70 136/268 47 48
Gardening Hours 155/252 70 87 182/280 77 136
Shopping Hours 233/257 107 96 259/286 150 252
Outings Hours 181/244 104 103 196/280 147 149
Socialising Hours 229/256 644. 767 234/282 667 883
Help managing ﬁnances Hours 222/264 61 88 225/290 84 107
a Inpatient services plus other items used by at least 10% of either group.
b Mean for valid users only.
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TABLE 55 Patients: mean costs by resource category at baseline (for the previous 3 months), 6 months
(previous 6 months) and 12 months [previous 6 months (£, 2009–10 prices)]
Intervention (n=450) Control (n=478) Intervention– controla
Resource Valid n Mean SD Valid n Mean SD
Mean
difference 95% CI p-value
LSCTC
development and
staff training
450 39 64 478 0 – 41 26 to 57 0.000
Stroke admission 450 13,127 9670 478 12,471 8666 1243 –1533 to 4019 0.380
Institutionalisation
Baseline 442 11 209 474 18 231 –7 –36 to 21 0.608
6 months 327 274 1516 348 159 619 137 –32 to 306 0.113
12 months 298 162 631 327 194 785 –17 –129 to 95 0.766
Secondary care
Baseline 442 625 2832 474 824 2892 –199 –670 to 173 0.294
6 months 327 1150 3547 348 1121 2541 56 –410 to 522 0.813
12 months 298 822 2027 327 986 2468 –124 –522 to 273 0.540
Community-based services
Baseline 442 208 500 474 206 450 2 –59 to 64 0.946
6 months 327 1380 1777 348 1317 1652 57 –260 to 373 0.726
12 months 298 1042 1690 327 1267 2418 –212 –689 to 265 0.383
Other health and social care services
Baseline 442 10 107 474 6 53 4 –7 to 15 0.451
6 months 327 9 45 348 26 260 –18 –47 to 11 0.221
12 months 298 9 66 327 19 140 –12 –34 to 9 0.269
Informal care
Baseline 442 2390 10,102 474 2086 3698 304 –668 to 1277 0.539
6 months 327 11,033 11,783 348 10,841 8721 300 –1216 to 1817 0.698
12 months 298 8404 9126 327 9323 8582 –872 –2449 to 704 0.278
a Comparisons of 6- and 12-month costs includes covariates for the baseline value of the same cost category, baseline age,
baseline NEADL score and sex.
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TABLE 56 Caregivers: mean costs by resource category at baseline (for the previous 3 months), 6 months
(previous 6 months) and 12 months [previous 6 months (£, 2009–10 prices)]
Resource
Intervention (n=450) Control (n=478) Intervention– controla
Valid n Mean SD Valid n Mean SD
Mean
difference 95% CI p-value
LSCTC
development and
staff training
450 39 64 478 0 – 41 26 to 57 0.000
Institutionalisation
Baseline Not assessed at baseline Not assessed at baseline
6 months 327 0 – 340 0 – – – –
12 months 286 0 – 313 1 6 –1 –2 to 0.4 0.248
Secondary care
Baseline 442 109 373 474 373 4130 –276 –661 to 109 0.161
6 months 327 364 1719 340 209 616 166 –30 to 362 0.096
12 months 286 241 935 313 284 1331 –31 –217 to 155 0.742
Community-based services
Baseline 442 61 91 474 62 94 –1 –13 to 11 0.835
6 months 327 118 157 340 123 151 –5 –37 to 28 0.781
12 months 286 100 132 313 116 141 –16 –39 to 8 0.196
Informal care
Baseline 442 2570 4166 474 2606 3042 –49 –518 to 419 0.836
6 months 327 10,626 8950 340 10,949 8836 –145 –1471 to 1180 0.830
12 months 286 9370 7094 313 10,055 7125 –643 –1758 to 471 0.258
a Comparisons of 6- and 12-month costs includes covariates for the baseline value of the same cost category, baseline
age and sex.
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TABLE 57 Patients: mean total costs at baseline (for the previous 3 months), 6 months (previous 6 months),
12 months (previous 6 months) and over 1 year (£, 2009–10 prices)
Costs
Intervention (n=450) Control (n=478) Intervention– controla
Valid n Mean SD Valid n Mean SD
Mean
difference 95% CI p-value
Total health and social care
Baseline 442 855 2974 474 1054 2975 –200 –585 to 186 0.310
6 monthsb 327 15,861 11,565 348 15,541 10,234 1184 –1505 to 3872 0.388
12 months 298 2037 2804 327 2465 4041 –347 –1119 to 425 0.378
1 yearb 272 17,406 12,741 298 17,752 12,235 563 –2986 to 4112 0.756
Total societal
Baseline 442 3243 10,642 474 3140 4952 105 –959 to 1168 0.847
6 monthsb 327 26,894 16,832 348 26,381 14,274 1127 –1681 to 3935 0.432
12 months 298 10,440 9889 327 11,788 9738 –1234 –2953 to 485 0.159
1 yearb 272 37,453 23,667 298 37,884 19,993 167 –4163 to 4497 0.940
a Comparisons of 6- and 12-month costs includes covariates for the baseline value of the same cost category, baseline age,
baseline NEADL score and sex.
b Including the cost of LSCTC development and staff training and the initial stroke admission.
TABLE 58 Caregivers: mean total costs at baseline (for the previous 3 months), 6 months (previous 6 months),
12 months (previous 6 months) and over 1 year (£, 2009–10 prices)
Costs
Intervention (n=450) Control (n=478) Intervention– controla
Valid n Mean SD Valid n Mean SD
Mean
difference 95% CI p-value
Total health and social care
Baseline 442 170 396 474 435 4131 –277 –663 to 108 0.159
6 monthsb 327 525 1756 340 331 672 207 5 to 408 0.045
12 months 286 341 993 313 401 1375 –47 –241 to 147 0.636
1 yearb 268 785 1604 285 708 1785 96 –186 to 379 0.505
Total societal
Baseline 442 2741 4204 474 3041 5057 –327 –926 to 273 0.286
6 monthsb 327 11,151 9084 340 11,280 8902 99 –1248 to 1446 0.885
12 months 286 9711 7119 313 10,455 7247 –644 –1777 to 489 0.265
1 yearb 268 21,147 14,434 285 22,024 13,774 –574 –3112 to 1964 0.658
a Comparisons of 6- and 12-month costs includes covariates for the baseline value of the same cost category, baseline age
and sex.
b Including the cost of LSCTC development and training.
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ABLE 59 Patients and caregivers: utility scores and QALYsa
QALYs
Intervention (n=450) Control (n=478) Intervention– controlb
Valid n Mean SD Valid n Mean SD
Mean
difference 95% CI p-value
Patients, utility scores
Baseline 426 0.36 0.37 459 0.40 0.36 –0.02 –0.08 to 0.04 0.538
6 months 319 0.44 0.34 337 0.44 0.35 0.00 –0.04 to 0.05 0.835
12 months 287 0.47 0.35 311 0.46 0.34 0.03 –0.02 to 0.08 0.290
Patients to QALYs
6 months 309 0.21 0.16 324 0.21 0.15 0.00 –0.01 to 0.01 0.835
12 months 258 0.24 0.16 276 0.23 0.16 0.01 –0.01 to 0.03 0.443
1 year 249 0.46 0.30 266 0.45 0.30 0.01 –0.02 to 0.05 0.520
Caregivers to utility scores
Baseline 438 0.80 0.23 471 0.79 0.25 0.01 –0.03 to 0.04 0.660
6 months 323 0.78 0.24 338 0.78 0.23 –0.02 –0.04 to 0.01 0.239
12 months 284 0.81 0.20 313 0.77 0.24 0.02 –0.01 to 0.05 0.236
Caregivers to QALYs
6 months 317 0.40 0.10 333 0.39 0.11 –0.00 –0.01 to 0.0 0.239
12 months 262 0.40 0.10 283 0.39 0.11 –0.00 –0.01 to 0.01 0.950
1 year 257 0.80 0.19 279 0.78 0.20 –0.00 –0.02 to 0.02 0.674
a Available case analysis excluding those who died or were lost to follow-up.
b Comparisons of 6- and 12-month costs includes covariates for baseline utility score, baseline age, and sex (and baseline
NEADL score for patients).
DOI: 10.3310/hta17460 HEALTH TECHNOLOGY ASSESSMENT 2013 VOL. 17 NO. 46TSensitivity analysesAll sensitivity analyses conﬁrmed conclusions from the base-case conclusions except for sensitivity analysis 2,
adopting the replacement cost approach for informal care, which led to the between group difference in
mean societal costs for caregivers changing from £99 to –£831. However, although the direction of
difference changed, the difference between groups remained statistically non-signiﬁcant. Substituting the
base-case value with this new value for the consideration of related ICERs (Table 60) would result in the
intervention group dominating the control group based on CBS scores (the only case of the intervention
group's dominance at the primary end point of 6 months) and an unlikely trade-off of lower costs for
fewer QALYs.73
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DOI: 10.3310/hta17460 HEALTH TECHNOLOGY ASSESSMENT 2013 VOL. 17 NO. 46Cost-effectiveness and cost–utilityOf the 16 cost–outcome combinations examined for the cost-effectiveness and cost–utility analyses, none
was based on statistically signiﬁcant between-group differences for both cost and outcome elements.
The intervention group ‘dominated’ in seven combinations, the control group ‘dominated’ in ﬁve, the
intervention group had both higher costs and better outcomes in nine, and the remaining three involved an
unlikely trade-off of lower costs for worse outcomes. Where relevant, indicative ICERs are presented for
information (Table 61), but these and the term ‘dominates’ should be interpreted with caution for most
combinations given the small magnitude and lack of statistical signiﬁcance in differences in costs or
outcomes except for caregivers having higher health and social care costs at 6 months. ICERs ranged from
£96 for an additional point improvement on the CBS based on 1-year health and social care costs for
caregivers to £1.18M for an additional patient QALY based on their health and social care costs at 6 months.
Cost-effectiveness planes show that although differences in patient health and social care costs, NEADL
scores (Figure 11) and QALYs (Figure 12) between the two groups do vary around the point estimates, they
are strongly centred around zero, i.e. no difference in either costs or outcomes. In contrast, the caregiver
cost-effectiveness planes suggest that health and social care costs are higher in the intervention group and,
while CBS differences are clustered around zero (i.e. no difference; Figure 13), QALYs differences are
clustered to the left of zero (i.e. lower in the intervention group; Figure 14).
Figures 15–18 show probabilities that the intervention group is cost-effective compared with the control
group. In the patient evaluation, probabilities of cost-effectiveness were similar from both cost perspectives.
Maximum probabilities of cost-effectiveness for the threshold ranges examined for each outcome
measure were 51% at £2000 for an additional point improvement on the NEADL scale (see Figure 15)TABLE 61 Patients and caregivers: ICERs for intervention over control at 6 months and over 1 year for each
cost perspective
Cost perspective
Additional cost per
additional point on
the NEADL scale
Additional cost per
additional point on
the CBS
Additional cost per
additional QALY
Patients, 6 months
Health and social care Control dominates (£1184/–0.2) N/A £1,184,000 (£1184/0.001)
Societal Control dominates (£1127/–0.2) N/A £1,127,000 (£1127/0.001)
Patients, 1 year
Health and social care 1126 (£563/0.5) N/A £51,182 (£563/0.011)
Societal 334 (£167/0.5) N/A £15,182 (£167/0.011)
Caregivers, 6 months
Health and social care N/A 414 (£207/0.5) Control dominates
(£207/–0.004)
Societal N/A 198 (£99/0.5) Control dominates
(£99/–0.004)
Caregivers, 1 year
Health and social care N/A £96 (£96/1) Control dominates
(£96/–0.004)
Societal N/A Intervention dominates
(–£574/1)
Not applicable
(–£574/–0.004)
N/A, not applicable.
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FIGURE 11 Patients: cost-effectiveness plane of incremental total health and social care costs and point changes on
the NEADL scale at 6 months.
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IGURE 12 Patients: cost-effectiveness plane of incremental total health and social care costs and QALYs at 6 months.
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76Fand 34% for an additional QALY (this was the same across all QALY thresholds examined) (see Figure 16).
In the caregiver evaluation, probabilities of cost-effectiveness were higher based on the societal
perspective than for the health and social care perspective, given that the latter costs were higher in the
intervention group compared with the control group. Probabilities of cost-effectiveness were reasonable for
CBS point improvements (see Figure 17), up to a maximum of 62% and 68% from the health and social
care and societal perspectives, respectively, at the maximum threshold examined (£2000), although it is
unknown what the willingness to pay for a CBS point improvement would be in practice. However, as for
the patient evaluation, probabilities of cost-effectiveness based on QALYs were low (see Figure 18), not
exceeding 2% from the health and social care perspective for the range examined. Thus, the intervention
is unlikely to be considered cost-effective from either patient or caregiver perspectives at current policy
thresholds of £20,000–30,000 per QALY gained.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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IGURE 13 Caregivers: cost-effectiveness plane of incremental total health and social care costs and point changes on
he CBS at 6 months.
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FIGURE 14 Caregivers: cost-effectiveness plane of incremental total health and social care costs and QALYs at 6 months.
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IGURE 15 Patients: probability that the intervention is cost-effective compared with the control at 6 months, from
ach cost perspective, for a range of willingness-to-pay values for an additional point improvement on the
EADL scale.
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IGURE 16 Patients: probability that the intervention is cost-effective compared with the control at 6 months, from
ach cost perspective, for a range of willingness-to-pay values for an additional QALY.
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DOI: 10.3310/hta17460 HEALTH TECHNOLOGY ASSESSMENT 2013 VOL. 17 NO. 46FIGURE 17 Caregivers: probability that the intervention is cost-effective compared with the control at 6 months, from
each cost perspective, for a range of willingness-to-pay values for an additional point improvement on the CBS.
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FIGURE 18 Caregivers: probability that the intervention is cost-effective compared with the control at 6 months, from
each cost perspective, for a range of willingness-to-pay values for an additional QALY.
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DOI: 10.3310/hta17460 HEALTH TECHNOLOGY ASSESSMENT 2013 VOL. 17 NO. 46Chapter 6 DiscussionKey ﬁndingsThe TRACS trial was a pragmatic, multicentre cluster RCT of a complex intervention. The trial was designed
to evaluate the effectiveness of the LSCTC (LSCTC compared with usual care when implemented in SRUs
across the UK in different health-care settings, with different patient populations). The trial evaluated
whether the LSCTC improved physical and psychological outcomes for patients and their caregivers after
disabling stroke, and sought to determine if such a training programme was cost-effective. Eighteen SRUs
were randomised to implement the intervention as a part of their standard practice, and 18 SRUs were
randomised to continue usual practice. A total of 928 patient and caregiver dyads were recruited into the
trial: 450 in the intervention arm and 478 in the control arm.Primary outcomesStroke patients attending intervention SRUs did not demonstrate a clinically signiﬁcant improvement in
functional independence compared with stroke patients attending the control SRUs at 6 months post
registration. The burden for caregivers of stroke patients attending intervention SRUs was not signiﬁcantly
different to that of caregivers of stroke patients attending the control SRUs at 6 months. There was no
difference in patient recovery or caregiver burden between the intervention and control groups.Secondary outcomesThere were no statistically signiﬁcant differences in stroke patients' mood, health state, functional ability and
health-related quality of life or in the number of deaths, hospital readmissions or institutionalisations
between the intervention and control arms at both 6 and 12 months post registration. Similarly, there
were no statistically signiﬁcant differences in caregivers' social restriction, mood, health state, or any
difference in deaths, hospitalisation and institutionalisation at 6 or 12 months for those caregivers of
patients attending intervention SRUs compared with those attending control SRUs. There was no difference
in the outcome of patients' and caregivers' physical and psychological well-being between the
intervention and control groups.Economic evaluationThe economic evaluation suggests that from a patient perspective, health and social care costs, societal costs
and outcomes are similar for the intervention and control groups at 6 months, 12 months and over 1 year.
CEACs based on the net beneﬁt approach, which accounted for uncertainty around point estimates of
differences and potential willingness-to-pay thresholds of up to £2000 per point improvement on the NEADL
scale and up to £50,000 for an additional QALY, suggest that the intervention group is less likely to be
cost-effective than the control group.
From a caregiver perspective, societal costs and outcomes are similar between the two groups at 6 months,
12 months and over 1 year. Health and social care costs were on average £207 higher (95% CI £5 to £408)
in the intervention group at 6 months, but this difference was no longer apparent at 12 months or over
1 year. Caregiver CEACs suggested that the intervention group is less likely to be cost-effective than the
control group based on QALYs for thresholds up to £50,000 per QALY gain, but, based on the CBS, it has
between 53% and 63% probability of cost-effectiveness for thresholds of £500 to £2000 per point81
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82improvement on this scale from the health and social care perspective and 63–68% from the societal
perspective. The value of a one point change in this measure and the willingness to pay for it from a policy-
making viewpoint is unclear.
Informal care costs were considerable in size and notably increased total care costs. However, conclusions
were broadly similar from both health and social care and societal perspectives.
The ability of the EQ-5D to detect changes in quality of life in these patient and caregiver groups is unclear
and needs further exploration.SafetyTraining of caregivers was not detrimental to patients. No unexpected SAEs occurred in the trial, and the
number of falls between registration and discharge from the SRU were minimal in both control and
intervention arms.Comparison of Training Caregivers After Stroke with the
single-centre studyThe LSCTC was evaluated in a single-centre RCT of 300 patients by Kalra et al.19 This study reported a
signiﬁcant cost reduction for those patients treated using the LSCTC, as well as a signiﬁcant reduction in
caregiver burden, and improved quality of life and mood for both patients and their caregivers. The TRACS
trial assessed the LSCTC using a multicentre, pragmatic design, wherein the LSCTC was implemented
as a part of standard practice and delivered by all members of the MDT, and its effectiveness was
assessed across different health-care settings and a larger heterogeneous population. The large multicentre
pragmatic RCT did not replicate the ﬁndings of the single-centre study. The LSCTC does not provide
any beneﬁt to patients' long-term recovery or psychological well-being, nor does it reduce caregivers'
burden or enhance psychological well-being compared with usual care. The LSCTC was found to be
no more cost-effective than standard care.
It is important to note that the recruitment of patients in the single-centre study took place almost 10 years
ago. Since that time stroke guidance has highlighted the importance of involving caregivers throughout the
stroke patients stay on the SRU.39,75 Comparison of the caregiver burden scores in the single-centre study at
3 months (intervention median=43; control median=51) and the TRACS trial at 6 months (intervention
mean=46.3; control mean=45.7) suggest that caregivers may receive more support, resulting in less burden.
However, although some of the differences identiﬁed in the single-centre study may have been lost as
general stroke care has improved, we believe that it is unlikely that standard care has improved to such a
degree that caregivers needs have been successfully met. Indeed, the caregiver burden scores in both the
intervention and control arms indicate a level of burden that still needs addressing, with a score of 45 relating
to a high level of caregiver burden.Strengths and limitations of the studyThe TRACS trial is the largest stroke rehabilitation trial completed to date (worldwide), with 930 patient and
caregiver dyads registered to the trial. It successfully recruited to target, demonstrating that large, multicentre
cluster RCTs of stroke rehabilitation are feasible.
The TRACs trial was one of the ﬁrst large multicentre stroke rehabilitation trials to use the new SRN. The
establishment of the local SRNs helped to determine the geographical regions selected for participation in
the TRACS trial. The availability of SRN researchers in hospitals across entire regions allowed TRACS centresNIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta17460 HEALTH TECHNOLOGY ASSESSMENT 2013 VOL. 17 NO. 46to be recruited from an excellent spread of locations and health service types – from rural community
hospitals in the South West Peninsula to large urban acute hospitals in central London. The SRN researchers
assisted with the successful minimisation of selection bias in the TRACS trial, allowing recruitment by
research staff that was entirely independent of the clinical MDTs. The invaluable support of the SRN no
doubt ensured the successful recruitment of clusters and participants to target in the TRACS trial. In addition,
the design of the TRACS trial has been a pioneer in bridging the chasm between clinical staff and
research, by involving members of the MDTs in the research process. Many of the PIs in TRACS were
senior therapists/nurses, and all participating MDTs have received an insight into the research process
as a consequence of taking part in this pragmatic trial.Study design
The TRACS trial followed closely the Medical Research Council (MRC) guidance on the evaluation of a
complex intervention: a cluster RCT design was chosen as the most appropriate design for the evaluation of
the LSCTC; outcome measures were carefully considered; an economic evaluation was conducted; and
process data were collected. In addition, a parallel, complementary process evaluation study [funded by the
National Institute for Health Research (NIHR) Research for patient beneﬁt funding stream] was conducted to
examine the nature and inﬂuence of SRU contexts on team- and patient-focused practices, on
implementation processes of the LSCTC, and on the beliefs, understanding and actions of health
professionals, stroke survivors and caregivers. The ﬁndings of this study have proved invaluable in
interpreting the TRACS trial results and are discussed further below.Internal validity
Clusters
Thirty-six clusters were randomised equally between control and intervention study arms, stratiﬁed by
geographical region and NSSA score. Following randomisation, the characteristics of the SRUs were found to
be well balanced. No clusters were lost to follow-up during the trial. However, some units struggled to
achieve the target recruitment of 25 patient and caregiver dyads. Low recruitment in some SRUs was
compensated for by increasing the recruitment target in high-recruiting SRUs. The loss of power in the trial
caused by the unequal cluster sizes was compensated for by increasing the target recruitment beyond 900.
The process data collected in the TRACS trial indicates that, aside from the implementation of the
LSCTC, there were few changes to the process of care affecting the involvement of patients and
caregivers on SRUs throughout the course of the trial. More specialised stroke community teams and
early supported discharge teams have emerged since the beginning of the trial but were still only present
in one-third of the participating SRUs, and were balanced between study arms. Changes in the process
of care take a long time to implement, and have not inﬂuenced the overall standards of care in the
control and intervention SRUs taking part in the TRACS trial.Recruitment
Recruitment of patients and caregivers commenced after cluster randomisation of the SRUs. The large
sample size required in this trial, and the restricted length of hospital stay for all stroke patients, meant that it
was not possible to identify and recruit the entire trial cohort prior to cluster randomisation. Therefore, the
trial was carefully designed to avoid selection bias. Researchers independent of the clinical teams were used
to screen and recruit participants. Attempts were made to ensure that the MDTs were unaware of which
patients' and caregivers' had consented to provide trial data in study procedures, and MDT staff in the
intervention arm were required to complete the LSCTC for all eligible participants regardless of trial
participation. All participants were blinded to the SRUs treatment allocation. These design features proved
successful as both the numbers of participants recruited and their baseline characteristics were well balanced
between the study arms, demonstrating a lack of selection bias in the recruitment of participants. The
follow-up rate of 75% at 6 months required for the power calculation was nearly achieved in the trial, with
an actual follow-up rate of 74.4% for patients and 72.5% for caregivers.83
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84GeneralisabilityFour disparate geographical regions ensured a good representation of different health-care settings (acute/
community hospitals in rural and urban settings) and different SRU set-ups (combined acute and
rehabilitation, and rehabilitation). The eligibility criteria in TRACS were kept to a minimum in keeping with
the pragmatic trial design, to ensure that a representative stroke patient population was recruited. Patients
with language and cognitive impairment were included, and there was no ‘cut-off’ level of age or
disability. The results of the TRACS trial should be generalisable to all stroke patients returning home
requiring support from informal caregivers, and to these informal caregivers, in SRUs across the UK.Implementation of a complex interventionAs a pragmatic trial, the intervention was implemented as it would have been with any service initiative
within the NHS. The challenges of implementation were considered carefully in designing the delivery of the
training, and included choosing a method that (1) would be acceptable and feasible to MDT staff and
NHS management; (2) could easily be replicated in SRUs across the UK at the end of the trial; and (3) would
allow successful implementation of the LSCTC programme. Training was provided at two national training
days for each intervention site, during which practical issues of implementation were discussed. This was
supported by a training manual, CD and training records. The SRUs were asked to implement and embed
the intervention on the wards over a 4- to 6-month period prior to the start of patient recruitment. The intent
was that the training was cascaded down by staff who attended the training day to other staff on the
wards. It may be that this commonly used ‘cascade’ method was not as effective as we would have wished
and that other methods for implementing such service improvements should be considered.
The lack of in-depth piloting of the modiﬁed LSCTC and its implementation may be viewed as a weakness of
the present study. Although piloting was conducted on a sample of caregivers in each of the intervention
centres prior to the second training day, this may not have allowed sufﬁcient insight into the
complexities involved in successfully implementing a complex intervention as a part of standard care.Intervention complianceThe intervention was accepted well by the staff attending the training days, with recognition of the
importance of each of the core competencies, demonstrating ‘face validity’ for the intervention.
A component of the intervention was the completion of the TRACS training record (see Appendix 1).
Completed training records were returned to the trial manager and included as a standard monitoring report
to the TMG and TSC. This enabled us to monitor the intervention delivery and the compliance for each
patient in terms of competencies obtained. We felt that this level of monitoring was in keeping with the
pragmatic trial design. Concerns about compliance were explored by the trial manager. In two instances for
which compliance was very poor, letters were sent from the chief investigator to the local PIs and these were
followed up with visits from the trial manager. Higher-level monitoring, for example, by check visits
to the intervention units, would be potentially threatening to participating staff, probably observe
unrepresentative practice, provide only a few observations and be research resource intensive.
The completion and return of this record varied across the SRUs, with an overall compliance rate of 43.6%
(range 0.0–92.9%). These data indicate that some units did not implement the LSCTC as robustly as
envisaged; however, half of the participating centres had a compliance rating of over 60% (one-third
>75%). The measure of compliance, provided by the TRACS development team, was deﬁned as completion
of all six mandatory components of the training or sign-off of the training record by clinical staff. This may
be a strict assessment of compliance. Compliance rates are compatible with other trials evaluating
complex interventions.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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on a stroke unit. Moreover, few studies have assessed the compliance of the interventions that they are
evaluating. Four previous studies15,17,19,76 have investigated inpatient interventions delivered by a specialist
individual or team on a SRU. However, only one of these studies measured and reported compliance with the
intervention. In this study, completed by Larson et al.,15 compliance (deﬁned as patient attendance at a
minimum of ﬁve out of the six education sessions offered) was 50%. It is disappointing that some centres do
not appear to have implemented the intervention consistently, but it is emphasised that the compliance
analysis show no evidence of higher levels of patient independence or lower level of caregiver burden in the
SRUs with better levels of intervention compliance.Complementary Process Evaluation Study (separate papers in preparation)
A complementary, independent process evaluation study was conducted alongside the TRACS trial. This
study investigated the implementation of the LSCTC, and the views of MDT staff, patients and caregivers on
the LSCTC in a sample of six intervention SRUs. Observations and interviews were also completed in four
control SRUs so that comparisons could be made. The ﬁndings of the process evaluation study has provided
valuable and insightful data to inform interpretation of the TRACS trial results.Interpretation of resultsThe observations conducted on the SRUs in the process evaluation study reﬂected the completion rate of
training records in the main trial – the LSCTC was observed successfully in some SRUs, some of the time in
other SRUs, and not at all in one SRU. The key ﬁndings of the process evaluation study were that the LSCTC
was only one of a number of competing priorities for SRU teams. Members of staff were trained to deliver
the LSCTC and then expected to train their teams but training did not reach all staff, particularly nurses.
Therapy staff were the most actively involved with training delivery in the observed units. Different disciplines
often worked separately with caregivers rather than the MDT working together as a team. Caregiver training
was typically delivered very late in the inpatient stay. Staff concern with reducing risk and safe discharge
often meant caregiver training involved passive observation and not active engagement and practice. For
caregivers, the stroke was a shock, this impacted on their understanding of what had happened and
readiness to participate in training. After discharge, caregivers' recall of information and training was
very limited.
The LSCTC was implemented using cascade training. Although training did occur in all centres, the staff
attending varied, and the time available to cascade the training was relatively brief. In general, nurses
received less training, and for a shorter amount of time. Training tools were left on each unit to help support
new members of staff, but the process evaluation study suggests that these resources were not well utilised.
Stroke survivors' abilities could change rapidly once at home, so home visits and early supported discharge
schemes provided opportunities for in situ training, which was valued. Caregivers perceived the training to be
important, but it only addressed one of many areas of adjustment with which to cope.
It may be speculated from process evaluation work that the intervention was more robustly implemented
when key members of the MDT took ownership of the LSCTC and training records. This form of working is
more similar to that used in the single-centre study, for which the training was completed by a small, highly
experienced, team.Economic evaluationThe economic evaluation from the patient perspective suggests that the intervention and control groups
have similar costs and outcomes at all of the assessment points considered. From the caregiver perspective,
the intervention group had higher health and social care costs at 6 months (for equivalent outcomes). Costs85
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86and outcomes over the longer term and from the societal perspective were similar, and illustrate that
increasing the breadth and length of such an evaluation can provide alternative conclusions. However, even
1 year is a relatively short time horizon in the context of a lifetime and it is unclear whether or not our
ﬁndings would hold over patient and caregiver lifetimes.
The cost ﬁndings are in contrast with those from the single-centre study,19,29 which found a statistically
signiﬁcant difference in total patient health and social care costs over 1 year of £4043 in favour of the
intervention group, largely due to a lower length of stay (–12 days) for the initial stroke admission. Total
patient health and social care costs over 1 year in the present study were £563 lower in the control group
(although not statistically signiﬁcant) and we found no difference in the average length of stroke unit stay for
the initial stroke admission (45 and 42 days in the intervention and control groups, respectively), which
interestingly was similar to that for the control group in the single-centre study (43 days). It is unclear
whether the intervention, or the way it was implemented, simply did not impact on discharge practices in the
study stroke units, or whether or not other factors (e.g. care standards) differed over time and place to
reduce the potential for earlier discharge that existed in the single-centre study.
With regards to caregiver costs, we cannot discount the possibility that providing caregivers with more
structured training increased their use of health and social care resources and their provision of informal care
to the patient as an appropriate response to their and the patients' needs. However, if this was the case, any
potential beneﬁts of this were not evident in the outcome measures we examined.
Examining cost and outcome differences based on point estimates gave a mixed set of conclusions across the
various time point and perspectives but the meaningfulness of these is unclear given the lack of statistically
signiﬁcant differences in costs and outcomes except for higher caregiver health and social care costs at
6 months. There were no differences in patient or caregiver QALYs at 6 months, 12 months or over 1 year,
and CEACs based on patient and caregiver QALYs suggested that the intervention group was less likely to be
cost-effective compared with the control group. The single-centre study on which this was based19,29 also
failed to detect any QALY differences. As we used no additional health-related quality-of-life measure, it is
unclear whether there truly were no differences or whether the EQ-5D was unable to detect changes in
quality of life. Any such limitation of the EQ-5D may be addressed in future research with the new ﬁve-level
version (EQ-5D-5L), which has been developed to improve the instrument's sensitivity and to reduce its
ceiling effects.
Patient CEACS based on the NEADL score suggested equivalent probabilities of cost-effectiveness for the two
groups but caregiver CEACs based on the CBS suggested 53–68% probability of cost-effectiveness for
thresholds of £500–2000 per point improvement on the CBS. However, the value of a one point change in
this measure and the willingness to pay for it from a policy-making viewpoint is unclear.
The cost of developing the intervention and training ward staff in its use was estimated at an average of
£39 per patient/caregiver dyad across the whole intervention group. The average cost was higher at
£82 when considering only those known to have received some caregiver training. This is relatively
inexpensive in the context of the average cost of an acute stroke bed-day (£294) and the average stroke
admission cost in this sample (£13,127 and £12,471 in the intervention group and control group,
respectively). We did not include the cost of delivering the intervention to caregivers to avoid
double-counting admission costs. However, this exclusion is unlikely to have affected the ﬁndings, ﬁrst
because these costs are likely to be small in the context of total care costs and, second, because
there was little difference in the amount of time spent with caregivers in each group.
Although the difﬁculties of reliably assessing informal care inputs is well known, the study suggests that the
informal care burden for caregivers of stroke patients is sizeable. Patient care costs were 70% higher in both
intervention and control groups at 6 months when informal care costs were added in. Caregiver costs
were 21% and 34% higher in the intervention and control groups, respectively, when the costs of the inputs
they provided were considered. These care inputs and their costs remained high at 12 months, thus theNIHR Journals Library www.journalslibrary.nihr.ac.uk
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own health is further evidenced by the noticeable increase in their use of community- and secondary-based
care in the post-stroke period compared with baseline.
There were two main limitations with the economic evaluation, both of which are common to evaluations of
this type. First, resource-use data were collected retrospectively by self-report as this was the most efﬁcient
way of collecting data for a large sample, across a large geographical area and from a broad perspective
incorporating primary health care, secondary health care, social care and informal care. Such data may be
subject to recall bias, but a trade-off between reliability and scope was necessary given the trial design.
Second, the cost-effectiveness and cost–utility analyses were performed on subsamples of cases with
available data for both costs and relevant outcomes. However, overall follow-up rates were very good given
the features of the trial (multicentre, older participants, follow-up period 6/12 months after the acute event),
and sensitivity analyses that imputed missing costs and QALY data suggested that ﬁndings from the
incomplete sample analyses were fairly robust.Overall evidenceA recent Cochrane review has examined the effectiveness of non-pharmacological interventions for
caregivers of stroke survivors in reducing caregiver burden or enhancing caregiver well-being.14 Eight relevant
studies were found that assessed information and support interventions, psychoeducational interventions
and caregiver training. The combined sample size of the eight studies was 1007. The conclusions of this
review was that it is not, at present, possible to determine the usefulness of information and support
interventions, or psychoeducational interventions on reducing caregiver burden, or enhancing their
psychological well-being or health-related quality of life. The results of the caregiver training programme in
the single-centre study looked promising, appearing to reduce caregiver burden, depression, and improve
health-related quality of life for caregivers. The purpose of TRACS was to see if this caregiver training
programme – the LSCTC, continued to show beneﬁts to caregivers and stroke patients if it was implemented
as a part of standard practice in SRUs across the UK. The TRACS trial (n=928) has almost doubled the sample
size of the Cochrane Review, providing conclusive evidence that there is no difference between the LSCTC
and usual care with respect to stroke patients' recovery, caregivers' burden, or other physical and
psychological outcomes, nor is it cost-effective when compared with usual care. Caregivers need more than
just an inpatient structured training programme to improve the patients and their own outcomes.
The ﬁndings of the process evaluation study completed in parallel with TRACS suggest that caregiver training
while the stroke patient is in hospital may not be the optimal time to complete such training. The LSCTC
competes with other priorities for MDT staff, and caregivers are experiencing stress, making any such training
less effective at that time point. Caregiver training in the community, by a dedicated experienced team,
might be more beneﬁcial for patients and their caregivers.
Of the eight studies reviewed by Legg et al.,14 three interventions were completed while the stroke patient
was still in hospital, one was completed both as an inpatient and continued once at home, two were
longer-term community interventions and the location of delivery of two were unclear, although both
recruited patients in the acute inpatient setting. The timing/setting of the intervention in these studies did not
have any clear inﬂuence on the effectiveness of these interventions.87
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DOI: 10.3310/hta17460 HEALTH TECHNOLOGY ASSESSMENT 2013 VOL. 17 NO. 46Chapter 7 ConclusionsImplications for clinical practiceThe intervention evaluated had reported beneﬁts in a previous single-centre evaluation but these beneﬁts
have not been replicated in this large, multicentre trial in which the intervention was evaluated in a range of
settings with a greater diversity of patient populations. There was no difference between the LSCTC and
usual care with respect to improving stroke patients' recovery, reducing caregivers' burden, or improving
other physical and psychological outcomes, nor is it cost-effective when compared with usual care.
Compliance with the intervention varied across stroke units but analysis demonstrated no link between the
degree of compliance and associated patient or caregiver outcomes, indicating that a dose effect is unlikely.
The LSCTC provided a structured framework for caregiver training. It is possible that the immediate
post-stroke period, when potential caregivers are coming to terms with their new situation, may not be the
ideal time for the delivery of structured training. The intervention approach might be more relevant if
delivered after discharge by community-based teams.Implications for researchThe TRACS trial is the world's largest completed stroke rehabilitation trial. We have demonstrated for the ﬁrst
time that this methodology can feasibly be implemented in stroke rehabilitation research, which represents
a major step forward in research methodology for this large client group. The TRACS trial ﬁlls some of
the gaps in evidence of the recent Cochrane review. Despite the promising results of the single-centre study,
the results of TRACS provides conclusive evidence that there is no difference between the LSCTC and usual
care on stroke patients' functional independence, caregivers' burden, or other physical and psychological
outcomes, nor is it cost-effective when compared with usual care. Caregivers need more than just an
inpatient structured training programme to improve the patients and their own outcomes.
Future studies should consider carefully the optimal delivery of any caregiver interventions – whether or not
the staff have the time and opportunity to implement the intervention, and when is the optimal timing
of the intervention for the caregiver. Caregiver interventions may be more effective in the post-acute phase,
once patients are back home and caregiving has become a reality.89
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This cluster, randomised, controlled trial is designed to evaluate the clinical and cost-effectiveness of a
structured, competency-based training programme for caregivers of stroke patients returning home with
stroke-related disabilities. The trial aims to recruit 950–1000 patients and caregivers in 36 stroke
rehabilitation units. The intervention developed by Kalra and colleagues is known as the London Stroke Carer
Training Course (LSCTC) and comprises a number of carer training sessions, competency assessment and one
follow up session after discharge. The multidisciplinary teams (MDTs) in the units randomised to the
intervention group will be trained to deliver the LSCTC, whilst those randomised to the control group will
continue to provide usual care as per the National Guidelines. The primary outcomes are extended activities
of daily living for the patient and caregiver burden measured at six months after recruitment. Secondary
outcomes include cost-effectiveness, with ﬁnal follow-up at twelve months.117
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12-month follow-up
Patient and caregiver complete postal questionnaires
6-month follow-up
Patient and caregiver complete postal questionnaires
Clinical research team collects patient discharge/home visit data
Conduct usual care for caregivers as per
national guidelines
•
•
Provide information and advice
Set goals for rehabilitation and discharge
planning 
Conduct caregiver training as per LSCTC
•
•
•
Caregiver training sessions
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at the end of the training
One follow-up session after discharge 
Register patient and caregiver
Conduct baseline assessments
Obtain written informed consent from the patient/caregiver declaration for the patient
and
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LSCTC staff training for MDT
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SRU randomised to follow the
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A cluster randomised controlled trial of a structured training programme for
caregivers of in-patients after stroke
Stroke remains a major health problem in the 21st Century with incidence rates of 1.65 per 1000 population
for ﬁrst ever strokes [1]. Robust evidence supports the recommendation that patients with moderate or
severe symptoms should be referred to hospital with the expectation of admission to a stroke unit [2]. Stroke
is a family illness generating considerable personal, ﬁnancial and societal burdens. After a recommended
initial hospital admission [2], up to 80% of patients are discharged home and many will be dependent on
informal caregivers, usually family members, to provide assistance with activities of daily living, including
bathing, dressing, and toileting [3]. For some, this avoids or delays admission to institutional care and the
economic value of the informal care provided is considerable [4]. This burden of care, however, has an
important effect on caregivers' physical and psychosocial well-being [5] with up to 48% of caregivers
reporting health problems, two-thirds a decline in social life [6] and high self-reported levels of strain. These
issues are compounded by families being over-protective and a perception of lack of respite with reluctance
to leave the patient alone [3]. With the current emphasis on shorter hospital stays caregivers will play an
increasingly important role in the care and continued rehabilitation of patients after stroke. The successful
adjustment of patients and their caregivers to the aftermath of stroke is clearly interlinked. Caregivers have
an important role in enhancing patients' rehabilitation, and coping strategies that lead to negative
experiences are associated with increasing dependence [7]. The caregivers of patients with poor physical and
emotional states are likely to have poor emotional outcomes themselves [8]. Effective training of caregivers
therefore should not only improve their own health but also the recovery and adjustment of the stroke
patient [9]. However, despite the physical, psychological and social consequences of caregiving, its economic
beneﬁt to society and its importance in patient recovery, caregivers' central role is often given low priority in
the management of stroke [10] and there are missed opportunities for structured skills training [11].
Caregivers identify information and skills training required to implement physical care as the most important
pre-discharge needs [12]. Caregiver support is a key component of stroke unit care yet, as currently provided,
is not compatible with their expressed needs and their ability to care is not assessed [9, 12].
These deﬁciencies have recently been addressed in a single centre, randomised controlled trial (RCT) by Kalra
et al. [13]. They reported the effectiveness of a purposely designed systematic and structured training
programme for caregivers which included assessment in competencies in skills essential for the day-to-day
management of disabled stroke survivors (The London Stroke Carer Training Course, LSCTC). The LSCTC was
effective in decreasing caregiver burden and in decreasing their anxiety and depression, improving
psychological outcomes for patients and reducing overall costs [14]. However, there are important limitations
to the generalisability of the trial ﬁndings as the LSCTC was tested in a single centre, delivered by a separate
specialist team that might be expected to have heightened motivation and expertise, and the patient
population was predominantly recruited from a middle class suburban area who might be more responsive to
a training and education programme. In addition, having demonstrated beneﬁt for caregivers on a range
of domains, it is now important to evaluate the effectiveness of the LSCTC programme on improving
patient outcomes. We therefore seek to embed the LSCTC in usual practice and thereby test wider
generalisability in settings where the population, health and social care provision are different.AIMS AND OBJECTIVESThe aim of the TRACS trial is to evaluate the clinical and cost-effectiveness of a structured competency
based caregiver-training programme (LSCTC) on improved patient outcomes in patients with a conﬁrmed
primary diagnosis of new stroke by comparison to usual practice according to the National Guidelines
for Stroke.119
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120Primary Patient Objective:
The primary patient objective of the trial will be to determine whether a structured, competency-based
training programme (LSCTC) for caregivers improves physical outcomes for patients after disabling stroke.
Primary Caregiver Objective:
The primary caregiver objective of the trial will be to determine whether a structured, competency-based
training programme (LSCTC) for caregivers reduces burden for caregivers of patients after disabling stroke.
Secondary Objectives:
The secondary objectives are:
1. To determine whether the provision of the LSCTC for caregivers improves physical and psychological
outcomes for patients after disabling stroke;
2. To determine whether the provision of the LSCTC for caregivers improves physical and psychological
outcomes for caregivers of patients after disabling stroke;
3. To assess whether such a training programme is cost-effective based on (a) patient outcomes, from both
health/social care and societal perspectives and (b) caregiver outcomes, from a health care perspective.DESIGNTRACS has been designed as a pragmatic, multicentre, cluster randomised, controlled trial with blinded
follow-up. 950–1000 stroke patients with residual disability and their caregivers will be recruited, where the
patient is likely to return home with the support of the caregiver. The unit of randomisation will be the
participating stroke rehabilitation units, 18 will deliver the London Stroke Carer Training Course (LSCTC) to
all caregivers of in-patients and 18 will continue to deliver usual care as per the National Guidelines for
Stroke. Blinded follow-up will be through postal questionnaire at six and twelve months after recruitment.
A cluster randomised trial design has been purposely selected to reduce between-group treatment
contamination. Although patient-level randomisation was used in the earlier single centre study [13], the
LSCTC was delivered by a small, purposefully trained team (nurse and therapists) and intensive monitoring
was required to reduce treatment contamination. However, in routine stroke unit care, the LSCTC
intervention will not be delivered by a discrete team but will be incorporated into usual practice by the whole
multidisciplinary team (MDT). Patient level randomisation has the consequence therefore that the
MDT will need to operate two approaches (usual care and the LSCTC). The risk of contamination will be high
as it will not be possible to blind members of the MDT and the new care process is likely to be extended to
patients in the usual care group. Monitoring to reduce opportunities for treatment contamination, as
undertaken in the single centre study, would be considerably more difﬁcult in the context of a multi
centre trial. Randomisation will therefore be at the level of the stroke unit. In order to minimise selection bias,
there will be a clear separation between the provision of the intervention by clinical staff and the
recruitment and consent of patients and caregivers by the research practitioners.CENTRE ELIGIBLITY, RANDOMISATION AND PROCESS EVALUATION
CENTRE ELIGIBILITY
Stroke rehabilitation units will be deﬁned according to the deﬁnition provided by the Royal College of
Physicians of London for the National Sentinel Stroke Audit 2006 [15].NIHR Journals Library www.journalslibrary.nihr.ac.uk
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l Consultant physician with responsibility for stroke
l Formal links with patient and caregiver organisations
l Multidisciplinary meetings at least weekly to plan patient care
l Provision of information to patients about stroke
l Continuing education programmes for staff.
A stroke unit will be deﬁned by the presence of 4/5 of these criteria. Additional criteria will be that a
substantial number of patients on the unit will have a diagnosis of stroke, that the unit will be able to deliver
the LSCTC and that the majority of patients are discharged to a permanent place of residence.CENTRE RANDOMISATION
Eligible centres that agree to participate will be registered and randomised to the trial. The Principal
Investigator for each centre will provide the following information prior to randomisation:
l Name of Stroke unit
l Stroke unit centre code
l Stroke unit address and telephone number
l Geographical region
l Name of Consultant physician with responsibility for stroke
l Name of main contact
l Conﬁrmation of willingness to participate
l Score on the key 12 indicator score of the 2006 National Stroke Audit (NSSA) [15]
l Average monthly admission ﬁgures for past 12 months
l Number of beds
l Conﬁrmation that a substantial number of patients on the unit will have a diagnosis of stroke
l Conﬁrmation of eligibility by conﬁrming at least 4/5 of the following centre eligibility criteria:
¢ Consultant physician with responsibility for stroke
¢ Formal links with patient and caregiver organisations
¢ Multidisciplinary meetings at least weekly to plan patient care
¢ Provision of information to patients about stroke
¢ Continuing education programmes for staff.Cluster randomisation will be performed centrally at the Clinical Trials Research Unit (CTRU). The eligible
stroke rehabilitation units will be randomised on a 1:1 basis to either the intervention group or the control
group. The randomisation will be stratiﬁed by the following stroke unit co-variates: geographical region
and quality of care (as deﬁned by on and above or below the median score on the key 12 indicator score
of the 2006 National Stroke Audit (NSSA) [15]). Block randomisation will ensure these important
covariates are balanced between the arms of the trial.Staff Training in Centres Randomised to the Intervention (LSCTC)
Training on the implementation and delivery of the LSCTC will be provided at each of the 18 stroke
rehabilitation units randomised to the intervention prior to commencement of patient recruitment. The
training will be provided by an LSCTC training team who were part of the LSCTC implementation team in the
initial single centre study [13]. The LSCTC training team will not be involved in the research procedures.
An initial meeting will discuss the structured competencies based training and practical implementation
aspects, re-enforced by illustrative cases and involving sessions of role play. Each unit will be provided
with the competencies assessment tool presented in a ‘training manual’ and required to develop an initial
case load of patients and caregivers. These practical experiences will be used for discussion at a second
centrally based training session which staff from the 18 stroke rehabilitation units will attend four weeks after
the ﬁrst. Subsequent to this, the staff will gradually increase the delivery of the LSCTC until it becomes an121
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122integral part of the ward care process. Members of the trial team will visit each site and use the completed
caregivers' competencies assessment tool as a basis for discussions on structure and process. A further
training session will be arranged if necessary to provide feedback and support, and discuss any problems with
LSCTC provision. The LSCTC training team will be available, by telephone, to provide clinical support
throughout the intervention period. Stroke units will open to recruitment three to six months after the initial
training meeting when the research practitioners are happy that the LSCTC has been implemented correctly.PROCESS EVALUATION
Process data will be used to inform the health economic quantiﬁcation and describe the care process that
prepares patients and caregivers for discharge in the participating centres (stroke rehabilitation units).
Data will be collected at the following time points:Pre-recruitment
A process questionnaire will be completed by the Research Manager, Principal Investigator and the stroke
rehabilitation unit MDT.
Observations of current practice.
Process case report forms (CRFs) to record staff time input into caregiver support will be completed by
the MDT.During the Trial
A process questionnaire will be completed by the trial researchers and the stroke rehabilitation unit MDT.
Observations of current practice will be undertaken by a researcher independent of trial procedures*.
Process case report forms (CRFs) to record staff time input into caregiver support will be completed by
the MDT.
Qualitative interviews will be conducted with a purposeful sample of stroke patients and caregivers up to
three months post discharge from a participating stroke rehabilitation unit*.
Additional questions regarding caregiver support will be added to the six month follow–up caregiver postal
questionnaire pack (see section 0).When Recruitment has ended
Qualitative interviews will be conducted with a purposeful sample of MDT members to capture their
experience of delivering the intervention*.
*Please note that the activities denoted (*) above will be incorporated into a process evaluation sub-study
and separate ethical approval will be sought.PATIENT AND CAREGIVER ELIGIBILITY
INCLUSION CRITERIA:
All patients with the following characteristics are eligible for this trial:
l Have a conﬁrmed primary diagnosis of new stroke.
l Are medically stable.
l Are likely to return home with residual disability at the time of discharge.NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta17460 HEALTH TECHNOLOGY ASSESSMENT 2013 VOL. 17 NO. 46l Have a caregiver available, deﬁned as the main person, other than health, social, or voluntary care
provider, helping with activities of daily living and/or advocating on behalf of the patient, is willing and
able to provide support to the patient after discharge.
l Written informed patient consent/a caregiver declaration and caregiver consent will be obtained prior to
any trial speciﬁc procedures.Exclusion Criteria:
Unless the patients exhibit the following characteristics:
l In need of palliative care.
l If discharge is planned within one week of admission to the current stroke unit.
l If the patient or caregiver was registered to the trial on a previous admission.
l Patients involved in other stroke research network adopted studies will also be recruited into this study
unless: 1) the patient is recruited into the ActNoW study (which assesses intensive speech therapy
versus no speech therapy); 2) the patient is ﬁrst recruited into another trial involving 6 and 12 months
follow up questionnaires (currently only the STICH study).PATIENT AND CAREGIVER RECRUITMENT AND REGISTRATION
SCREENING
The clinical research team will complete a log of all patients and caregivers screened for eligibility including
those who are not registered either because they are ineligible or because they decline participation.
Anonymised information will be collected including:
l the reason not eligible for trial participation or
l eligible but declined
l eligible and consented
l age
l gender
l ethnicity
l relationship of the patient to the caregiver
l living circumstances (live alone , co-habit or in residential/nursing home)
l living circumstances (caregiver co-resident or non-resident)
l length of hospital stay.RECRUITMENT PROCESS
Recruitment to the trial and baseline assessment will be undertaken by a member of the clinical research
team, (independent of the clinical team) who will visit the stroke rehabilitation units at least once a
week to liaise with the clinical team, assess patient and caregiver suitability and obtain informed consent
from both patients and caregivers to undertake baseline and follow-up assessments. Rates of identiﬁcation,
recruitment and refusals will be monitored for all sites (see Section 8.1) Identiﬁcation rates will be
monitored against past admission rates for each site.INFORMED CONSENT
A verbal explanation of the trial and Patient and Caregiver Information Sheets will be provided by the clinical
research team for the patient and caregiver to consider. These will include detailed information about the
rationale, design and personal implications of the study. Following information provision, patients and
caregivers will be given sufﬁcient time to consider participation and will be given the opportunity to
discuss the trial with their family and healthcare professionals before they are asked whether they
would be willing to take part in the trial. Information about the trial will be repeated again if the patients
and caregivers require time to consider their participation and the participants (patient and caregiver)123
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124will again have the opportunity to ask questions and confer with other members of their family. Consent will then
be taken. The right of the patient and caregiver to refuse consent without giving reasons will be respected.
Assenting patients and caregivers will then be invited to provide informed, written consent to complete
baseline and follow up assessments. For patients unable to read/sign the consent form due to stroke related
disabilities, and for those with problems of comprehension, a caregiver declaration will be sought. For
patients unable to consent for themselves, this study complies with the Mental Capacity Act (MCA) 2005. In
such cases, the caregiver will act as consultee. The caregiver will be advised to set aside their own views and
provide advice on the participation of the patient in the research, taking into consideration the patient's
wishes and interests. Research participants will not be required to do anything which is contrary to any
advance decisions or statements that have been made by them in relation to their treatment or any
other matter. Advance decisions made by the patient about their preferences and wishes will always
take precedence.
The caregiver will also be approached to provide consent on their own behalf. Formal assessment of eligibility
and informed consent will be undertaken by a member of the clinical research team. The patient and
caregiver will remain free to withdraw from the study at any time without giving reasons and without
prejudicing any further treatment. The original consent forms will be retained in the investigator site ﬁle. A
copy of the patient and caregiver consent forms will be given to the patient and caregiver respectively.
Further copies will be ﬁled in the patient hospital notes and a fourth set of copies will form part of the central
study archive and be returned to the CTRU.
Informed written patient consent/caregiver declaration and caregiver consent for entry into the trial will be
obtained prior to patient and caregiver registration. The responsibility for the overall care of the patient
remains with the attending clinical teams.REGISTRATION
Patients and caregivers will be registered with the CTRU following informed consent, conﬁrmation of
eligibility and collection of baseline data. Registration will be performed centrally using the CTRU automated
24-hour telephone registration system. Authorisation codes and PINs, provided by the CTRU, will be required
to access the registration system.
When eligibility has been conﬁrmed and the necessary details obtained (see Section 0) patients and
caregivers will be allocated trial numbers.
DIRECT LINE FOR 24-HOUR REGISTRATION: +44 (0)113 343 4928TREATMENTAll patients in this study will be treated within an organised stroke service (stroke unit). The clinical research
team will be available to all participating stroke units (control and intervention groups) to provide support
regarding the research procedures.USUAL CARE (CONTROL GROUP)
In stroke rehabilitation units randomised to the control group, usual care for caregivers following national
guidelines [2] will include:
l provision of information on stroke and its consequences, prevention, and management options
l involvement in goal setting for rehabilitation and discharge planningNIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta17460 HEALTH TECHNOLOGY ASSESSMENT 2013 VOL. 17 NO. 46l encouragement to attend nursing and therapy activities to learn about patients' abilities and informal
instruction on facilitating transfers, mobility and activities of daily living tasks
l advice on community services, beneﬁts and allowances, including contact information provided for
voluntary support services for caregivers.CAREGIVER TRAINING PROGRAMME (INTERVENTION GROUP)
In stroke rehabilitation units randomised to the intervention group usual care will be augmented by provision
of the LSCTC programme incorporated into ward practice (see Section 0). Caregivers will receive sessions of
the structured training programme depending on need [12, 13]. Caregivers' competencies will be assessed
(and signed off) at the end of training. In addition, one “follow through” session will be provided either
through a telephone call or home visit by an appropriate member of the clinical team (member of MDT,
community stroke team or other professional who normally completes such a follow up on discharge) to
adapt skills learnt to the home environment.
As part of the LSCTC programme, caregivers will receive:
Instruction by appropriate professionals on common stroke related problems and their prevention,
management of pressure areas and prevention of bed sores, continence, nutrition, positioning, gait
facilitation, and advice on beneﬁts and local services.
“Hands-on” training in lifting and handling techniques, facilitation of mobility and transfers, continence,
assistance with personal activities of daily living and communication, tailored to the needs of
individual patients.WITHDRAWAL
In line with usual clinical care, cessation or alteration of regimes at any time will be at the discretion of
attending clinical teams, clinicians or the patients and caregivers themselves. Where caregivers or patients
wish to withdraw, there will be clariﬁcation of whether this is withdrawal from postal or medical records
follow up or both.DATA COLLECTION/ASSESSMENTSParticipating stroke rehabilitation units will be expected to maintain a ﬁle of essential trial documentation
(Investigator Site File), which will be provided by CTRU, and keep copies of all completed CRFs for the trial.
Stroke rehabilitation unit usual practice will be determined by the process evaluation (see section 0).
Patient and caregiver assessments will be undertaken as follows:
l Registration and Baseline (after consent but prior to registration)
l Discharge/Home visit
l 6-month follow-up
l 12-month follow-up.REGISTRATION AND BASELINE DATA
Patients and caregivers who meet the inclusion criteria and provide informed written consent (for baseline
assessment and follow-up) will be registered to the trial. The TRACS research practitioners will provide details
at registration, including:
l Patient details including initials and date of birth
l Caregiver details including initials and date of birth
l Centre code
l Name of the research practitioner conducting the registration125
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126l Conﬁrmation of eligibility
l Conﬁrmation of written informed consent
The TRACS clinical research team will also record additional baseline information including:
Centre details:
l Hospital name
l Centre code
l Name of the research practitioner conducting the registration.
Patient details:
l Name
l Gender
l Date of birth (age to be calculated*)
l Ethnicity
l NHS ID
l Hospital ID
l Conﬁrmation of eligibility
l Modiﬁed Rankin score [16]
l Living circumstances*
l Relationship of the patient to the caregiver
l Address and telephone number
l GP address and telephone number
l Preferred language
l Education and employment
l Name of attending physician
l Date of patient admission
l Date of stroke
l Classiﬁcation of stroke type
l Language ability
l Short Orientation-Memory-Concentration Test (6CIT) [17]
l Pre-stroke independence*
l Verbal subsection of the Glasgow Coma Scale [17, 18]
l Ability to lift both arms off the bed*
l Ability to walk independently*
l Barthel Index [19] (pre-stroke activities of daily living)
l Previous stroke
Caregiver details:
l Name
l Gender
l Date of birth
l Ethnicity
l Conﬁrmation of eligibility
l Modiﬁed Rankin score [16]
l Address and telephone number
l GP address and telephone number
l Preferred language
l Education and employmentNIHR Journals Library www.journalslibrary.nihr.ac.uk
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be collected:
l The Nottingham Extended Activities of Daily Living Scale (NEADL) [20, 21] for pre-stroke independence
l Hospital Anxiety and Depression Scale (HADS) [22] (post stroke mood)
l EQ-5D [23–25] (post stroke health state)
l Barthel Index [19, 26] (post-stroke activities of daily living)
l Stroke Impact Scale [27–30] (post stroke functional ability and health related quality of life)
l Patient Client Service Receipt Inventory (CSRI) [14, 31] (pre-stroke economic outcome)
The caregivers will complete the following questionnaires at baseline:
l Frenchay activities index [32, 33] (social restriction)
l HADS [22] (mood)
l EQ-5D [23–25] (post-stroke health state)
l Caregiver Client Service Receipt Inventory (CSRI; pre-stroke economic outcome)
The six factors (highlighted by *) from the Edinburgh stroke case mix adjuster [34, 35] will enable an
adjustment for case mix to be made.
Patients and caregivers will be provided with change of address cards to be returned to the CTRU by
post if required.DISCHARGE/HOME VISIT DATA
The TRACS clinical research team will record the following information for patients at discharge:
l Date of discharge.
l Destination at discharge.
l Pre-discharge home visit details.
l Details of Expected Serious Adverse Events (see Section 0) between the date of consent and
date of discharge
l Documented evidence regarding the patient's care process.ADDITIONAL DATA COLLECTED FOR THE INTERVENTION GROUP
During the LSCTC intervention period (between the date of consent and date of the home visit) members of
the stroke rehabilitation unit MDT will record their inputs into delivering the LSCTC (for the purposes of the
economic evaluation) and caregiver compliance with the LSCTC including:
l number of training sessions
l time taken
l competencies sign offFOLLOW-UP DATA
Patients and caregivers will be followed-up by the CTRU via postal questionnaires at six and twelve months.
This will be supported by postal and telephone reminders if questionnaires are not returned within two
weeks. If necessary, a ‘masking’ system will be used so that research administration staff can undertake
telephone reminders blind to the patients' and caregivers' regional telephone code. All losses to follow-up,
through death, withdrawal and loss of contact will be fully reported by the clinical research team.
Completion rates will be monitored as agreed by the DMEC, TSC and TMG in the monitoring schedule. If
completion falls below an acceptable standard agreed by the DMEC, TSC and TMG, patients and caregivers
may be contacted by telephone to complete the primary outcome measures (NEADL and caregiver
burden scale).127
© Queen's Printer and Controller of HMSO 2013. This work was produced by Forster et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided
that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to:
NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
APPENDIX 4
128All patients and caregivers who are registered into the study will be considered as part of the intention to
treat population and efforts will be made to follow them up when appropriate.
The CTRU will check with the GP whether the patient and caregiver are alive prior to contact. If the patient
has died, no further follow-up will be undertaken. If the caregiver has died, patient follow-up will still be
undertaken. In both cases their death will be recorded on the appropriate form and the cause will be
established through contact with the GP and reference to electronic or paper health records. When patient
and caregiver survival status has been established postal questionnaires will be sent out by the CTRU.
The following questionnaires will be included in the postal packs for patients:
l NEADL [20, 21]
l HADS [22] (mood)
l EQ-5D [23–25] (health state)
l Barthel Index [19, 26] (activities of daily living)
l Stroke Impact Scale [27–30] (functional ability and health related quality of life)
l Patient CSRI [14, 31] (economic outcome).
l If the patient was aware of receiving / being denied better treatment because of this research
(at 12 month follow-up only).
The following questionnaires will be included in the postal packs for caregivers:
l Caregivers Burden Scale [36]
l Frenchay activities index (social restriction) [32–33]
l HADS [22] (mood)
l EQ-5D [23–25] (health state)
l Caregiver CSRI (economic outcome)
l Additional questions relating to:
¢ Caregiver support during the intervention period (at six month follow-up only)
¢ If the caregiver is still caring for the patient
¢ If the caregiver was aware of receiving / being denied an enhanced training package
(at 12 month follow-up only)
¢ Caregiver's stroke knowledge [37, 38].
The TRACS team will record the following information for patients and if necessary caregivers, at six and
twelve months post registration using electronic or paper health and patient social care records:
l Death
l Hospital re-admissions
l Institutionalisation
l Treatment on an emergency outpatient basis.ASSESSMENT INSTRUMENTS
The assessment instruments have been incorporated into patient and caregiver assessment packs. All
instruments have been used extensively in previous stroke research, are sensitive to change, valid and
reliable. They have been reviewed by the Consumer Research Advisory Group attached to the Academic Unit
of Elderly Care and Rehabilitation who felt that the questions were understandable, relevant and
appropriate. Information on who completed the outcome measures will be requested, proxy responses will
be allowed. Where the patient is unable to complete the questionnaire due to stroke related disabilities
(visual/motor) a friend/relative/carer can complete the questionnaire using the patient's verbal responses.
Where the patient is unable to communicate answers and/or understand the questions, a proxy can completeNIHR Journals Library www.journalslibrary.nihr.ac.uk
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the two groups.Nottingham Extended Activities Of Daily Living Scale (NEADL)
Physical and social independence will be measured using the Nottingham Extended ADL Scale (NEADL)
[20, 21]. It was designed as a postal questionnaire and assesses aspects of physical and social independence
performance across 22 items (score range 0–66) grouped in four categories (mobility, kitchen, domestic
and leisure activities). It has been widely used as an outcome measure in rehabilitation trials [39, 40]. It has
proven validity, reliability [41] and has demonstrated responsiveness to change and able to discriminate
between services [42].Hospital Anxiety And Depression Scale (HADS)
Both patients and caregivers mood will be assessed using the 14 component Hospital Anxiety and
Depression Scale (HADS) [22]. It was initially developed as an instrument to identify anxiety disorders and
depression in medical outpatients [22], but has since proven to exhibit wider generalisability [43].EQ-5D
The non-disease-speciﬁc EQ-5D instrument [23–25] will be used to evaluate health-related quality of life for
both patients and caregivers via a six component questionnaire. It was developed to yield a fundamental
index of health, which can be used to calculate quality-adjusted life-year (QALY) gains, and thus will facilitate
the health economic evaluation.Barthel Index
Patient activities of daily living and mobility will be assessed using the Barthel Index [19, 26]. This
instrument will be used to evaluate the patient's disability and level of dependence on their caregiver
via assessment of their ability in bathing, transferring from bed to chair, dressing, feeding, mobility,
climbing stairs, toilet use, grooming, and bladder and bowl continence.Stroke Impact Scale
Functional ability and health related quality of life of the patients will be measured using the Stroke Impact
Scale [27–30]. This scale consists of eight components measuring strength, memory and thinking, emotion,
communication, activities and independent activities of daily living, mobility, hand function, and social
participation. It was developed for use as a self reporting questionnaire, which has proven to be reliable, valid
and sensitive to change [27, 44]. SIS has also been validated for use as a postal questionnaire [45].Client Service Receipt Inventory (CSRI)
Data on patient socio-demographics and use of health and other formal care services and informal care
will be collected using a Client Service Receipt Inventory validated for use with stroke patients [14, 31].
A reduced form of this instrument will be used with caregivers.Caregiver Burden Scale
Caregiver burden will be measured using a proven and reliable Caregiver Burden Scale [36]. This 22-item
scale will assess various aspects of caregiver burden including general strain, isolation, disappointment,
emotional involvement and environment.Frenchay Activities Index
The social restriction on caregivers will be assessed using the Frenchay Activities Index [32, 33]. Although
initially validated to assess the activities of acute stoke patients, this assessment instrument is applicable to
caregivers of patients with disabling stroke [13].Definition of End of Trial
The end of the trial is deﬁned as the date the last twelve month postal questionnaire pack is completed.129
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130SERIOUS ADVERSE EVENTS PROCEDURES
GENERAL DEFINITIONS
An adverse event (AE) is:
l any unintentional, unfavourable clinical sign or symptom
l any new illness or disease or the deterioration of existing disease or illness
l any clinically relevant deterioration in any laboratory assessments or clinical tests.
A serious adverse event (SAE) is deﬁned in general as an untoward event which:
l is fatal or life threatening
l requires or prolongs hospitalisation
l is signiﬁcantly or permanently disabling or incapacitating
l constitutes a congenital anomaly or a birth defect or
l may jeopardise the participant and may require medical or surgical intervention to prevent one of the
outcomes listed above.
A SAE occurring to a research participant, where in the opinion of the chief investigator the event is related
and unexpected will be reported to the main Research Ethics Committee (REC).
The National Research Ethics Service (NRES) deﬁnes related and unexpected SAEs as follows:
l ‘related’ – that is, it resulted from administration of any research procedures; and
l ‘unexpected’ – that is, the type of event is not listed in the protocol as an expected occurrence.TRACS OPERATIONAL DEFINITIONS
Events such as patient falls and caregiver musculoskeletal injury represent an inherent consequence of an
active rehabilitation process and therefore cannot be entirely avoided. Similarly, in this patient population,
acute illness resulting in hospitalisation, new medical problems and deterioration of existing medical
problems are expected.Expected AE/SAEs – not reportable
In recognition of this, events fulﬁlling the deﬁnition of an adverse event (except those listed in Section 0) will
not be reported in this study.
In addition, Serious Adverse Events will not be reported as follows:
l Episode of acute illness (e.g. further stroke, cardiovascular event, infection) occurring between the time
of consent and date of discharge.Expected AEs/SAEs – standard reporting
The following Serious Adverse Events are not common but are expected within the patient study population
during patient hospitalisation and will be reported by the clinical research team between the date of consent
and date of discharge using a standardised discharge CRF.
l Patient falls with or without fracture will be reported when they occur at any time between the date of
consent and date of discharge.
The following AEs and SAEs are expected within the patient study population following discharge from
hospital and will be established during follow-up and self-reported by patients within the Client ServiceNIHR Journals Library www.journalslibrary.nihr.ac.uk
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and social care records:
l Death (SAE)
l Hospital admissions and re-admissions for any reason (SAE)
l Institutionalisation (AE)
l Treatment on an emergency outpatient basis (AE).
In addition, caregiver hospitalisation, institutionalisation and death are expected and will be subject to
standard reporting using the caregiver postal questionnaire pack at follow-up. If necessary The TRACS clinical
research team will also collect this data using electronic or paper health and social care records
As these events are expected within the study population they will not be subject to expedited reporting to
the main REC. They will however, be included in the annual safety report provided to the main REC.Unexpected and related SAEs – expedited reporting
All Related/Unexpected SAEs occurring to either the patient or caregiver from the date of consent up to
twelve months post registration must be recorded on the Related/Unexpected Serious Adverse Event Form
and faxed to the CTRU within 24 hours of the clinical research staff becoming aware of the event. The
original form should also be posted to the CTRU in real time and a copy retained on site.
For each Related/Unexpected SAE the following information will be collected:
l date of SAE
l full details in medical terms with a diagnosis, if possible
l its duration (start and end dates; times, if applicable)
l action taken
l outcome.
Any follow-up information should be faxed to CTRU as soon as it is available. Events will be followed up until
the event has resolved or a ﬁnal outcome has been reached.
CTRU Fax number for reporting Related/Unexpected Serious Adverse Events: 0113 343 1471
All Related/Unexpected SAEs will be reviewed by the Chief Investigator and subject to expedited reporting to
the Sponsor and the main REC by the CTRU on behalf of the Chief Investigator within 15 days.
Responsibilities of the Chief Investigator, CTRU, Trial Steering Committee (TSC), Data Monitoring and Ethics
Committee (DMEC) and Sponsor will be detailed in a study speciﬁc Work Instruction.HEALTH ECONOMICSGiven that health care resources are ﬁnite it is important to demonstrate the economic implications of any
new intervention. The single centre study found that LSCTC reduced costs, largely as a result of reduced
length of stay. It is unclear whether this ﬁnding is generalisable to other settings due to variations across
stroke rehabilitation units in, for example, discharge policies, availability of beds, staff mix and patient
case-mix. Therefore, a comprehensive economic evaluation will assess the cost-effectiveness of the LSCTC in
this multi-centre trial, based on both patient and caregiver outcomes. It will be carried out from a health care
perspective for the caregiver outcome evaluation, and both a health/social care perspective (health care
resources and other formal care agencies) and a societal perspective (health care resources, other formal care
agencies and informal care inputs) for the patient outcome evaluation and will follow the familiar stages of
an economic evaluation [46]. Brieﬂy, this involves measuring the resources associated with each treatment131
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132approach from the chosen analysis perspective(s), estimating the total costs of those resources and then,
importantly, linking costs with outcomes. The economic evaluation will be fully integrated into the
effectiveness evaluation, with the same criteria adopted for trial eligibility, randomisation and
intervention modes.
Data will be collected retrospectively at baseline (for the previous three months) and then at 6 and 12 months
(for the time since previous assessment) which will allow estimation of total costs over 1 year (and therefore a
comparison with the cost ﬁndings from the single centre study). Data on use of health and other formal
care resources and informal care will be collected using a Client Service Receipt Inventory (CSRI) validated for
use with stroke patients [14, 31]. A reduced version of this instrument, containing questions about
use of core health care services, will be used with caregivers. In both cases, it will be completed as a
self-complete questionnaire alongside other measures at baseline, 6 months and 12 months. Self-reports
of patient and carer inpatient admissions will be veriﬁed against hospital records.
Unit costs will be attached to each service or element of support in turn, using the best available estimates of
long-run marginal opportunity cost which will include capital and overhead elements. National unit costs will
be used where possible to facilitate generalisability of results, with new local estimations calculated where
necessary. Informal care costs will be estimated using the opportunity cost method (the value of the
opportunities forgone by caregivers as a result of time spent on caregiving). The cost of LSCTC inputs
(including staff training) will be incorporated into the evaluation. Average unit costs per session of LSCTC will
be calculated and multiplied by the number of sessions received by each caregiver. If necessary, adjustments
will be made to unit costs of the stroke rehabilitation units in order to avoid double-counting staff inputs.
Unit costs will be combined with resource volumes to obtain a total cost per patient, from each analysis
perspective, at each assessment point, for both patient and caregiver evaluations and over the entire period
of participation in the trial.
All costs will be reported as mean values with standard deviations. To accommodate a cluster randomisation
design, differences in costs between groups will be tested by multi level modelling.
The primary economic analysis will take the form of a cost-effectiveness analysis. This will involve combining
and comparing total average costs from each analysis perspective with the primary outcome measures
(patient NEADL and Caregiver Burden Scale) in the form of incremental cost-effectiveness ratios (ICERs) to
represent additional cost per additional point on the NEADL for the patient evaluation and the Caregiver
Burden Scale for the caregiver evaluation.
A secondary economic analysis will examine quality of life outcomes through cost-utility analyses, again from
each analysis perspective, exploring cost per quality-adjusted life-year (QALY) gained for both patients and
caregivers. Health states will be measured at each assessment point (baseline, 6 months and 12 months)
using the EQ-5D. Utility weights from a United Kingdom general population survey [47] will be applied to
these health states to calculate quality-adjusted life-years. Quality-adjusted life-year outcomes will be
examined in terms of change between post-stroke and each follow-up point, using linear interpolation to
calculate the area under the QALY curve. Given the wide range of other outcome domains of interest in the
study, a supplementary cost-consequence analysis will additionally present total average costs for each trial
arm alongside all outcome measures.
Sensitivity analyses will alter any key assumptions made in the economic analyses (e.g. unit costs of
stroke rehabilitation units, LSCTC and informal care) to explore the consequences for the results. Uncertainty
around the cost-effectiveness and cost-utility of LSCTC will also be explored using incremental
cost-effectiveness planes and cost-effectiveness acceptability curves (CEACs) based on the net beneﬁt
approach [48]. The CEAC reveals to the decision-maker the likelihood of LSCTC being cost-effective relative
to usual care given different (implicit monetary) values placed on incremental improvements in the NEADL,
Caregiver Burden Scale and QALYs. CEACs will be based on bootstrapped (to account for non-normally
distributed data) regressions of study group upon net beneﬁts, controlling for clusters.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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ﬁnal follow-up at 12 months to assess whether any intervention effect is sustained.PRIMARY ENDPOINTS
Patient endpointl Nottingham Extended Activities of Daily Living (NEADL) [20, 21] as completed by the patient at
six months.Caregiver endpointl Caregivers Burden Scale [36] as completed by the caregiver at six months.SECONDARY ENDPOINTS
Patient endpoints at six monthsl Hospital Anxiety and Depression Scale (HADS) (mood) [22]
l EQ-5D (health state) [23–25]
l Barthel Index (activities of daily living) [19, 26]
l Stroke Impact Scale [27–30] (functional ability and health related quality of life)
l Death
l Hospital re-admission
l Institutionalisation
l Total costsPatient endpoints at twelve monthsl Nottingham Extended Activities of Daily Living (NEADL)
l Hospital Anxiety and Depression Scale (HADS)
l EQ-5D
l Barthel Index
l Stroke Impact Scale
l Death
l Institutionalisation
l Hospital re-admission
l Total costsCaregiver endpoints at six monthsl Frenchay activities index [32, 33] (social restriction)
l HADS
l EQ-5D
l Death
l Hospitalisation
l Institutionalisation
l Total costs133
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134Caregiver endpoints at twelve monthsl Caregivers Burden Scale
l Frenchay activities index (social restriction)
l HADS
l EQ-5D
l Death
l Hospitalisation
l Institutionalisation
l Total costsSTATISTICAL CONSIDERATIONS
SAMPLE SIZE
Thirty-six stroke rehabilitation units each recruiting 25 patients, will result in 450 patients in each group and
provide close to 90% power at 5% signiﬁcance level to detect a clinically relevant difference of six points
(as deﬁned in the TOTAL study [39, 49]) on the primary patient outcome, the NEADL (scored 0–66, SD 18).
A range of 3–9 points has been taken to be a clinically relevant difference in previous studies. We have taken
6 points as a difference of clinical relevance to the patient and caregiver (patient requiring less help in at least
two activities) and also substantive enough to inﬂuence commissioners to change service delivery. The
sample size takes account of an inﬂation factor of 1.9 due to clustering (cluster size of 19 after loss to
follow-up; Intracluster Correlation Coefﬁcient (ICC) no greater than 0.05 [50]) and 25% loss to follow-up.
The assumption that the ICC will be no larger than 0.05 is based on methodological research [51] showing
that ICCs for patient outcomes in the community are generally less than 0.05. This sample size of 900
patients will provide more than 85% power at the 5% signiﬁcance level to detect an effect size of one third
in any of the other outcomes. Such an effect size is usually considered moderate. So, for instance, this will
ensure more than 85% power to detect a difference of 4.3 points on the Caregiver Burden Scale at six
months, assuming the same variability as in the single centre study [13] (i.e. ds of 12.9 at 6 months).
Although the differences observed in the single centre study were larger (6.2, 6.7, 8.7 at 3, 6 and 12 months
respectively), it is unrealistic to predict that a multi-centre trial would ﬁnd such large effects. In addition
with a sample of 900 the trial will have more than 85% power to detect the annual admission cost
difference of £3175 as found in the single centre study [14].
The power of the trial is adversely affected by a higher than expected loss to follow-up (likely to be closer to
30%) and unequal cluster sizes (extent of the imbalance unknown until end of recruitment). Hence, to
preserve ﬁnal power of close to 90%, the trial should aim to recruit between 950 and 1000 patients.ACCRUAL
Based on a recently completed study [52] involving six stroke units and an ongoing pilot, it is anticipated
that 40% of patients/caregivers on a stroke unit will fulﬁl the entry criteria. Based on recruitment rates in
previous studies [53, 54] and the ongoing pilot study, it is conservatively estimated that at least 50% of
these will provide informed consent. The average number of patients admitted annually per unit is at
least 120, this provides a pool of 4,320 to recruit from and therefore it is estimated that a recruitment rate
of 75 patients per month, just over 2 per month for each participating site is more than achievable.Statistical AnalysisStatistical analysis is the responsibility of the CTRU Statistician. A ﬁnal statistical analysis plan will be written
and reviewed before any ﬁnal analysis is undertaken. All statistical testing will be performed at a 2-sided 5%
signiﬁcance level.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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The Intention to Treat (ITT) population is deﬁned as all patients registered for active follow-up regardless of
non-compliance with the intervention. All patients (and the corresponding caregivers) within a stroke unit
will be analysed according to the intervention that stroke unit was randomised to. All analyses and data
summaries will be carried out using the ITT population.
A per-protocol analysis will be considered if there are a considerable number of protocol violators. This
decision will be made jointly by the trial statistician in co-operation with other members of the Trial
Management Group on examination of the population. The decision will be made without reference to the
endpoint data.OUTLINE ANALYSIS PLAN
As the trial is cluster randomised, the primary outcome measures, the six month NEADL score and the
Caregiver Burden Scale, will each be compared between the intervention and control groups using a
two-level hierarchical model, with patients (or caregivers) nested within stroke rehabilitation units.
Patient-level covariates, such as patient baseline scores, the Edinburgh stroke case-mix adjuster [35], and the
caregiver baseline HADS score, and stroke unit-level covariates, such as the key 12 indicator score will be
included in the analysis. Secondary outcomes for patients and caregivers will be analysed using similar
multi-level models. Effect sizes and 95% conﬁdence intervals will be reported.
Three of the secondary caregiver outcomes (death, hospitalisation and institutionalisation) will be
summarised by treatment group. No formal statistical comparison between the intervention and control
groups will be undertaken for these outcomes.
A secondary analysis will explore the relationship between outcome and compliance with the LSCTC
(e.g. number of sessions, number of formal competency assessments conducted and ‘signed off’). Process
data collected in the control stroke units will be summarised at each time point to ascertain whether
care in the control arm has changed over the course of the trial.
The proportion of non-responders will be compared between randomised groups. Missing items within
individual outcome measures will be treated according to instructions for that particular measure.
Simple imputation will be used if there are no instructions. A sensitivity analysis will be performed using
the last available observation of the NEADL for all patients lost to follow-up to assess the impact of
missing follow-up data on the analysis of the primary endpoint. Further secondary analyses will utilise a
two-stage model incorporating deaths and primary outcomes, if there is a large number of deaths or an
imbalance in the death rates between the two arms.
The number of patients reporting a SAE and details of all SAEs will be reported for each treatment group.
All outcomes will be analysed at the end of the trial but recruitment and safety will be monitored at regular
intervals. Outcomes will be summarised once during recruitment for monitoring by the Data Monitoring and
Ethics Committee (DMEC).INTERIM ANALYSIS
No formal interim analyses are planned.PLANNED SUB-GROUP ANALYSES
No sub-group analyses are planned.135
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DATA MONITORING
Data will be monitored for quality and completeness by the CTRU, using established veriﬁcation,
validation and checking processes. Missing data, except individual data items collected via the postal
questionnaires, will be chased until it is received, conﬁrmed as not available, or the trial is at analysis.
Reminders will be sent to patients and caregivers if postal questionnaires are not returned on time.
Rates of recruitment and refusals will be monitored for all sites on a monthly basis to check for
differential recruitment rates between control and intervention sites. The completed competencies
assessment tool for all trial participants in the intervention units will be returned to the CTRU and a summary
of this will be included in a standard monitoring report to the Trial Management Group (TMG), Trial
Steering Committee (TSC) and Data Monitoring and Ethics Committee (DMEC). This will enable
monitoring of the intervention delivery and compliance.
The CTRU, Academic Unit of Elderly Care and Rehabilitation and the University of Leeds (Sponsor)
reserve the right to intermittently conduct source data veriﬁcation on a sample of patients. Source data
veriﬁcation will involve direct access to patient notes at the participating stroke rehabilitation units and the
collection of copies of consent forms and other relevant investigation reports. A monitoring schedule including
primary end point, compliance and safety data will be deﬁned and agreed by the DMEC, TSC and TMG.DATA MONITORING AND ETHICS COMMITTEE
An independent DMEC will be established to review the safety and ethics of the trial. Detailed unblinded
reports will be prepared by the CTRU for the DMEC during set-up and annually thereafter. SAEs will be
summarised by treatment group in a monthly report sent to the DMEC. This will enable monitoring of safety
rates between control and intervention sites.TRIAL STEERING COMMITTEE (TSC)
A TSC will be established to provide overall supervision of the trial, in particular trial progress, adherence
to protocol, patient safety, and consideration of new information. The committee will meet once during
the set-up period and every six months thereafter for the duration of the trial.CLINICAL GOVERNANCE ISSUES
To ensure responsibility and accountability for the overall quality of care received by patients during the
study period, clinical governance issues pertaining to all aspect of routine management will be brought
to the attention of the DMEC and where applicable to individual NHS Trusts.QUALITY ASSURANCE AND ETHICAL CONSIDERATIONS
QUALITY ASSURANCE
The trial will be conducted in accordance with current MRC Good Clinical Practice (GCP) guidelines, NHS
Research Governance Framework and through adherence to CTRU Standard Operating Procedures (SOPs).ETHICAL CONSIDERATIONS
The trial will be performed in accordance with the recommendations guiding physicians in biomedical
research involving human subjects adopted by the 18th World Medical Assembly, Helsinki, Finland, 1964,
amended at the 52nd World Medical Association General Assembly, Edinburgh, Scotland, October 2000.
Informed written consent will be obtained from the patients and caregivers prior to registration into the study.
The right of a patient and caregiver to refuse participation without giving reasons will be respected. The patient
and caregiver will remain free to withdraw at any time from the study without giving reasons and without
prejudicing the patient's further treatment. The study will be submitted to and approved by a main Research
Ethics Committee (REC) and the appropriate REC for each participating stroke unit prior to enteringNIHR Journals Library www.journalslibrary.nihr.ac.uk
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patient and caregiver information sheets, consent forms and all other relevant study documentation.CONFIDENTIALITYAll information collected during the course of the trial will be kept strictly conﬁdential. Information will be
held securely on paper and electronically at the CTRU. The CTRU will comply with all aspects of the 1998
Data Protection Act and operationally this will include:
l consent from patients to record personal details including name, date of birth, address and
telephone number, NHS ID, hospital ID, GP name and address;
l consent from caregivers to record personal details including name, date of birth, address and
telephone number, GP name and address;
l appropriate storage, restricted access and disposal arrangements for patient and caregiver personal
and clinical details;
l consent from patients and caregivers for access to their medical records by responsible individuals
from the research team or from regulatory authorities, where it is relevant to trial participation;
l consent from patients and caregivers for the data collected for the trial to be used to evaluate safety
and develop new research;
l patient and caregiver name, address and telephone number will be collected when a patient
and caregiver are registered into the trial but all other data collection forms that are transferred to
or from the CTRU will be coded with a trial number and will include two patient and caregiver
identiﬁers, usually their initials and date of birth.
If a patient or caregiver withdraws consent from further trial participation their data will remain on ﬁle
and will be included in the ﬁnal study analysis.ARCHIVING
At the end of the trial, data will be securely archived at the CTRU and participating stroke rehabilitation
units for a minimum of 5 years. If a patient or caregiver withdraws consent for their data to be used,
it will be conﬁdentially destroyed.STATEMENT OF INDEMNITYThis trial is sponsored by the University of Leeds and the University of Leeds will be liable for negligent
harm caused by the design of the trial. The NHS has a duty of care to patients treated, whether or
not the patient is taking part in a clinical trial, and the NHS remains liable for clinical negligence and
other negligent harm to patients under this duty of care.STUDY ORGANISATIONAL STRUCTURE
RESPONSIBILITIES
Chief Investigator
As deﬁned by the NHS Research Governance Framework, the Chief Investigator is responsible for the design,
management and reporting of the study.Clinical Trials Research Unit (CTRU)
The CTRU will have responsibility for conduct of the trial in accordance with the Research Governance
Framework, MRC GCP standards and CTRU SOPs.137
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Trial Management Group (TMG)
The TMG, comprising the Chief Investigator, research manager, CTRU team and co-investigators will be
assigned responsibility for the clinical set-up, on-going management, promotion of the trial, and for the
interpretation of results. Speciﬁcally the TMG will be responsible for (i) protocol completion, (ii) CRF
development, (iii) obtaining approval from the main REC and supporting applications for Site-Speciﬁc
Assessments (SSA), (iv) completing cost estimates and project initiation, (vi) appointing and facilitating the
TSC and DMEC, (vii) reporting of serious adverse events, (vii) monitoring of screening, recruitment, consent,
treatment and follow-up procedures, safety, data quality and compliance (viii) interpretation of results and
contribution to publications.Clinical Trials Research Unit (CTRU)
The CTRU will provide set-up and monitoring of trial conduct to CTRU SOPs and MRC GCP standards
including randomisation design and implementation, patient and caregiver registration, database
development and provision, protocol development, CRF design, trial design, monitoring schedule and
statistical analysis of clinical endpoints for the trial. In addition the CTRU will support main REC, SSA and R&D
submissions and clinical set-up, ongoing management including training, monitoring reports and promotion
of the trial. The CTRU will be responsible for the database administrative functions, data management
including postal follow-up and telephone reminders, safety reporting, all statistical analyses of clinical
endpoints and drafting of publications. The CTRU will have responsibility for the conduct of the study in
accordance with the Research Governance Framework and CTRU SOPs.Clinical Research Team
The Clinical Research Team will comprise the Research Manager, Senior Clinical Research Practitioners and
Clinical Research Practitioners organised in a hub and spoke model. The Research Manager will be based at
Bradford and will be responsible for the day-to-day running of the trial, centre set-up, liaison with,
recruitment and supervision of the other clinical research team members. They will also co-ordinate the
centre initiation and LSCTC training.
The Research Practitioners will lead the implementation of the trial across geographical regions to recruit
patients and caregivers and undertake data collection.LSCTC Training Team
The LSCTC training for staff at the stroke rehabilitation units randomised to the intervention group will be
provided by an ‘LSCTC training team’, who were part of the LSCTC implementation team in the initial single
centre study [13].Multidisciplinary Teams at Participating Stroke Rehabilitation Units
The intervention (usual care or LSCTC) will be delivered by the MDTs at the participating stroke
rehabilitation units.Health Economics
Anita Patel and Martin Knapp will assist the CTRU in database development and will be responsible for the
design of the economic questionnaires, collation of unit costs, and the conduct, interpretation and writing up
of the economic evaluation.Trial Steering Committee (TSC)
The Trial Steering Committee, with an Independent Chair, will provide overall supervision of the trial, in
particular trial progress, adherence to protocol, patient safety and consideration of new information. It will
include an Independent Chair and not less than two other independent members. The Chief Investigator and
other members of the TMG will attend the TSC meetings to present and report progress.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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The DMEC will review the safety and ethics of the trial by reviewing interim data during recruitment.PUBLICATION POLICYThe success of the trial depends upon the collaboration of all participants. For this reason, credit for the main
results will be given to all those who have collaborated in the trial, through authorship and contributor ship.
Uniform requirements for authorship for manuscripts submitted to medical journals will guide authorship
decisions. These state that authorship credit should be based only on substantial contribution to:
l conception and design, or acquisition of data, or analysis and interpretation of data;
l drafting the article or revising it critically for important intellectual content;
l and ﬁnal approval of the version to be published;
l and that all these conditions must be met (www.icmje.org).
In light of this, the Chief Investigator, research manager, Co-Applicants and relevant senior CTRU staff will be
named as authors in any publication. In addition, all collaborators will be listed as contributors for the main
trial publication, giving details of roles in planning, conducting and reporting the trial.
To maintain the scientiﬁc integrity of the trial, data will not be released prior to the end of the trial, either for
trial publication or oral presentation purposes, without the permission of the Trial Steering Committee or the
Chief Investigator. In addition, individual collaborators must not publish data concerning their patients which
is directly relevant to the questions posed in the trial until the main results of the trial have been published.References© Qu
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Training Course training costs
T able 62 summarises costs related to each component of the LSCTC development and staff training.Tables 63–73 provide further details of the calculations of each of the components.
TABLE 62 London Stroke Carers Training Course unit cost: summary of all staff training components
LSCTC development and staff training Costs (£, 2009–10 prices)
1. Core training and refresher training: developmenta
Stafﬁng costs, main training 6662
Stafﬁng costs, refresher training 1017
Total 7680
2. Core training: preparation
Stafﬁng costs 3554
Total 3554
3. Refresher training: preparation
Stafﬁng costs, training team 753
Total 753
4. Core training: delivery
Stafﬁng costs, training team 10,230
Other costs 13,086
Total 23,317
5. Refresher training: delivery
Stafﬁng costs, training team 3197
Other costs 2407
Total 5603
6. Local refresher visits: delivery
Stafﬁng costs, training team 12,513
Other costs 4080
Total 16,593
continued
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TABLE 62 London Stroke Carers Training Course unit cost: summary of all staff training components (continued )
LSCTC development and staff training Costs (£, 2009–10 prices)
7. Ward staff time
Attendance at main training 27,667
Attendance at refresher training 4626
Local cascaded training, trainers 1577
Local cascaded training, trainees 6881
Attendance at local refresher training 4327
Total 45,077
Total cost
Total including development costs 102,577
Total excluding development costs 94,897
Cost per minute of input to caregivers, including development costsb 0.60
Cost per minute of input to caregivers, excluding development costsb 0.56
a The development of the training programme and materials was a thorough process that would not require the same
level of inputs for future implementation or major reworking for several years. We report the unit cost with and without
this component because although it was a necessary cost for implementation of the intervention, such development
costs are not always considered in cost-effectiveness analyses.
b We transformed the total costs of the development and staff training into an average cost per minute of caregiver
training to enable this cost to vary at the individual level according to inputs provided to each caregiver, rather than
be a ﬁxed cost across all participants. We calculated this as follows. First, we multiplied the average amount of time
spent with each caregiver in the trial intervention arm (136 minutes) by the total number of eligible patients identiﬁed
during the screening/recruitment process (n=1256) to estimate the total caregiver input time that the staff training
potentially ‘purchased’ (29,210 minutes/487 hours). We then divided the total training cost (£102,577 including
development costs) by this total input time to estimate the training cost per minute of caregiver input provided (£0.60).
This cost per minute was applied to each intervention arm participant according to the amount of time input provided
by ward staff to the caregiver.
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ABLE 63 Staff time unit costs (£) 2009–10
Salary grade, band and point
Salary,
basic86
Salary,
on-costs
aSalary,
overheads79
Salary,
total per
annum
b,cSalary, total
per hour
worked87
Salary, total
per minute
worked
Training team
Academic Grade 8, point 3788 36,715 11,015 47,730 95,459 56.39 0.94
Academic Grade 6, point 2688 26,523 7957 34,480 68,960 40.74 0.68
Academic Grade 10, point 5288 57,201 17,160 74,361 148,723 87.86 1.46
NHS Band 7, point 35 39,273 11,782 18,855 69,909 41.30 0.69
NHS Band 7, point 31 34,410 10,323 16,520 61,253 36.19 0.60
NHS Band 5, point 20 23,345 7004 11,208 41,556 24.55 0.41
NHS Band 4, point 14 19,495 5849 9359 34,703 20.50 0.34
Ward staff
NHS Band 1, point 2d 13,588 4076 6523 24,188 14.29 0.24
NHS Band 2, point 4 14,359 4308 6894 25,560 15.10 0.25
NHS Band 3, point 9 16,698 5009 8017 29,724 17.56 0.29
NHS Band 4, point 14 19,495 5849 9359 34,703 20.50 0.34
NHS Band 5, point 20 23,345 7004 11,208 41,556 24.55 0.41
NHS Band 6, point 26 28,816 8645 13,834 51,295 30.30 0.51
NHS Band 7, point 30 33,436 10,031 16,052 59,519 35.16 0.59
NHS Band 8, point 42 53,256 15,977 25,568 94,800 56.00 0.93
cNHS Senior House Ofﬁcer80 31,900 7818 6422 46,140 21.65 0.36
cNHS Consultant79 120,200 31,482 42,361 194,043 108.25 1.80
cNHS Social worker79 30,633 9010 19,850 59,493 39.66 0.66
a Assuming 100% full economic cost overhead rate for university-employed staff, 36.93% indirect and capital overheads
for NHS Bands 2–8 staff as per a hospital physiotherapist unit cost,87 and overheads as speciﬁed in the unit costs for
medical and social worker staff.88
b Assuming 27 days' annual leave, 8 bank holidays and a 37.5-hour working week as NHS terms and conditions of
service.87 Excludes additional payments.
c Costs for both consultant and senior house ofﬁcer (assumed Foundation 1) include additional payments. Working
time differed to other staff: 41.4 working weeks per year/43.3 working hours per week for consultants, 44.4 working
weeks per year/48 working hours per week for senior house ofﬁcers and 40 working weeks per year/37.5 working
hours per week for social workers.
d Student nurse pay band was unspeciﬁed so Band 1 point 2 was assumed.
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ABLE 64 London Stroke Carer Training Course unit cost: development of core training and refresher training
Resource Activity Hours per activity
Costs
(£, 2009–10 prices)
A. Core training: April to November 2007
Academic Grade 8, point 37 Administration – training manuals,
Royal College of Nursing continuing
professional development
accreditation and talks
35 1974
Academic Grade 8, point 37 Post-meeting feedback 5 282
Academic Grade 8, point 37 Post-meeting compiling compact discs 8 451
NHS Band 7, point 35a Development time 20 818
NHS Band 7, point 35a Development time 17 706
NHS Band 7, point 35a Development time 23 929
Academic Grade 10, point 52a Development time 17 1502
Core training, total development cost 6662
B. Refresher training: August 2009
Academic Grade 8, point 37 Compiling training manual and
training compact disc, version 2
14 789
NHS Band 7, point 35a Development time 2 74
NHS Band 7, point 35a Development time 2 74
Academic Grade 10, point 52a Development time 1 79
Refresher training, total development cost 1017
C. Development, total cost (A+B)
7680
a During the ﬁrst development phase prior to the main training sessions, the four trainers did not distinguish
between development of the intervention and preparation for delivering the training events in their records of time
inputs because the two activities were closely intertwined. Training delivery would be expected to have some recurrent
preparation cost; therefore, we assumed that of the total time recorded by them during the development phase, 90%
was for development and 10% for preparation. The latter, 10%, was allocated to the training event preparation
component of the LSCTC unit cost.
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ABLE 65 London Stroke Carers Training Course unit cost: preparation for four core training days and one refresher
raining day
Resource Activity Hours per activity
Costs
(£, 2009–10 prices)
A. Core training: April – November 2007
Academic Grade 8, point 37 Arranging Leeds training event×2 10 564
Academic Grade 8, point 37 Arranging Leeds travel and attendance×2 10 564
Academic Grade 8, point 37 Arranging London training event×2 10 564
Academic Grade 8, point 37 Arranging London travel and attendance×2 10 564
NHS Band 5, point 20 Administration – training manuals composition 35 859
NHS Band 7, point 35a Preparation time 2.2 91
NHS Band 7, point 35a Preparation time 1.9 78
NHS Band 7, point 35a Preparation time 2.5 103
Academic Grade 10, point 52a Preparation time 1.9 167
Core training, total preparation cost 3554
B. Refresher training: August 2009
Academic Grade 8, point 37 Arranging London refresher event 5 282
Academic Grade 8, point 37 Arranging London travel and attendance 5 282
NHS Band 4, point 14 Administration – training manuals and
compact disc, version 2
8 164
NHS Band 7, point 35a Preparation time 0.2 8
NHS Band 7, point 3a Preparation time 0.2 8
Academic Grade 10, point 52a Preparation time 0.1 9
Refresher training, total
preparation cost
753
C. Preparation, total cost (A+B)
4308
a During the ﬁrst development phase prior to the main training sessions, the four trainers did not distinguish
between development of the intervention and preparation for delivering the training events in their records of time
inputs because the two activities were closely intertwined. Training delivery would be expected to have some recurrent
preparation cost; therefore, we assumed that of the total time recorded by them during the development phase, 90%
was for development and 10% for preparation. The latter, 10%, was allocated to the training event preparation
component of the LSCTC unit cost.
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TABLE 66 London Stroke Carers Training Course unit cost: delivery of four core training days and one refresher
training day
Resource Activity Hours per activity
Costs
(£, 2009–10 prices)
A. Core training: April to November 2007
Trainers' time
Academic Grade 8, point 37 Travel and attendance 40 2256
NHS Band 7, point 35 Travel and attendance 36 1487
NHS Band 7, point 35 Travel and attendance 36 1487
NHS Band 7, point 35 Travel and attendance 36 1487
Academic Grade 10, point 52 Travel and attendance 40 3514
A1. Total cost, trainers' time 10,230
Non-staff inputsa
Room hire and catering,
Leeds day 1
760
Room hire and catering,
Leeds day 2
336
Room hire and catering,
London day 1
753
Room hire and catering,
London day 2
627
Travel costs, trainers and
attendees, Leeds day 1
1423
Travel costs, trainers and
attendees, Leeds day 2
1472
Travel costs, trainers and
attendees, London day 1
1242
Travel costs, trainers and
attendees, London day 2
1051
Royal College of Nursing
accreditation
273
Filming and production of
training compact discs
4097
Copying compact discs 140
Printing of training manual
ﬁles and paperwork
284
Printing of training records 629
A2. Total cost, non-staff
inputsa
13,086
A3. Core training delivery,
total cost (A1+A2)
23,317
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ABLE 66 London Stroke Carers Training Course unit cost: delivery of four core training days and one refresher
raining day (continued )
Resource Activity Hours per activity
Costs
(£, 2009–10 prices)
B. Refresher training: August 2009
Academic Grade 8, point 37 Travel and attendance 15 846
NHS Band 7, point 35 Travel and attendance 9 372
NHS Band 7, point 35 Travel and attendance 9 372
Academic Grade 10, point 52 Travel and attendance 15 1318
NHS Band 7, point 31 Travel and attendance 8 290
B1. Total cost, trainers' time 3197
Room hire and catering,
London
232
Travel costs, trainers and
attendees, London
2175
B2. Total cost, non-staff inputs 2407
B3. Refresher training delivery, total cost (B1+B2) 5603
C. Delivery, total cost (A1+A2+B1+B2)
28,920
a Non-staff costs occurring in 2007 were inﬂated to 2009–10 prices using the Gross Domestic Product deﬂator: 2.77%
for 2007–8 to 2008–9 and 1.63% for 2008–9 to 2009–10.88
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ABLE 68 London Stroke Carers Training Course unit cost: ward staff costs for attending core training events
Centre Totala,b
NHS
Band 5
NHS
Band 6
NHS
Band 7
NHS
Band 8
NHS
consultant
NHS
unknownc
Costs
(£, 2009–10
prices)
3 n 2 1 2 3
Attendance time
(minutes)
660 300 660 1020
Total travel time
(minutes)
480 240 480 720
Cost (£) 467 275 673 713 2129
5 n 1 2 1
Attendance time
(minutes)
360 660 360
Total travel time
(minutes)
240 480 240
Cost (£) 306 673 246 1225
1ad n 1 2.5 4
Attendance time
(minutes)
360 510 1230
Total travel time
(minutes)
240 600 960
Cost (£) 246 566 1292 2104
1bd n 1 2.5 4
Attendance time
(minutes)
360 510 1230
Total travel time
(minutes)
240 600 960
Cost (£) 246 566 1292 2104
15 n 2 1 1
Attendance time
(minutes)
660 360 360
Total travel time
(minutes)
480 240 240
Cost (£) 467 306 558 1331
13 n 1 2
Attendance time
(minutes)
360 660
Total travel time
(minutes)
240 480
Cost (£) 246 1060 1306
18 n 1 4
Attendance time
(minutes)
360 1320
Total travel time
(minutes)
240 960
Cost (£) 246 1163 1409
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ABLE 68 London Stroke Carers Training Course unit cost: ward staff costs for attending core training events
continued )
Centre Totala,b
NHS
Band 5
NHS
Band 6
NHS
Band 7
NHS
Band 8
NHS
consultant
NHS
unknownc
Costs
(£, 2009–10
prices)
7 n 2 2 2
Attendance time
(minutes)
660 660 660
Total travel time
(minutes)
480 480 480
Cost (£) 581 673 1060 2314
6 n 2 2
Attendance time
(minutes)
660 660
Total travel time
(minutes)
480 480
Cost (£) 467 673 1140
12 n 2 1 1
Attendance time
(minutes)
660 360 360
Total travel time
(minutes)
480 240 240
Cost (£) 581 354 1080 2015
11 n 3
Attendance time
(minutes)
960
Total travel time
(minutes)
720
Cost (£) 857 857
17 n 3 1
Attendance time
(minutes)
1020 300
Total travel time
(minutes)
720 240
Cost (£) 887 319 1206
4 n 2 1
Attendance time
(minutes)
660 360
Total travel time
(minutes)
480 240
Cost (£) 581 354 935
16 n 1
Attendance time
(minutes)
360
Total travel time
(minutes)
240
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ABLE 68 London Stroke Carers Training Course unit cost: ward staff costs for attending core training events
ontinued )
Centre Totala,b
NHS
Band 5
NHS
Band 6
NHS
Band 7
NHS
Band 8
NHS
consultant
NHS
unknownc
Costs
(£, 2009–10
prices)
14 n 4 2
Attendance time
(minutes)
1320 720
Total travel time
(minutes)
960 480
Cost (£) 1163 708 1871
8 n 3
Attendance time
(minutes)
1020
Total travel time
(minutes)
720
Cost (£) 887 887
10 n 3 4
Attendance time
(minutes)
660 1380
Total travel time
(minutes)
720 960
Cost (£) 704 1381 2084
9 n 2 2
Attendance time
(minutes)
660 660
Total travel time
(minutes)
480 480
Cost (£) 467 581 1049
2 n 4
Attendance time
(minutes)
1320
Total travel time
(minutes)
960
Cost(£) 1345 1345
Total cost for attending main training events 27,667
a Attendees' travel time was not measured. A conservative estimate of 4 hours per attendee was assumed.
b The sample size refers to the number of each staff band attending across the range of sessions offered (rather than
the number of unique staff) and, thus, includes the same ward staff more than once if they attended multiple sessions.
c For staff whose pay band was unknown, the middle band of the qualifying band range, Band 5, and its midpoint, 20,
were assumed. For staff for whose band was reported as a range of 5–7, costs were calculated as for the middle Band,
6. For staff whose band was reported as a range of 3–8, costs were calculated as for the middle Band, 7.
d Centres 1a and 1b attendance data for the core training events were combined; therefore, the number of staff in each
band and thus the associated time was split evenly between them.
Note 1a and 1b: These were randomised as a single centre but consisted of two SRUs within the same NHS trust.
Consequently, some training was completed separately at each site and so costs were calculated separately.
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TABLE 69 London Stroke Carers Training Course unit cost: ward staff costs for attending refresher training event
Centre Totala,b
NHS
Band 4
NHS
Band 5
NHS
Band 6
NHS
Band 7
NHS
Band 8
Costs
(£, 2009–10
prices)
3 n
Attendance time (minutes)
Total travel time (minutes)
Cost (£) 0
5 n
Attendance time (minutes)
Total travel time (minutes)
Cost (£) 0
1a n
Attendance time (minutes)
Total travel time (minutes)
Cost (£) 0
1b n
Attendance time (minutes)
Total travel time (minutes)
Cost (£) 0
15 n
Attendance time (minutes)
Total travel time (minutes)
Cost (£) 0
13 n 1 1
Attendance time (minutes) 360 360
Total travel time (minutes) 240 240
Cost (£) 246 306 552
18 n 2
Attendance time (minutes) 720
Total travel time (minutes) 480
Cost (£) 492 492
7 n 1
Attendance time (minutes) 360
Total travel time (minutes) 240
Cost (£) 354 354
6 n 1 1
Attendance time (minutes) 360 360
Total travel time (minutes) 240 240
Cost (£) 246 306 552
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ABLE 69 London Stroke Carers Training Course unit cost: ward staff costs for attending refresher training event
ontinued )
Centre Totala,b
NHS
Band 4
NHS
Band 5
NHS
Band 6
NHS
Band 7
NHS
Band 8
Costs
(£, 2009–10
prices)
12 n
Attendance time (minutes)
Total travel time (minutes)
Cost (£) 0
11 n 1
Attendance time (minutes) 360
Total travel time (minutes) 240
Cost (£) 306 306
17 n
Attendance time (minutes)
Total travel time (minutes)
Cost (£) 0
4 n
Attendance time (minutes)
Total travel time (minutes)
Cost (£) 0
16 n
Attendance time (minutes)
Total travel time (minutes)
Cost (£) 0
14 n 1 1
Attendance time (minutes) 360 360
Total travel time (minutes) 240 240
Cost (£) 246 354 600
8 n 1 1
Attendance time (minutes) 360 360
Total travel time (minutes) 240 240
Cost (£) 204 306 510
10 n 1 1
Attendance time (minutes) 360 360
Total travel time (minutes) 240 240
Cost (£) 246 354 600
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TABLE 69 London Stroke Carers Training Course unit cost: ward staff costs for attending refresher training event
(continued )
Centre Totala,b
NHS
Band 4
NHS
Band 5
NHS
Band 6
NHS
Band 7
NHS
Band 8
Costs
(£, 2009–10
prices)
9 n 1
Attendance time (minutes) 360
Total travel time (minutes) 240
Cost (£) 306 306
2 n 1
Attendance time (minutes) 360
Total travel time (minutes) 240
Cost (£) 354 354
Total cost for attending refresher training event 4626
a Attendees' travel time was not measured. A conservative estimate of 4 hours per attendee was assumed.
b The sample size refers to the number of each staff band attending across the range of sessions offered (rather than the
number of unique staff) and, thus, includes the same ward staff more than once if they attended multiple sessions.
Note 1a and 1b: These were randomised as a single centre but consisted of two SRUs within the same NHS trust.
Consequently, some training was completed separately at each site and so costs were calculated separately.
TABLE 70 London Stroke Carers Training Course unit cost: ward staff costs for delivering cascaded training
Centre Total
NHS
Band
4
NHS
Band
5
NHS
Band
6
NHS
Band
7
NHS
Band
8
Researcher
Grade 6
Researcher
Grade 8
Costs
(£, 2009–10
prices)
3 n 5
Attendance
time (minutes)
300
Cost (£) 123 123
5 n
Attendance
time (minutes)
Cost (£) 0
1a n
Attendance
time (minutes)
Cost (£) 0
1b n
Attendance
time (minutes)
Cost (£) 0
15 n
Attendance
time (minutes)
Cost (£) 0
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TABLE 70 London Stroke Carers Training Course unit cost: ward staff costs for delivering cascaded training
(continued )
Centre Total
NHS
Band
4
NHS
Band
5
NHS
Band
6
NHS
Band
7
NHS
Band
8
Researcher
Grade 6
Researcher
Grade 8
Costs
(£, 2009–10
prices)
13 n 2
Attendance
time (minutes)
120
Cost (£) 112 112
18 n 14
Attendance
time (minutes)
235
Cost (£) 120 120
7 n 1 1
Attendance
time (minutes)
60 60
Cost (£) 56 56 112
6 n 1 10
Attendance
time (minutes)
240 480
Cost (£) 98 283 382
12 n 9
Attendance
time (minutes)
320
Cost (£) 163 163
11 n 4
Attendance
time (minutes)
130
Cost (£) 66 66
17 n
Attendance
time (minutes)
Cost (£) 0
4 n
Attendance
time (minutes)
Cost (£) 0
16 n
Attendance
time (minutes)
Cost (£) 0
14 n
Attendance
time (minutes)
Cost (£) 0
continued
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TABLE 70 London Stroke Carers Training Course unit cost: ward staff costs for delivering cascaded training
(continued )
Centre Total
NHS
Band
4
NHS
Band
5
NHS
Band
6
NHS
Band
7
NHS
Band
8
Researcher
Grade 6
Researcher
Grade 8
Costs
(£, 2009–10
prices)
8 n 5
Attendance
time (minutes)
140
Cost (£) 71 71
10 n 4
Attendance
time (minutes)
220
Cost (£) 150 150
9 n 4 4
Attendance
time (minutes)
160 150
Cost (£) 66 77 142
2 n 7
Attendance
time (minutes)
230
Cost (£) 136 136
Total cost for delivering cascaded training 1577
Note 1a and 1b: These were randomised as a single centre but consisted of two SRUs within the same NHS trust.
Consequently, some training was completed separately at each site and so costs were calculated separately.
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TABLE 72 London Stroke Carers Training Course unit cost: ward staff costs for receiving local refresher training
Centre Totala
NHS
Band
2
NHS
Band
3
NHS
Band
5
NHS
Band
6
NHS
Band
7
NHS
Band
8
NHS
consultant
Senior
house
ofﬁcer
Social
worker
Cost
(£, 2009–
10 prices)
3 n 1 8 1 4 1
Attendance
time
(minutes)
30 270 45 150 45
Cost (£) 8 111 23 89 81 311
5 n 2 8 6 1 2
Attendance
time
(minutes)
30 135 90 15 30
Cost (£) 12 69 53 27 20 181
1a n 6 2 4
Attendance
time
(minutes)
90 90 130
Cost (£) 37 46 77 160
1b n 4 3 2 2 2
Attendance
time
(minutes)
50 45 25 25 25
Cost (£) 21 23 15 45 9 112
15 n 2 1 8 2 1 2
Attendance
time
(minutes)
50 20 200 60 30 60
Cost (£) 13 6 82 31 18 56 204
13 n 2 6
Attendance
time
(minutes)
40 130
Cost (£) 16 66 83
18 n 4
Attendance
time
(minutes)
80
Cost (£) 41 41
7 n 1 3 2 2
Attendance
time
(minutes)
20 140 100 100
Cost (£) 5 57 59 93 214
continued
DOI: 10.3310/hta17460 HEALTH TECHNOLOGY ASSESSMENT 2013 VOL. 17 NO. 46
185
© Queen's Printer and Controller of HMSO 2013. This work was produced by Forster et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided
that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to:
NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
TABLE 72 London Stroke Carers Training Course unit cost: ward staff costs for receiving local refresher training
(continued )
Centre Totala
NHS
Band
2
NHS
Band
3
NHS
Band
5
NHS
Band
6
NHS
Band
7
NHS
Band
8
NHS
consultant
Senior
house
ofﬁcer
Social
worker
Cost
(£, 2009–
10 prices)
6 n 1 7 7 1
Attendance
time
(minutes)
60 320 340 60
Cost (£) 15 131 201 40 386
12 n 2 1 16 7 3 2 1
Attendance
time
(minutes)
20 45 705 315 135 90 30
Cost (£) 5 13 289 161 80 84 54 685
11 n 1 9
Attendance
time
(minutes)
60 390
Cost (£) 25 199 224
17 n 1 6 5 1 2
Attendance
time
(minutes)
40 240 240 40 100
Cost (£) 10 98 122 24 180 434
4 n 1 6
Attendance
time
(minutes)
30 195
Cost (£) 12 99 112
16 n 8 2 7 2
Attendance
time
(minutes)
260 65 225 65
Cost (£) 107 33 133 117 390
14 n 5 6 2 1 1
Attendance
time
(minutes)
110 140 40 10 10
Cost (£) 28 71 24 18 7 147
8 n 1 3
Attendance
time
(minutes)
30 90
Cost (£) 12 46 58
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TABLE 72 London Stroke Carers Training Course unit cost: ward staff costs for receiving local refresher training
(continued )
Centre Totala
NHS
Band
2
NHS
Band
3
NHS
Band
5
NHS
Band
6
NHS
Band
7
NHS
Band
8
NHS
consultant
Senior
house
ofﬁcer
Social
worker
Cost
(£, 2009–
10 prices)
10 n 4 4 5 4
Attendance
time
(minutes)
95 145 125 70
Cost (£) 24 59 64 41 188
9 n 1 3 5 2
Attendance
time
(minutes)
45 135 210 75
Cost (£) 11 55 107 70 243
2 n 1 4 3
Attendance
time
(minutes)
45 180 135
Cost (£) 11 74 69 154
Total cost for receiving further refresher training 4327
a The sample size refers to the number of each staff band attending across the range of sessions offered (rather than
the number of unique staff) and, thus, includes the same ward staff more than once if they attended multiple sessions
Note 1a and 1b: These were randomised as a single centre but consisted of two SRUs within the same NHS trust.
Consequently, some training was completed separately at each site and so costs were calculated separately.
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TABLE 73 London Stroke Carers Training Course unit cost:
total ward staff costs
Centre
Total cost per centre
(£, 2009–10 prices)
3 3731
5 1406
1a 2264
1b 2216
15 1536
13 2836
18 2288
7 3240
6 3173
12 5034
11 1526
17 1640
4 1047
16 744
14 2618
8 1975
10 3263
9 2345
2 2196
Total cost for ward staff 45,077
Average ward staff cost per centre 2372
Note 1a and 1b: These were randomised as a single centre
but consisted of two SRUs within the same NHS trust.
Consequently, some training was completed separately at
each site and so costs were calculated separately.
APPENDIX 6
188
NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta17460 HEALTH TECHNOLOGY ASSESSMENT 2013 VOL. 17 NO. 46Appendix 7 Literature review search strategyNote: Searching only for controlled trials.
Added relevant terms:
(community NEAR/2 network*)
(community NEAR/2 support*)
(support* NEAR/2 conversation*)
(patient NEAR/3 feedback)
(patient NEAR/3 education)ID Search Hits Edit Delete
#1 Medical subject heading (MeSH) descriptor Cerebrovascular Disorders, this term only 1339 Edit Delete
#2 MeSH descriptor Basal Ganglia Cerebrovascular Disease explode all trees 20 Edit Delete
#3 MeSH descriptor Brain Ischemia explode all trees 1862 Edit Delete
#4 MeSH descriptor Carotid Artery Diseases explode all trees 836 Edit Delete
#5 MeSH descriptor Stroke, this term only 3232 Edit Delete
#6 MeSH descriptor Brain Infarction explode all trees 624 Edit Delete
#7 MeSH descriptor Cerebrovascular Trauma explode all trees 19 Edit Delete
#8 MeSH descriptor Hypoxia-Ischemia, Brain explode all trees 87 Edit Delete
#9 MeSH descriptor Intracranial Arterial Diseases explode all trees 772 Edit Delete
#10 MeSH descriptor Intracranial Arteriovenous Malformations, this term only 43 Edit Delete
#11 MeSH descriptor Intracranial Embolism and Thrombosis explode all trees 230 Edit Delete
#12 MeSH descriptor Intracranial Hemorrhages explode all trees 1080 Edit Delete
#13 MeSH descriptor Vasospasm, Intracranial, this term only 84 Edit Delete
#14 MeSH descriptor Vertebral Artery Dissection, this term only 2 Edit Delete
#15 MeSH descriptor Aneurysm, Ruptured, this term only 91 Edit Delete
#16 MeSH descriptor Brain Injuries, this term only 745 Edit Delete
#17 MeSH descriptor Brain Injury, Chronic, this term only 25 Edit Delete
#18 MeSH descriptor Carotid Arteries explode all trees 883 Edit Delete
#19 MeSH descriptor Endarterectomy, Carotid, this term only 424 Edit Delete
#20 MeSH descriptor Endarterectomy, this term only 108 Edit Delete
#21 MeSH descriptor Heart Septal Defects, Atrial, this term only 95 Edit Delete
#22 MeSH descriptor Atrial Fibrillation, this term only 2056 Edit Delete189
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ID Search Hits Edit Delete
#23 (brain* or cerebr* or cerebell* or cortical or vertebrobasilar or hemispher* or
intracran* or intracerebral or infratentorial or supratentorial or MCA or “anterior
circulation” or “posterior circulation” or “basal ganglia”) and (ischemi* or ischaemi*
or infarct* or thrombo* or emboli* or occlus* or hypox* or vasospasm or obstruction
or vasculopathy)
8321 Edit Delete
#24 (“lacunar infarct*” or “cortical infarct*”) 14 Edit Delete
#25 (brain* or cerebr* or cerebell* or intracerebral or intracran* or parenchymal or
intraventricular or infratentorial or supratentorial or “basal gangli*” or subarachnoid or
putaminal or putamen or “posterior fossa”) and (haemorrhage* or hemorrhage* or
haematoma* or hematoma* or bleed*)
4420 Edit Delete
#26 (“vertebral artery dissection” or “cerebral art* disease*”) 39 Edit Delete
#27 (brain or intracranial or “basal ganglia” or lenticulostriate) and (vascular) and (disease*
or disorder or accident or injur* or trauma* or insult or event)
1038 Edit Delete
#28 (ischemic or ischaemic or apoplectic) and (event or events or insult or attack*) 3721 Edit Delete
#29 (“cerebral vein” or “cerebral venous” or sinus or sagittal) and (thrombo*) 262 Edit Delete
#30 (CVDST or CVT) 37 Edit Delete
#31 (intracranial or “cerebral art*” or “basilar art*” or “vertebral art*” or vertebrobasilar
or “vertebral basilar”) and (stenosis or ischemia or ischaemia or insufﬁciency or
arteriosclero* or atherosclero* or occlus*)
937 Edit Delete
#32 (venous or arteriovenous or “brain vasc*”) and malformation* 199 Edit Delete
#33 (brain or cerebral) and (angioma* or hemangioma* or haemangioma*) 17 Edit Delete
#34 (carotid*) 3418 Edit Delete
#35 (“patent foramen ovale” or PFO) 112 Edit Delete
#36 (atrial or atrium or auricular) and ﬁbrillation 3557 Edit Delete
#37 (“asymptomatic cervical bruit”) 7 Edit Delete
#38 (aphasi* or apraxi* or dysphasi* or dysphagi* or “deglutition disorder*” or “swallow*
disorder*” or dysarthri* or hemipleg* or hemipar* or paresis or paretic or hemianop*
or hemineglect or spasticity or anomi* or dysnomi* or “acquired brain injur*” or
hemiball* )
4485 Edit Delete
#39 (unilateral or visual or hemispatial or attentional or spatial) and neglect 313 Edit Delete
#40 (brain or cerebral or intracranial or communicating or giant or basilar or “vertebral
artery” or berry or saccular or ruptured) and aneurysm*
1008 Edit Delete
#41 MeSH descriptor Aphasia explode all trees 131 Edit Delete
#42 MeSH descriptor Anomia, this term only 8 Edit Delete
#43 MeSH descriptor Hemiplegia, this term only 377 Edit Delete
#44 MeSH descriptor Hemianopsia, this term only 20 Edit Delete
#45 MeSH descriptor Paresis explode all trees 269 Edit Delete
#46 MeSH descriptor Deglutition Disorders, this term only 404 Edit Delete
#47 MeSH descriptor Dysarthria, this term only 34 Edit Delete
#48 MeSH descriptor Pseudobulbar Palsy, this term only 4 Edit Delete
#49 MeSH descriptor Muscle Spasticity, this term only 429 Edit Delete
#50 (stroke or poststroke or post NEXT stroke or cerebrovasc* or “brain vasc*” or “cerebral
vasc*” or cva* or apoplex* or “ischemi* attack*” or “ischaemi* attack*” or tia* or
“neurologic* deﬁcit*” or SAH or AVM)
31,157 Edit Delete
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ID Search Hits Edit Delete
#51 (#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR
#13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19 OR #20 OR #21 OR #22 OR #23
OR #24 OR #25 OR #26 OR #27 OR #28 OR #29 OR #30 OR #31 OR #32 OR #33 OR
#34 OR #35 OR #36 OR #37 OR #38 OR #39 OR #40 OR #41 OR #42 OR #43 OR #44
OR #45 OR #46 OR #47 OR #48 OR #49 OR #50)
43,189 Edit Delete
#52 (SR-STROKE) 15,097 Edit Delete
#53 (#51 AND NOT #52) 28,092 Edit Delete
#54 MeSH descriptor Caregivers, this term only 865 Edit Delete
#55 MeSH descriptor Friends, this term only 58 Edit Delete
#56 MeSH descriptor Parents explode all trees 2023 Edit Delete
#57 MeSH descriptor Spouses, this term only 170 Edit Delete
#58 MeSH descriptor Visitors to Patients, this term only 22 Edit Delete
#59 MeSH descriptor Home Nursing, this term only 269 Edit Delete
#60 MeSH descriptor Community Networks, this term only 79 Edit Delete
#61 MeSH descriptor Parent-Child Relations explode all trees 968 Edit Delete
#62 MeSH descriptor Interpersonal Relations explode all trees 3269 Edit Delete
#63 MeSH descriptor Family, this term only 809 Edit Delete
#64 MeSH descriptor Family Characteristics explode all trees 594 Edit Delete
#65 MeSH descriptor Family Relations, this term only 117 Edit Delete
#66 MeSH descriptor Intergenerational Relations, this term only 21 Edit Delete
#67 MeSH descriptor Family Therapy, this term only 573 Edit Delete
#68 MeSH descriptor Family Nursing, this term only 15 Edit Delete
#69 MeSH descriptor Family Health, this term only 301 Edit Delete
#70 (carer* or caregiv* or “care giv*” or care NEXT giv*) 4765 Edit Delete
#71 (family or families or spous* or parent or parents or father* or mother* or friend or
friends or husband* or wife or wives or partner or partners)
30,648 Edit Delete
#72 (home or communit*) and (caring or care*) or (community NEAR/2 network*) 16,360 Edit Delete
#73 (home NEXT based) 1559 Edit Delete
#74 (community NEXT based) or (community NEAR/2 network*) 3323 Edit Delete
#75 (homebased or communitybased) 1069 Edit Delete
#76 “home nursing” 367 Edit Delete
#77 (non NEXT professional) and (care or nursing) 78 Edit Delete
#78 (nonprofessional or informal or unpaid) and (care or nursing) 728 Edit Delete
#79 “next of kin” or (relatives) 33,281 Edit Delete
#80 (#54 OR #55 OR #56 OR #57 OR #58 OR #59 OR #60 OR #61 OR #62 OR #63 OR #64
OR #65 OR #66 OR #67 OR #68 OR #69 OR #70 OR #71 OR #72 OR #73 OR #74 OR
#75 OR #76 OR #77 OR #78 OR #79)
73,994 Edit Delete
#81 (#53 AND #80) 5562 Edit Delete
#82 MeSH descriptor Community Networks, this term only 79 Edit Delete
#83 MeSH descriptor Social Support, this term only 1862 Edit Delete
#84 MeSH descriptor Social Isolation, this term only 117 Edit Delete
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ID Search Hits Edit Delete
#85 MeSH descriptor Social Welfare, this term only 39 Edit Delete
#86 MeSH descriptor Patient Education as Topic, this term only 5338 Edit Delete
#87 MeSH descriptor Professional-Family Relations, this term only 110 Edit Delete
#88 MeSH descriptor Altruism, this term only 29 Edit Delete
#89 MeSH descriptor Helping Behavior, this term only 52 Edit Delete
#90 MeSH descriptor Social Adjustment, this term only 753 Edit Delete
#91 MeSH descriptor Adaptation, Psychological, this term only 2471 Edit Delete
#92 MeSH descriptor Stress, Psychological, this term only 2751 Edit Delete
#93 MeSH descriptor Anxiety, this term only 4079 Edit Delete
#94 MeSH descriptor Depression, this term only 4232 Edit Delete
#95 MeSH descriptor Emotions, this term only 1534 Edit Delete
#96 MeSH descriptor Family, this term only with qualiﬁer: PX 318 Edit Delete
#97 MeSH descriptor Respite Care, this term only 26 Edit Delete
#98 MeSH descriptor Day Care, this term only 262 Edit Delete
#99 (attitude* or perception* or belief* or expectation* or satisfaction or emotion* or
relationship* or support* or control or adjust* or guid* or information or advi* or
help* or train*) and (carer* or caregiv* or “care giv*”)
4444 Edit Delete
#100 (attitude* or perception* or belief* or expectation* or satisfaction or emotion* or
relationship* or support* or control or adjust* or guid* or information or advi* or
help* or train*) and (care NEXT giv*)
482 Edit Delete
#101 (anxiet* or stress* or fatigue* or resent* or burden* or cope* or coping) 50,135 Edit Delete
#102 (moral*) and (oblig* or duty or duties or responsibilit*) 75 Edit Delete
#103 (social or psychosocial or practical or group*) and (information or advice or help or
support or network)
200,444 Edit Delete
#104 “post discharge” or postdischarge 708 Edit Delete
#105 (respite) 111 Edit Delete
#106 MeSH descriptor Quality of Life, this term only 11,312 Edit Delete
#107 (health or problem* or mood*) and (carer* or caregiv* or “care giv*”) 3292 Edit Delete
#108 (health or problem* or mood*) and (care NEXT giv*) 421 Edit Delete
#109 MeSH descriptor Self-Help Groups, this term only 495 Edit Delete
#110 “self help” NEXT group* 626 Edit Delete
#111 (selfhelp NEXT group*) 28 Edit Delete
#112 (self NEXT “help group”) 86 Edit Delete
#113 (community NEAR/2 network*) 118 Edit Delete
#114 (community NEAR/2 support*) 226 Edit Delete
#115 (support* NEAR/2 conversation*) 3 Edit Delete
#116 (patient NEAR/3 feedback) 259 Edit Delete
#117 (patient NEAR/3 education) 7378 Edit Delete
#118 (#82 OR #83 OR #84 OR #85 OR #86 OR #87 OR #88 OR #89 OR #90 OR #91 OR #92
OR #93 OR #94 OR #95 OR #96 OR #97 OR #98 OR #99 OR #100 OR #101 OR #102
OR #103 OR #104 OR #105 OR #106 OR #107 OR #108 OR #109 OR #110 OR #111
OR #112)
23,4748 Edit Delete
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DOI: 10.3310/hta17460 HEALTH TECHNOLOGY ASSESSMENT 2013 VOL. 17 NO. 46Appendix 8 Appendix to Chapter 4Completion of London Stroke Carers Training Course
training recordsTABLE 74 Completion of competency items (mandatory components)
Training components (mandatory) Registered (N=450), n (%)
Carer has demonstrated understanding of:
1. Relative having a stroke
Achieved 232 (51.6)
Not achieved 94 (20.9)
Training record not completed 124 (27.6)
2. What a stroke is
Achieved 211 (46.9)
Not achieved 115 (25.6)
Training record not completed 124 (27.6)
4. Healthy lifestyle and prevention
Achieved 220 (48.9)
Not achieved 106 (23.6)
Training record not completed 124 (27.6)
12. Compliance with medication
Achieved 146 (32.4)
Not achieved 180 (40.0)
Training record not completed 124 (27.6)
13. Post-discharge recommendations and help
Achieved 199 (44.2)
Not achieved 127 (28.2)
Training record not completed 124 (27.6)
14. Knowledge and skills to home environment
Achieved 160 (35.6)
Not achieved 166 (36.9)
Training record not completed 124 (27.6)
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TABLE 75 Number of non-mandatory components achieved
No. of components achieved Registered (N=450), n (%) Cumulative N patients (%)
8 6 (1.3) 6 (1.3)
7 12 (2.7) 18 (4.0)
6 30 (6.7) 48 (10.7)
5 31 (6.9) 79 (17.6)
4 56 (12.4) 135 (30.0)
3 47 (10.4) 182 (40.4)
2 60 (13.3) 242 (53.8)
1 41 (9.1) 283 (62.9)
0 3 (0.7) 286 (63.6)
Missing 164 (36.4) 450 (100.0)
TABLE 76 Completion of competency items: non-mandatory components
Training components (non-mandatory) Registered (N=450), n (%)
3. Specific stroke-related problems
Appropriate and achieved 204 (45.3)
Appropriate but not achieved 5 (1.1)
Not completed 79 (17.6)
Not appropriate 38 (8.4)
No training record returned 124 (27.6)
5. Dietary needs and feeding techniques
Appropriate and achieved 75 (16.7)
Not completed 20 (4.4)
Not appropriate 231 (51.3)
No training record returned 124 (27.6)
6. Communication with dysphasic relative
Appropriate and achieved 65 (14.4)
Not completed 13 (2.9)
Not appropriate 248 (55.1)
No training record returned 124 (27.6)
7. Managing washing and dressing
Appropriate and achieved 167 (37.1)
Appropriate but not achieved 1 (0.2)
Not completed 30 (6.7)
Not appropriate 128 (28.4)
No training record returned 124 (27.6)
APPENDIX 8
194
NIHR Journals Library www.journalslibrary.nihr.ac.uk
TABLE 76 Completion of competency items: non-mandatory components (continued )
Training components (non-mandatory) Registered (N=450), n (%)
8. Limb positioning and skin integrity
Appropriate and achieved 131 (29.1)
Appropriate but not achieved 1 (0.2)
Not completed 25 (5.6)
Not appropriate 169 (37.6)
No training record returned 124 (27.6)
9. Continence management
Appropriate and achieved 60 (13.3)
Not completed 17 (3.8)
Not appropriate 249 (55.3)
No training record returned 124 (27.6)
10. Bowel management
Appropriate and achieved 54 (12.0)
Appropriate but not achieved 1 (0.2)
Not completed 19 (4.2)
Not appropriate 252 (56.0)
No training record returned 124 (27.6)
11. Assisting mobility and safe transfers
Appropriate and achieved 239 (53.1)
Not completed 26 (5.8)
Not appropriate 61 (13.6)
No training record returned 124 (27.6)
TABLE 77 Number of time logs completed by site
Centre
Yes,
n (%)
No,
n (%)
Not required,
n (%)
Conﬁrmed not
completed by site,
n (%)
Conﬁrmed lost
by site, n (%)
Time logs not
completed,
n (%)
Total,
n
Control 211 (44.1) 4 (0.8) 174 (36.4) 78 (16.3) 9 (1.9) 2 (0.4) 478
19 17 (50.0) 0 (0.0) 14 (41.2) 3 (8.8) 0 (0.0) 0 (0.0) 34
20 18 (66.7) 0 (0.0) 3 (11.1) 6 (22.2) 0 (0.0) 0 (0.0) 27
21 9 (29.0) 0 (0.0) 19 (61.3) 3 (9.7) 0 (0.0) 0 (0.0) 31
22 9 (50.0) 0 (0.0) 9 (50.0) 0 (0.0) 0 (0.0) 0 (0.0) 18
23 14 (56.0) 3 (12.0) 7 (28.0) 0 (0.0) 0 (0.0) 1 (4.0) 25
24 1 (8.3) 0 (0.0) 2 (16.7) 9 (75.0) 0 (0.0) 0 (0.0) 12
25 17 (44.7) 1 (2.6) 20 (52.6) 0 (0.0) 0 (0.0) 0 (0.0) 38
26 12 (52.2) 0 (0.0) 8 (34.8) 3 (13.0) 0 (0.0) 0 (0.0) 23
continued
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TABLE 77 Number of time logs completed by site (continued )
Centre
Yes,
n (%)
No,
n (%)
Not required,
n (%)
Conﬁrmed not
completed by site,
n (%)
Conﬁrmed lost
by site, n (%)
Time logs not
completed,
n (%)
Total,
n
27 11 (31.4) 0 (0.0) 14 (40.0) 10 (28.6) 0 (0.0) 0 (0.0) 35
28 7 (30.4) 0 (0.0) 5 (21.7) 11 (47.8) 0 (0.0) 0 (0.0) 23
29 16 (53.3) 0 (0.0) 12 (40.0) 0 (0.0) 1 (3.3) 1 (3.3) 30
30 1 (7.7) 0 (0.0) 3 (23.1) 9 (69.2) 0 (0.0) 0 (0.0) 13
31 12 (46.2) 0 (0.0) 9 (34.6) 5 (19.2) 0 (0.0) 0 (0.0) 26
32 17 (68.0) 0 (0.0) 7 (28.0) 0 (0.0) 1 (4.0) 0 (0.0) 25
33 9 (52.9) 0 (0.0) 2 (11.8) 0 (0.0) 6 (35.3) 0 (0.0) 17
34 11 (32.4) 0 (0.0) 14 (41.2) 9 (26.5) 0 (0.0) 0 (0.0) 34
35 15 (46.9) 0 (0.0) 15 (46.9) 1 (3.1) 1 (3.1) 0 (0.0) 32
36 15 (42.9) 0 (0.0) 11 (31.4) 9 (25.7) 0 (0.0) 0 (0.0) 35
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FIGURE 19 Number of training sessions undertaken by carers: intervention. Missing= there is no information about
the number of training sessions.
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DOI: 10.3310/hta17460 HEALTH TECHNOLOGY ASSESSMENT 2013 VOL. 17 NO. 46Patient safetyTABLE 78 Number of patients with falls and SAEs by SRUs (% is out of patients registered by the SRU)
SRU No. registered Patients with falls, n (%) Patients with SAEs, n (%)
Intervention 450 35 (7.8) 2 (0.4)
1 20 1 (5.0) 0 (0.0)
2 21 1 (4.8) 0 (0.0)
3 24 2 (8.3) 0 (0.0)
4 30 2 (6.7) 0 (0.0)
5 32 1 (3.1) 0 (0.0)
6 32 1 (3.1) 0 (0.0)
7 27 0 (0.0) 0 (0.0)
8 23 5 (21.7) 0 (0.0)
9 29 3 (10.3) 0 (0.0)
10 25 1 (4.0) 1 (4.0)
11 16 1 (6.3) 0 (0.0)
12 35 4 (11.4) 0 (0.0)
13 14 2 (14.3) 0 (0.0)
14 35 4 (11.4) 0 (0.0)
15 19 0 (0.0) 0 (0.0)
16 17 3 (17.6) 1 (5.9)
17 25 2 (8.0) 0 (0.0)
18 26 2 (7.7) 0 (0.0)
Control 478 35 (7.3) 3 (0.6)
19 34 2 (5.9) 0 (0.0)
20 27 5 (18.5) 0 (0.0)
21 31 6 (19.4) 0 (0.0)
22 18 3 (16.7) 0 (0.0)
23 25 0 (0.0) 0 (0.0)
24 12 1 (8.3) 1 (8.3)
25 38 2 (5.3) 0 (0.0)
26 23 6 (26.1) 0 (0.0)
27 35 4 (11.4) 1 (2.9)
28 23 0 (0.0) 0 (0.0)
29 30 1 (3.3) 0 (0.0)
30 13 0 (0.0) 0 (0.0)
31 26 0 (0.0) 0 (0.0)
32 25 0 (0.0) 0 (0.0)
33 17 0 (0.0) 0 (0.0)
34 34 1 (2.9) 0 (0.0)
35 32 1 (3.1) 0 (0.0)
36 35 3 (8.6) 1 (2.9)
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TABLE 79 List of SAEs
SAE criteria Description of fall
1 Signiﬁcantly or permanently
disabling or incapacitating
Fainted while in bathroom, low BP 88/46mmHg
2 Prolonged hospitalisation Patient found on ﬂoor near bed, patient not attempting to get up, appeared
confused. Bruising to arm and face
3 Prolonged hospitalisation No description or explanation possible. X-ray showed fracture of distal clavicle
4 Prolonged hospitalisation Patient found on ﬂoor in bathroom – conﬁrmed with fractured hip. Has had
dynamic hip screw
5 Life threatening Patient was due to be discharged that day – fell while standing leaning on a table.
Fractured neck of femur – acute hospitalisation for repair and surgery. Then on 25
August 2009 was transferred to Minehead hospital for rehabilitation after surgery
BP, blood pressure.
APPENDIX 8
198Sensitivity analysesTABLE 80 Results of sensitivity analyses
Patients' primary outcome at 6 months – adjusted scores
Sensitivity
analyses
Intervention,
mean (SE), n
Control,
mean (SE), n
Difference
(SE)
95% CI
of the
difference p-value
Unadjusted Adjusted
ICC ICC
Patients that
died (NEADL=0)
24.2 (0.97) 370 25.1 (0.96) 384 –0.9 (1.30) (–3.5 to 1.8) 0.507 0.016 0.027
Proxy responses
excluded
28.2 (1.08) 315 28.6 (1.07) 326 –0.4 (1.45) (–3.4 to 2.5) 0.766 0.017 0.038
TABLE 81 Time of completion of questionnaires at 6 months (in days)
Questionnaire Intervention, mean (SD), n Control, mean (SD), n Difference (95% CI) p-value
Patients 201.6 (14.08) 303 202.8 (14.13) 338 –1.2 (–3.4 to 1.0) 0.2862
Caregivers 201.6 (14.28) 304 201.6 (13.12) 320 0 (–2.1 to 2.2) 0.9836Additional follow-up dataTABLE 82 Additional questions at 12 months: patients
Additional questions Intervention (N=450), n (%) Control (N=478), n (%) Total (N=928), n (%)
Do you think your treatment was different because of the research?
Yes 34 (7.6) 42 (8.8) 76 (8.2)
No 91 (20.2) 94 (19.7) 185 (19.9)
Not sure 145 (32.2) 154 (32.2) 299 (32.2)
Missing 180 (40.0) 188 (39.3) 368 (39.7)
If yes, how do you think the treatment you received was different?
Much better 14 (41.2) 17 (40.5) 31 (40.8)
Better 14 (41.2) 23 (54.8) 37 (48.7)
Unsure 5 (14.7) 2 (4.8) 7 (9.2)
Worse 1 (2.9) 0 (0.0) 1 (1.3)
NIHR Journals Library www.journalslibrary.nihr.ac.uk
ABLE 83 Additional questions at 6 months: caregivers
Additional questions Intervention (N=450), n (%) Control (N=478), n (%) Total (N=928), n (%)
Do you feel adequately prepared to care for your relative/friend?
Yes 229 (50.9) 251 (52.5) 480 (51.7)
No 103 (22.9) 93 (19.5) 196 (21.1)
Missing 118 (26.2) 134 (28.0) 252 (27.2)
Are you still caring for your relative/friend?
Yes 296 (65.8) 323 (67.6) 619 (66.7)
No 37 (8.2) 25 (5.2) 62 (6.7)
Missing 117 (26.0) 130 (27.2) 247 (26.6)
I have received enough information about stroke recovery and rehabilitation
Yes 255 (56.7) 255 (53.3) 510 (55.0)
No 72 (16.0) 84 (17.6) 156 (16.8)
Missing 123 (27.3) 139 (29.1) 262 (28.2)
DOI: 10.3310/hta17460 HEALTH TECHNOLOGY ASSESSMENT 2013 VOL. 17 NO. 46TTABLE 84 Additional questions at 12 months: caregivers
Additional questions Intervention (N=450), n (%) Control (N=478), n (%) Total (N=928), n (%)
Are you still caring for your relative/friend?
Yes 266 (59.1) 284 (59.4) 550 (59.3)
No 20 (4.4) 20 (4.2) 40 (4.3)
Missing 164 (36.4) 174 (36.4) 338 (36.4)
Do you think your treatment was different because of the research?
Yes 28 (6.2) 42 (8.8) 70 (7.5)
No 99 (22.0) 95 (19.9) 194 (20.9)
Not sure 152 (33.8) 168 (35.1) 320 (34.5)
Missing 171 (38.0) 173 (36.2) 344 (37.1)
If yes how do you think the treatment you received was different?
Much better 9 (32.1) 19 (45.2) 28 (40.0)
Better 12 (42.9) 18 (42.9) 30 (42.9)
Unsure 4 (14.3) 3 (7.1) 7 (10.0)
Worse 3 (10.7) 1 (2.4) 4 (5.7)
Missing 0 (0.0) 1 (2.4) 1 (1.4)
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ABLE 86 A description of changes to process of care in SRUs
Change to process of care
Centre: 11
Change Organisational restructure from combined stroke unit to acute unit with community hospital rehabilitation unit
Date January 2009
Description The stroke unit changed from a combined acute and rehabilitation unit to a primarily acute unit (short stay or
short-term rehabilitation only), with a new long-term rehabilitation unit in a separate community hospital in a
nearby town
Impact Few patients on the stroke unit were eligible for TRACS owing to the short length of stay, or transfer to another
unit rather than discharge home. The new rehabilitation unit did not meet the stroke unit eligibility criteria, so
could not be included in TRACS. MDT staff on the stroke unit continued with the LSCTC where possible, but
very few patients were eligible for the intervention. Few patients' caregivers were given any training prior to
discharge, and few patients and caregivers were eligible for TRACS recruitment
Change to organisational structure of the stroke unit, not affecting usual process of care
Centre: 33
Change Merging of a primary care trust rehabilitation unit with the acute NHS trust combined stroke unit
Date April 2008
Description A number of patients admitted to 33 began to be transferred to the second hospital for stroke rehabilitation, as
this was now a part of the same NHS trust. This reduced the numbers of eligible TRACS patients at 33, as they
were no longer meeting the eligibility criteria of returning home from the participating stroke unit. The second
stroke unit met the trial criteria and staff rotated between the two units, had the same training and shared the
same stroke care processes. The second centre was included in TRACS as a part of centre 33
Impact Recruitment was able to continue
Centre: 31
Change Loss of the acute stroke unit within the hospital
Date October 2007 (pre-recruitment)
Description The acute stroke unit at centre 31 was closed and all strokes admitted to the acute unit at the nearby centre 22.
Both units had separate rehabilitation stroke units with independent staff, who were also independent to the
acute unit. Following admission to the acute unit, patients were transferred to one of the rehabilitation units at
centre 22 or 31
Impact Organisational issues at the acute unit meant that the transfer system was not working well initially. As a
consequence recruitment did not start until June 2008; however, by the end of the study the centre did achieve
the recruitment target
Centre: 15
Change Stroke unit became a hyperacute stroke unit
Date November 2008 to January 2010
Description Centre 15 was preparing to become a hyperacute stroke unit. As a consequence the focus was more on acute
care and the average length of stay on the ward was very short at 12 days – not many stay for >7 days to be
eligible for TRACS. Centre 15 became a hyperacute ward at the end of 2009 resulting in more acute beds (10,
compared with four previously) and 19 short-term rehabilitation beds
Impact No signiﬁcant change in usual involvement of patients and carers as a consequence of this organisational
change. Staff continued to rehabilitate patients and involve carers as much as possible within the short time
frame. The change did have an impact on recruitment, making it hard to ﬁnd and recruit eligible patients owing
to the acute focus
continued
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Centre: 12
Change Stroke rehabilitation unit moved from a community hospital to an acute hospital
Date January 2009
Description The move was planned prior to randomisation into TRACS, but the timing was not yet agreed. The move took
place in January 2009 when the entire centre moved to an acute hospital. The community hospital had two
interlinked wards of 30 elderly stroke beds. The new centre comprised of one elderly rehabilitation ward of
25 beds, 17 of which were dedicated stroke beds
Impact An unforeseen effect of the potential move was a loss of permanent staff at the original site owing to the
uncertainty – a lot of the nursing team were bank staff and the physiotherapists and occupational therapists
had a high turnover. This centre was an intervention centre and the high staff turnover did affect the
implementation of the LSCTC, as training was not cascaded successfully among staff, and low staff moral
reduced compliance with the new intervention. A positive effect of the move was a more settled staff team,
treating fewer stroke beds, which improved the implementation of, and compliance with, the LSCTC
TABLE 86 A description of changes to process of care in SRUs (continued)
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DOI: 10.3310/hta17460 HEALTH TECHNOLOGY ASSESSMENT 2013 VOL. 17 NO. 46Appendix 9 Patient and caregiver resource useTABLE 87 Patient resource use at baseline (in the previous 3 months)
Resource Unit
Intervention (N=450) Control (N=478)
N users/valid n Meana SD N users/valid n Meana SD
Residential care home Night 1/439 6.00 – 3/472 19.50 2.12
Nursing home Night 1/439 – – 1/474 60.00 –
Inpatient services Bed-day 42/441 13.61 21.40 67/472 10.63 14.35
Day hospital/day cases Activity 32/440 1.19 0.47 36/469 1.06 0.23
Accident and emergency Occurrence 35/442 1.31 0.64 33/469 1.32 0.61
Outpatient services Activity 111/437 1.88 1.54 126/466 2.24 2.50
Physiotherapist, hospitalb Visit 18/424 3.93 2.43 29/450 4.78 5.19
Occupational therapist,
hospitalb
Visit 7/423 3.83 3.54 17/451 3.67 2.35
Speech and language
therapist, hospitalb
Visit 7/424 3.00 2.16 5/448 2.00 1.00
Community-based services
GP
Surgery visit Visit 225/408 2.16 1.60 251/428 2.09 1.61
Home visit Visit 42/372 1.48 0.82 38/379 1.73 1.70
Telephone call Call 44/363 1.66 1.09 40/370 1.55 0.89
Practice nurse
Surgery visit Visit 111/383 1.82 1.12 124/392 1.96 1.85
Telephone call Call 9/359 1.75 1.04 13/366 1.80 1.10
Physiotherapist
Home visit Visit 6/416 2.17 0.75 5/435 2.25 1.26
Surgery visit Visit 9/417 2.50 2.45 7/435 7.83 15.77
Elsewhere Visit 1/416 – – 2/429 3.00 –
Occupational therapist
Home visit Visit 6/417 3.00 2.76 11/439 1.11 0.33
Surgery visit Visit 1/415 1.00 – 3/434 1.00 –
Elsewhere Visit 1/417 2.00 – 2/433 – –
Speech and language therapist
Home visit Visit 2/416 1.00 – 0/435 – –
Surgery visit Visit 1/417 – – 0/434 – –
Elsewhere Visit 0/415 – – 0/433 – –
Social worker
Home visit Visit 7/421 3.60 4.72 5/441 1.75 0.96
Telephone call Call 2/420 2.00 – 7/443 2.50 2.35
continued
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TABLE 87 Patient resource use at baseline (in the previous 3 months) (continued )
Resource Unit
Intervention (N=450) Control (N=478)
N users/valid n Meana SD N users/valid n Meana SD
Repeat prescription Occurrence 235/393 2.48 1.24 294/417 2.39 1.80
Community/district nurse Contact 26/413 6.05 11.29 29/442 3.77 4.84
Health visitor Contact 1/406 1.00 – 3/430 7.00 7.07
Geriatrician Contact 2/407 1.00 – 1/428 – –
Psychiatrist Contact 2/408 1.00 – 6/429 3.00 2.16
Psychologist Contact 2/407 4.00 1.41 3/428 1.00 0.00
Chiropodist Contact 58/411 1.53 0.92 63/436 1.83 2.14
Chiropractor Contact 3/407 3.50 0.71 2/430 4.00 –
Osteopath Contact 3/406 4.00 4.24 1/428 – –
Dentist Contact 61/410 1.39 1.00 65/433 1.54 1.13
Optician Contact 62/408 1.18 0.43 79/431 1.24 0.52
Day hospital Half-day 2/421 6.00 – 8/450 2.86 2.91
Social club Half-day 15/418 9.64 8.07 15/438 7.60 6.31
Lunch club Visit 9/420 8.38 4.10 12/441 10.60 11.14
Drop-in centre Visit 2/418 12.00 0.00 6/435 12.67 7.02
Meals on wheels Meal 4/424 60.00 – 4/451 15.50 20.51
Frozen meals Meal 8/423 32.67 49.74 7/444 52.00 27.71
Home help: personal care Visit 9/424 87.00 63.64 10/445 60.20 68.19
Home help: household care Visit 8/423 15.40 4.22 10/444 16.80 10.73
Home help: shopping care Visit 4/423 8.00 – 7/443 12.00 0.00
Social services day-care
centre
Hour 1/422 – – 5/443 17.00 26.85
Intermediate care team Contact 2/420 6.00 – 0/443 – –
Other services Occurrence 16/433 3.09 4.18 14/466 1.90 0.99
Informal care from co-residents
Personal care Hour 55/427 169.67 360.58 67/458 202.71 418.65
Providing transport Hour 83/430 100.98 322.55 94/453 82.52 150.68
Preparing meals Hour 110/429 155.62 258.25 127/454 124.91 111.47
Housework/laundry Hour 110/426 110.93 260.35 113/458 98.05 112.18
DIY Hour 53/420 127.40 446.07 68/446 39.89 47.35
Gardening Hour 87/423 73.40 289.08 90/447 44.90 56.70
Shopping Hour 117/429 77.08 247.10 130/453 54.29 50.74
Outings Hour 82/428 105.81 326.87 92/447 59.66 47.53
Socialising Hour 104/427 269.72 386.63 128/451 407.34 575.97
Help managing ﬁnances Hour 99/430 64.42 274.58 104/455 37.26 33.65
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ABLE 87 Patient resource use at baseline (in the previous 3 months) (continued )
Intervention (N=450) Control (N=478)
DOI: 10.3310/hta17460 HEALTH TECHNOLOGY ASSESSMENT 2013 VOL. 17 NO. 46TResource Unit N users/valid n Meana SD N users/valid n Meana SD
Personal care Hour 20/426 28.09 27.70 22/446 55.27 53.55
Providing transport Hour 43/421 32.36 44.06 63/443 38.16 52.31
Preparing meals Hour 29/423 58.29 59.55 35/444 81.74 98.63
Housework/laundry Hour 38/423 47.53 65.11 52/443 43.00 56.16
DIY Hour 23/420 21.00 21.43 28/435 19.46 21.27
Gardening Hour 26/421 21.19 20.77 50/437 18.68 21.03
Shopping Hour 46/423 32.42 32.40 57/441 27.65 26.58
Outings Hour 45/423 35.80 50.03 57/441 41.42 38.85
Socialising Hour 53/419 113.12 196.01 69/442 139.97 342.95
Help managing ﬁnances Hour 31/422 28.94 39.35 39/443 21.83 20.26
a Mean for valid user values only.
b Separate to other outpatient visits.
TABLE 88 Patient resource use at 6 months (in the previous 6 months)
Resource Unit
Intervention (N=450) Control (N=478)
N users/valid n Meana SD N users/valid n Meana SD
Stroke admission Bed-days 448/448 44.81 32.88 478/478 42.42 29.48
Residential care home Night 10/315 27.00 16.70 19/339 16.38 13.62
Nursing home Night 7/313 117.00 96.42 7/327 14.50 96.42
Inpatient services Bed-day 56/319 12.40 21.82 65/338 8.41 10.15
Day hospital/day cases Activity 27/314 1.41 0.97 26/336 1.46 0.71
Accident and emergency Occurrence 52/311 1.68 1.14 63/338 1.39 0.59
Outpatient services Activity 178/308 2.98 3.82 158/328 3.33 4.76
Physiotherapist, hospitalb Visit 97/258 9.20 16.37 114/289 8.56 7.93
Occupational therapist,
hospitalb
Visit 30/235 3.87 3.38 50/267 8.03 11.64
Speech and language
therapist, hospitalb
Visit 33/261 2.64 2.84 32/272 4.24 3.50
Community-based services
GP
Surgery visit Visit 177/270 3.28 2.32 202/301 3.01 2.04
Home visit Visit 124/252 2.14 1.61 135/267 2.26 1.93
Telephone call Call 85/230 1.82 1.11 95/247 2.31 1.93
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TABLE 88 Patient resource use at 6 months (in the previous 6 months) (continued )
Resource Unit
Intervention (N=450) Control (N=478)
N users/valid n Meana SD N users/valid n Meana SD
Practice nurse
Surgery visit Visit 116/241 3.06 3.34 116/250 2.78 3.14
Telephone call Call 35/215 2.48 2.83 32/219 2.19 1.55
Physiotherapist
Home visit Visit 159/264 8.58 8.33 158/285 10.48 11.32
Surgery visit Visit 9/231 3.00 1.41 13/252 3.40 2.63
Elsewhere Visit 6/222 2.20 0.84 14/246 9.43 8.79
Occupational therapist
Home visit Visit 164/270 7.50 8.76 144/284 6.10 8.08
Surgery visit Visit 1/222 – – 5/246 2.75 0.50
Elsewhere Visit 5/222 1.80 1.30 10/243 3.67 2.73
Speech and language therapist
Home visit Visit 65/262 7.41 7.58 65/271 6.46 5.60
Surgery visit Visit 1/243 4.00 – 2/250 3.00 0.00
Elsewhere Visit 6/242 2.50 1.91 12/252 5.43 2.99
Social worker
Home visit Visit 65/274 2.38 1.52 70/297 2.32 1.77
Telephone call Call 31/274 3.65 2.46 49/297 2.78 1.42
Repeat prescription Occurrence 208/264 4.62 2.72 253/288 4.90 3.22
Community/district
nurse
Contact 112/261 4.56 4.47 108/277 6.20 7.30
Health visitor Contact 25/236 2.73 1.72 19/249 2.93 2.37
Geriatrician Contact 0/231 – – 5/242 1.20 0.45
Psychiatrist Contact 11/235 2.55 2.70 5/244 2.25 0.50
Psychologist Contact 13/233 2.58 1.83 15/247 2.36 1.60
Chiropodist Contact 60/242 1.98 1.27 84/274 2.00 1.28
Chiropractor Contact 3/232 3.33 1.53 1/243 2.00 –
Osteopath Contact 1/232 2.00 – 0/242 – –
Dentist Contact 58/243 2.04 1.43 79/261 1.74 0.94
Optician Contact 66/247 1.31 0.74 92/264 1.51 1.10
Day hospital Half-day 15/278 4.36 2.92 20/299 5.80 6.20
Social club Half-day 15/277 4.64 3.27 19/290 6.56 11.89
Lunch club Visit 8/277 3.14 1.07 12/291 8.80 15.60
Drop-in centre Visit 7/275 8.83 8.26 10/294 3.13 1.96
Meals on wheels Meal 5/277 7.50 6.36 10/300 16.00 19.80
Frozen meals Meal 9/278 15.00 21.66 10/296 17.00 17.97
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TABLE 88 Patient resource use at 6 months (in the previous 6 months) (continued )
Resource Unit
Intervention (N=450) Control (N=478)
N users/valid n Meana SD N users/valid n Meana SD
Home help: personal
care
Visit 71/275 87.17 134.38 70/297 80.80 116.76
Home help: household
care
Visit 18/273 14.20 15.05 20/293 8.75 6.40
Home help: shopping
care
Visit 4/271 14.50 13.44 8/292 – –
Social services day-care
centre
Hour 9/275 3.17 2.04 12/296 4.14 5.34
Intermediate care team Contact 18/259 6.44 5.03 20/282 7.10 7.93
Other services Occurrence 27/308 3.29 3.27 20/327 9.69 10.64
Informal care from co-residents
Personal care Hour 206/302 225.67 332.01 211/317 323.65 448.95
Providing transport Hour 190/286 130.18 223.37 193/304 137.68 159.34
Preparing meals Hour 224/295 286.16 292.26 237/316 305.48 212.73
Housework/laundry Hour 228/299 220.26 293.08 239/313 238.28 197.90
DIY Hour 119/272 108.26 321.30 139/300 67.13 90.35
Gardening Hour 159/284 90.90 228.14 166/304 72.52 69.04
Shopping Hour 225/300 108.16 202.37 231/315 132.95 116.38
Outings Hour 182/288 127.10 223.29 187/310 132.41 121.74
Socialising Hour 213/289 980.38 1293.44 213/307 775.17 935.81
Help managing
ﬁnances
Hour 205/296 89.61 211.78 203/312 125.49 267.22
Informal care from non-residents
Personal care Hour 52/281 83.29 168.43 59/308 133.25 143.09
Providing transport Hour 102/282 50.10 113.02 118/311 45.02 54.52
Preparing meals Hour 53/278 28.42 27.81 57/305 95.05 130.70
Housework/laundry Hour 54/279 55.05 62.17 67/305 101.29 103.46
DIY Hour 56/274 26.71 30.40 48/303 36.18 58.56
Gardening Hour 61/276 25.94 22.43 56/304 25.39 30.89
Shopping Hour 75/280 45.26 64.18 81/306 52.03 43.76
Outings Hour 96/285 47.02 68.63 86/305 66.87 82.07
Socialising Hour 113/281 104.76 137.88 110/300 122.31 141.10
Help managing
ﬁnances
Hour 43/278 29.25 20.23 53/304 62.42 93.37
a Mean for valid user values only.
b Separate to other outpatient visits.
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TABLE 89 Patient resource use at 12 months (in the previous 6 months)
Resource Unit
Intervention (N=450) Control (N=478)
N users/valid n Meana SD N users/valid n Meana SD
Residential care home Night 17/283 22.33 26.88 25/312 23.41 29.24
Nursing home Night 10/277 13.00 9.70 7/305 9.33 5.13
Inpatient services Bed-day 43/288 8.75 12.10 58/312 9.19 12.31
Day hospital/day cases Activity 31/284 1.29 0.64 28/313 1.29 0.66
Accident and emergency Occurrence 48/284 1.58 1.45 52/311 1.56 0.92
Outpatient services Activity 126/281 2.68 2.23 130/310 2.99 2.55
Physiotherapist, hospitalb Visit 61/244 8.90 8.28 58/284 8.49 6.78
Occupational therapist,
hospitalb
Visit 23/237 9.00 8.80 17/275 5.73 7.54
Speech and language therapist,
hospitalb
Visit 18/238 7.88 12.78 20/277 4.89 3.77
Community-based services
GP
Surgery visit Visit 167/246 2.96 2.26 197/276 2.67 2.32
Home visit Visit 86/227 2.25 1.62 86/237 2.20 1.87
Telephone call Call 56/202 2.13 1.59 69/232 2.71 4.03
Practice nurse
Surgery visit Visit 110/223 2.61 2.91 135/248 2.50 2.94
Telephone call Call 17/195 2.33 1.88 22/213 2.53 2.15
Physiotherapist
Home visit Visit 54/232 8.09 10.55 44/265 6.32 7.62
Surgery visit Visit 6/217 3.75 4.27 18/268 2.85 1.63
Elsewhere Visit 6/210 4.20 4.49 9/260 13.50 8.80
Occupational therapist
Home visit Visit 34/230 7.77 10.08 39/267 4.00 4.32
Surgery visit Visit 2/220 – – 9/263 2.50 1.91
Elsewhere Visit 5/218 2.75 1.50 8/259 11.00 8.55
Speech and language therapist
Home visit Visit 31/234 7.04 7.03 32/268 4.18 4.11
Surgery visit Visit 1/224 6.00 – 6/263 4.50 3.87
Elsewhere Visit 1/223 1.00 – 8/260 7.00 6.68
Social worker
Home visit Visit 21/251 1.63 0.62 34/287 1.91 1.00
Telephone call Call 10/245 2.33 1.21 24/283 2.11 1.37
Repeat prescription Occurrence 191/234 5.25 4.19 226/265 4.98 2.67
Community/district nurse Contact 67/233 5.82 8.18 82/275 5.86 9.06
Health visitor Contact 6/217 6.83 6.94 12/251 2.09 1.45
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TABLE 89 Patient resource use at 12 months (in the previous 6 months) (continued )
Resource Unit
Intervention (N=450) Control (N=478)
N users/valid n Meana SD N users/valid n Meana SD
Geriatrician Contact 1/212 – – 1/249 1.00 –
Psychiatrist Contact 6/215 1.00 0.00 9/250 1.75 1.39
Psychologist Contact 6/213 1.67 0.58 7/248 1.83 1.33
Chiropodist Contact 78/241 2.30 1.38 80/273 2.24 1.50
Chiropractor Contact 6/214 2.67 2.08 4/250 2.25 1.29
Osteopath Contact 5/212 7.75 11.50 1/247 3.00 –
Dentist Contact 84/231 1.72 1.36 73/259 1.69 1.03
Optician Contact 69/223 1.49 1.04 75/261 1.27 0.56
Day hospital Half-day 12/252 5.00 5.63 12/288 6.91 11.35
Social club Half-day 14/249 12.38 16.18 19/286 7.85 7.82
Lunch club Visit 5/243 15.60 19.65 22/285 10.38 9.79
Drop-in centre Visit 6/245 8.67 9.87 13/285 7.60 9.62
Meals on wheels Meal 5/252 3.00 – 7/292 180.00 –
Frozen meals Meal 12/253 13.50 9.98 13/286 15.57 10.69
Home help: personal care Visit 42/250 92.89 84.71 42/289 164.00 175.57
Home help: household care Visit 15/250 20.75 10.87 19/287 72.40 105.67
Home help: shopping care Visit 7/248 – – 9/284 23.67 2.52
Social services day-care
centre
Hour 12/251 12.33 11.50 9/284 58.75 94.64
Intermediate care team Contact 8/243 204.00 277.19 11/273 13.80 25.83
Other services Occurrence 14/283 3.00 3.20 18/311 2.62 2.50
Informal care from co-residents
Personal care Hour 153/263 255.63 376.21 170/285 318.51 352.46
Providing transport Hour 139/253 109.69 104.41 158/281 150.18 146.17
Preparing meals Hour 175/263 280.73 156.79 206/287 318.34 216.04
Housework/laundry Hour 170/258 207.32 159.25 200/280 184.82 153.80
DIY Hour 97/247 46.29 45.23 116/268 56.02 61.29
Gardening Hour 123/250 74.41 86.83 134/273 72.78 86.83
Shopping Hour 174/257 101.15 85.04 183/279 115.19 92.91
Outings Hour 143/251 113.41 102.39 152/277 138.42 135.28
Socialising Hour 163/251 645.96 694.37 165/282 865.98 1000.19
Help managing ﬁnances Hour 161/259 145.16 491.49 163/283 76.23 80.10
Informal care from non-residents
Personal care Hour 34/257 89.08 108.84 41/287 78.65 108.78
Providing transport Hour 73/254 49.53 47.03 86/284 40.15 51.81
Preparing meals Hour 39/255 70.13 58.81 50/286 90.95 136.70
Housework/laundry Hour 40/255 81.71 64.93 60/287 87.83 106.61
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TABLE 89 Patient resource use at 12 months (in the previous 6 months) (continued )
Resource Unit
Intervention (N=450) Control (N=478)
N users/valid n Meana SD N users/valid n Meana SD
DIY Hour 43/248 53.68 108.21 46/278 36.35 48.84
Gardening Hour 50/251 27.17 23.55 52/281 45.93 74.34
Shopping Hour 44/256 59.25 62.26 70/287 42.57 43.15
Outings Hour 63/256 38.80 48.07 79/287 42.46 60.38
Socialising Hour 77/252 123.95 149.35 90/286 114.18 168.16
Help managing ﬁnances Hour 33/252 53.50 43.64 43/287 56.15 50.91
a Mean for valid user values only.
b Separate to other outpatient visits.
TABLE 90 Caregiver resource use at baseline (in the previous 3 months)
Resource Unit
Intervention (N=450) Control (N=478)
N users/valid n Meana SD N users/valid n Meana SD
Inpatient services Bed-day 7/440 0.06 0.66 16/470 0.36 3.66
Day hospital/day cases Activity 21/438 1.15 0.37 21/469 1.19 0.51
Accident and emergency Occurrence 13/407 1.69 1.70 23/436 1.23 0.61
Outpatient services Activity 88/440 2.31 2.03 92/470 2.05 1.90
Community-based services
GP
Surgery visit Visit 199/425 1.81 1.21 228/460 1.82 1.13
Home visit Visit 12/389 1.33 1.00 10/421 1.00 0.00
Telephone call Call 25/392 1.50 0.96 33/423 1.40 0.89
Practice nurse
Surgery visit Visit 120/404 1.61 1.35 101/430 1.83 2.75
Telephone call Call 2/388 2.00 1.41 13/420 1.45 0.69
Physiotherapist
Hospital visit Visit 7/404 3.71 3.20 16/436 5.54 9.51
Home visit Visit 2/399 2.00 – 2/429 – –
Surgery visit Visit 14/402 2.57 1.95 14/431 3.67 5.23
Elsewhere Visit 0/398 – – 4/428 4.50 2.12
Repeat prescription Occurrence 214/415 2.26 1.15 229/443 2.26 1.11
Community/district nurse Contact 7/398 1.67 0.82 5/434 2.00 1.41
Health visitor Contact 2/397 1.00 – 4/430 1.50 0.71
Psychiatrist Contact 40/404 1.41 0.66 34/433 1.38 0.56
Psychologist Contact 5/397 2.00 1.41 6/431 4.67 2.31
Chiropodist Contact 7/397 3.00 2.00 6/431 4.25 5.25
Chiropractor Contact 4/396 4.00 1.41 4/430 1.00 –
Osteopath Contact 3/400 1.50 0.71 4/430 1.50 0.71
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TABLE 90 Caregiver resource use at baseline (in the previous 3 months) (continued )
Resource Unit
Intervention (N=450) Control (N=478)
N users/valid n Meana SD N users/valid n Meana SD
Informal care for patient
Personal care Hour 72/420 116.95 172.87 105/451 82.80 106.69
Providing transport Hour 141/419 58.04 98.00 158/448 57.52 71.90
Preparing meals Hour 228/426 103.89 96.37 240/455 124.19 208.76
Housework/laundry Hour 229/421 77.22 113.96 254/452 87.18 113.46
DIY Hour 88/412 34.65 79.32 101/442 30.35 44.21
Gardening Hour 159/423 32.13 63.98 158/451 33.87 35.39
Shopping Hour 233/422 44.28 59.16 264/452 44.60 49.82
Outings Hour 140/414 59.96 86.75 163/443 65.36 83.45
Socialising Hour 239/425 281.30 409.07 269/448 274.38 399.62
Help managing ﬁnances Hour 175/425 26.64 56.94 193/450 35.02 45.93
a Mean for valid user values only.
TABLE 91 Caregiver resource use at 6 months (in the previous 6 months)
Resource Unit
Intervention (N=450) Control (N=478)
N users/valid n Meana SD N users/valid n Meana SD
Residential care home Night 0/319 – – 0/333 – –
Nursing home Night 0/316 – – 0/330 – –
Inpatient services Bed-day 20/320 0.36 2.29 15/335 0.20 1.33
Day hospital/day cases Activity 16/315 1.25 0.45 16/327 1.44 0.89
Accident and emergency Occurrence 20/309 1.74 1.63 24/319 1.33 0.66
Outpatient services Activity 83/315 2.96 2.64 93/326 2.73 2.16
Community-based services
GP
Surgery visit Visit 176/290 2.85 2.11 197/318 2.58 1.80
Home visit Visit 16/238 1.77 1.69 12/261 1.27 0.47
Telephone call Call 37/242 2.09 1.13 47/271 1.95 1.05
Practice nurse
Surgery visit Visit 116/267 2.17 1.90 111/287 1.95 1.88
Telephone call Call 12/234 2.55 1.97 21/262 1.87 1.36
Physiotherapist
Hospital visit Visit 10/256 4.78 4.79 15/280 2.31 1.38
Home visit Visit 4/252 7.25 8.77 6/275 8.75 6.99
Surgery visit Visit 12/256 2.64 3.26 10/277 3.00 2.26
Elsewhere Visit 2/249 3.50 3.54 5/272 3.00 1.41
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TABLE 91 Caregiver resource use at 6 months (in the previous 6 months) (continued )
Resource Unit
Intervention (N=450) Control (N=478)
N users/valid n Meana SD N users/valid n Meana SD
Repeat prescription Occurrence 152/273 4.26 2.34 178/299 4.54 2.89
Community/district nurse Contact 15/254 4.33 3.97 17/275 3.55 2.73
Health visitor Contact 3/249 5.00 2.65 4/272 1.50 0.58
Psychiatrist Contact 33/259 2.00 1.41 44/283 2.15 1.56
Psychologist Contact 5/246 4.20 2.86 4/273 3.00 1.83
Chiropodist Contact 5/248 3.00 1.83 5/273 3.75 2.50
Chiropractor Contact 1/249 2.00 – 6/271 2.67 1.53
Osteopath Contact 2/251 3.00 0.00 3/271 2.50 2.12
Informal care for patient
Personal care Hour 238/306 221.84 331.92 243/323 370.06 600.72
Providing transport Hour 201/295 140.40 219.80 201/309 144.36 171.54
Preparing meals Hour 282/310 252.51 239.41 295/330 285.67 227.19
Housework/laundry Hour 278/310 181.51 201.93 295/325 218.40 222.58
DIY Hour 130/285 99.12 311.09 151/290 56.34 62.17
Gardening Hour 181/294 81.84 209.96 196/307 63.76 71.43
Shopping Hour 281/307 108.58 181.74 297/321 111.38 106.71
Outings Hour 205/293 113.97 204.40 214/310 123.17 131.61
Socialising Hour 271/303 740.91 984.28 262/317 679.46 1023.29
Help managing ﬁnances Hour 258/309 69.55 172.02 268/317 72.44 95.80
a Mean for valid user values only.
TABLE 92 Caregiver resource use at 12 months (in the previous 6 months)
Resource Unit
Intervention (N=450) Control (N=478)
N users/valid n Meana SD N users/valid n Meana SD
Residential care home Night 0/281 – – 2/309 – –
Nursing home stay Night 0/281 – – 0/307 – –
Inpatient services Bed-day 18/282 0.27 1.90 15/306 0.27 2.85
Day hospital/day cases Activity 15/280 1.20 0.41 27/305 1.11 0.32
Accident and emergency Occurrence 17/267 1.69 1.14 16/293 1.57 1.16
Outpatient services Activity 71/275 2.89 3.04 82/303 2.42 1.66
Community-based services
GP
Surgery visit Visit 151/263 2.20 1.58 191/290 2.47 1.61
Home visit Visit 9/216 1.89 1.05 14/236 1.43 1.09
Telephone call Call 24/218 2.14 2.48 34/234 1.75 0.84
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TABLE 92 Caregiver resource use at 12 months (in the previous 6 months) (continued )
Resource Unit
Intervention (N=450) Control (N=478)
N users/valid n Meana SD N users/valid n Meana SD
Practice nurse
Surgery visit Visit 105/239 1.79 1.31 124/263 1.95 1.55
Telephone call Call 9/214 2.13 1.89 14/228 1.69 1.18
Physiotherapist
Hospital visit Visit 13/233 5.00 3.65 14/254 3.85 3.91
Home visit Visit 2/229 3.50 0.71 1/243 1.00 –
Surgery visit Visit 3/230 4.00 4.36 7/246 2.43 1.27
Elsewhere Visit 0/229 – – 2/243 3.00 1.41
Repeat prescription Occurrence 139/238 3.89 1.93 164/264 3.96 2.08
Community/district nurse Contact 8/232 7.43 11.12 10/250 9.00 10.00
Health visitor Contact 1/230 – – 4/244 2.75 1.50
Psychiatrist Contact 32/240 2.12 1.31 35/254 2.20 1.42
Psychologist Contact 5/229 6.60 6.88 6/246 5.00 4.30
Chiropodist Contact 5/230 5.25 2.75 1/244 6.00 –
Chiropractor Contact 2/230 4.00 – 0/243 – –
Osteopath Contact 1/229 2.00 – 3/244 4.00 2.00
Informal care for patient
Personal care Hour 187/256 243.81 346.07 207/288 278.90 398.06
Providing transport Hour 173/251 107.70 106.82 188/279 150.43 148.65
Preparing meals Hour 243/265 264.64 196.99 265/296 297.91 206.24
Housework/laundry Hour 229/260 194.84 180.61 257/289 191.98 179.30
DIY Hour 129/241 47.46 69.61 136/268 46.54 48.18
Gardening Hour 155/252 69.77 86.61 182/280 77.02 136.17
Shopping Hour 233/257 106.64 96.55 259/286 150.43 251.86
Outings Hour 181/244 103.84 102.82 196/280 146.99 148.80
Socialising Hour 229/256 644.07 767.11 234/282 666.61 882.95
Help managing ﬁnances Hour 222/264 61.35 87.78 225/290 84.19 107.49
a Mean for valid user values only
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